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 iii 
 
Studies towards the total synthesis of the polypropionate macrolide agycone Erythronolide B 
have been presented. Catalytic asymmetric AAC methodology has been applied to efficiently 
generate the C10-C13 and the C4-C5 stereocenters in the polypropionate fragments 105 and 209 
through β-lactones 76, 80, and 86 respectively. An efficient installation of the C2 and C3-
stereocenters in 193 was realized through a Lewis-base catalyzed Mukaiyama aldol reaction. 
Finally, a highly stereoselective aldol coupling of fragments 105 and 209 was used to join the 
fragments together. 
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1.0  INTRODUCTION 
1.1 POLYPROPIONATE NATURAL PRODUCTS 
Polyketide-derived natural products represent a large class of biologically active compounds that 
have found many applications. The polyketides possess very diverse structures which can be 
divided into subgroups: fatty acids, polypropionates and aromatic polyketides. Polypropionates 
can be further classified into three groups: polyether antibiotics, macrolides and spiroketals 
(Figure 1). Some of the most biologically active compounds are the polypropionates and as a 
result, their study has been a very active area of research. 
 
Polyketides
PolypropionatesFatty acids Aromatic polyketides
Macrolides
Polyether antibioticsSpiroketals
 
Figure 1. Classification of polyketides. 
 2 
1.2 THE ERYTHROMYCINS 
1.2.1 Occurrence, Biological Activity and Biosynthesis  
Erythromycins A (1) and B (2) are the best known members of the clinically important family of 
the 14-membered macrolide polyketides which are produced by a strain of the fungus 
Saccharopolyspera erythraeus formerly known as Streptomyces erythraeus.1 The aglycones of 
erythromycins A and B are called erythronolides A and B (3), respectively. The erythromycins 
were first isolated and discovered in 1952 from soil samples containing the fungus strain. The 
erythromycins are used for the treatment of infectious diseases caused by gram-positive 
bacteria.1 The potent antibiotic activity of erythromycins is due to their efficient inhibition of 
ribosomal-dependent protein biosynthesis in gram positive bacteria.1
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The biosynthetic pathway of erythromycins was proposed by Martin et al.2
                                                 
1 (a) McGuire, J. M.; Bunch, R. L.; Anderson, R. C.; Boaz, H. E.; Flynn, E. H.; Powell, H. M.;Smith, J. W. Antibiot. 
Chemother. (Washington, D. C.) 1952, 2, 281 (b) Macrolide Antibiotics; Omura, S., Ed.; Academic Press: Orlando, 
FL, 1984. 
 Like other 
polyketides, they are synthesised in Streptomyces and related bacteria by the repetitive and 
2 Martin, J. R.; Rosenbrook, W. Biochemistry 1967, 6, 435-440.  
 3 
stepwise condensation of acyl thioesters.3
                                                                                                                                                             
 
 The biosynthesis is initiated by a group of chain-
forming enzymes known as polyketide synthases (PKS) that sequentially adds units to a growing 
chain of a polyketide.  In the first phase of erythromycin biosynthesis, 6-deoxyerythronolide B 
(4) is biosynthesized in an iterative fashion, from one molecule of propionyl CoA 5 and six 
molecules of methylmalonyl CoA 6 (Scheme 1). The PKS possesses six modules and each 
module contains the three domains required to catalyze one cycle of chain extension 
[ketosynthase (KS), acyltransferase (AT) and acyl carrier protein  ACP)] as well as a variable set 
of domains [ketoreductase (KR), dehydratase (DH) and enoyl reductase (ER)] associated with 
keto group modification (depicted as a loop above the line of essential domains). DEBS 1 is 
preceded by a loading domain (AT and ACP) which accepts the starter unit propionate from 
propionyl-CoA, while DEBS 3 terminates with a thioesterase (TE) activity which is thought to 
catalyse the off-loading and cyclization of the fully-formed heptaketide intermediate to give 6-
deoxyerythronolide B (4). Throughout the entire biosynthetic sequence, the polyketide chains 
remain bound to the PKS. The three essential domains, KS, AT and ACP, co-operate to catalyze 
carbon–carbon bond formation by Claisen condensation, which results in  a β-keto ester 
intermediate. The variable set of domains between the AT and ACP then carry out reductive 
modification of the keto group before the next round of chain extension. Module 3 has no 
reductive domains and so the keto group (at C9) survives intact. In contrast, modules 1, 2, 5 and 6 
each contain a KR domain, which catalyze reduction of the keto group to a hydroxy group (the 
3 Staunton, J.; Weissman, K. J. Nat. Prod. Rep. 2001, 18, 380-416. 
 
 
 4 
hydroxyl groups at C13, C11, C5 and C3 respectively). In module 4, there is a full set of reductive 
domains (DH, ER and KR) and so complete reduction occurs to produce a methylene (at C7).  
 
Scheme 1: Synthesis of 6-Deoxyerythronolide B 
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 The first step of chain elongation in the catalytic cycle involves decarboxylative 
condensation of ACP bound methyl malonic acid 7 with KS bound propionate 8 (Figure 2). 
Subsequent acyl transfer of the newly formed ACP bound polypropionate (9→ 10 + 11) and 
preparation of the second ACP bound methyl malonic acid (11 + 6→7) sets the stage for a 
second iteration in as few as two steps. Reiteration of this process with the growing KS bound 
polypropionates 10 and intervening functional group manipulations produces 6-
deoxyerythronolide B in only 6 carbon-carbon bond forming reactions. 6-Deoxyerythronolide B 
is the first and common enzyme-free intermediate for all members of the erythromycin family 
(erythromycins A-F). In the second phase of erythromycin biosynthesis, as shown in Figure 3, 6-
deoxyerythronolide B is elaborated by several post-PKS steps (such as introduction of the sugar 
units, O-methylation and C12-hydroxylation), finally yielding the active erythromycin antibiotics. 
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Figure 2. The catalytic cycle of chain elongation 
 
 6 
This mechanism of iterative chain extension is the same for the biosynthesis of all 
aliphatic polyketides including the macrocyclic polyketides of the erythromycin family. The 
huge structural diversity found among natural polyketides arises from the selection of acetate or 
propionate as "starter" or "extender" units and from the differing ways of processing of the β-
keto group observed after each condensation. The stereochemical outcome of these processing 
steps is also specified for each cycle of chain extension. 
 
 7 
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Figure 3. Second phase in the biosynthetic pathway of erythromycins 
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1.2.2 Previous Syntheses of Erythronolide B 
The combination of therapeutic value and the densely functionalized complex architecture of 
their backbone have made the erythromycins an attractive target for synthesis and a popular 
platform for the invention and testing of numerous methodologies for polypropionate synthesis. 
Over the last few decades, many syntheses have been reported for the erythromycins themselves 
as well as a number of their aglycon derivatives including erythronolide A4 and B (3)5, 6-
deoxyerythronolide B (4)6, and (9S)-dihydroerythronolide A.7
So far, three total syntheses of erythronolide B have been reported, the first of which was 
completed by Corey in 1978.5a Later, Kochetkov (1987)5b and Mulzer (1991)5c also completed 
the synthesis of erythronolide B. All of the above syntheses were convergent and relied on C-C 
bond forming reaction between the two halves in the key step. Corey utilized the cis-fused 
bicycle 13 for the synthesis of the intermediate 14. The three stereocenters at C2, C4 and C5 of 14 
were set by three consecutive iodolactonizations of enone 12 (Scheme 2). Selective 
 However, despite the numerous 
synthetic approaches used for the synthesis of these complex polypropionates, very few have 
been applied in an iterative fashion that attempts to mimic the elegant approach displayed in 
Nature.  
                                                 
4 (a) Corey, E. J.; Hopkins, P. B.; Kim, S.; Yoo, S.; Nambiar, K. B.; Falck, J. R. J. Am. Chem. Soc. 1979, 101, 131. 
(b) Kochetkov, N. K.; Sviridov, A. F.; Ermolenko, M. S.; Yashunsky, D. V.; Borodkin, V. S. Tetrahedron 1989, 45, 
5109. (c) Muri, D.; Lohse-Fraefel, N.; Carreira, E. M. Angew. Chem., Int. Ed. 2005, 44, 4036-4038. 
5 (a) Corey, E. J.; Trybulski, E. J.; Melvin, L. S.; Nicolaou, K. C.; Secrest, J. R.; Lett, R.; Sheldrake, P. W.; Falck, J. 
R.; Brunelle, D. J.;Haslanger, M. F.; Kim, S.; Yoo, S. J. Am. Chem. Soc. 1978, 100, 4618-4620. (b) Kochetkov, N. 
K.; Sviridov, A. F.; Ermolenko, M. S.; Yashunsky, D. V.; Borodkin, V. S. Tetrahedron Lett. 1987, 28, 3835-3839. 
(c) Mulzer, J.; Kirstein, H. M.; Buschmann, J.; Lehmann, C.;Luger, P. J. Am. Chem. Soc. 1991, 113, 910-923. (d) 
Martin, S. F.; Lee, W-C.; Pacofsky, G. J.; Gist, R. P.; Mulhern, T. A. J. Am. Chem. Soc. 1994, 116, 4674–4688. 
6 (a)  Masamune, S.; Hirama, M.; Mori, S.; Ali, Sk. A.; Garvey, D. S.  J. Am. Chem. Soc. 1981, 103. 1568. (b) 
Evans, D. A.; Kim, A. S.; Metternich, R.; Novack, V. J. J. Am. Chem. Soc. 1998, 120, 5921-5942. (c) Crimmins, M. 
T.; Slade, D. J. Org. Lett. 2006, 8, 2191-2194. 
7 (a) Paterson, I.; Rawson, D. J. Tetrahedron Lett. 1989, 30, 7463-7466 (b) Peng, Z,-H.; Woerpel, K. A. J. Am. 
Chem. Soc. 2003, 125, 6018-6019. 
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hydrogenation of the carbonyl in 13 provided the alcohol at C3. The desired C8 center in 14 was 
installed by methylation which provided the thermodynamically more stable product. Bayer-
Villiger oxidation of 14 inserted a hydroxyl group at C6 of the C1-C9 intermediate (18) with 
retention of stereochemistry. The C10 to C15 fragment (19) was prepared by regioselective 
opening of epoxide 15 followed by hydrozirconation of a derivative of 16 to provide the vinyl 
bromide 17. Corey coupled his fragments at the C9-C10 bond by adding the optically active 
Grignard reagent 19 to the racemic thioester 18 derived from 17 and 14 respectively (eq 1). The 
resulting mixture of two diastereomers was separated and only one of them, diastereomer 20, 
was carried forward.  
 
Scheme 2: Corey’s synthesis of fragments 
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 Kochetkov applied the addition of sulfoxide 21/22 to ketone 23 to form the tertiary 
alcohol center at C6 in 24 (eq 2). Of the two sulfoxide diastereomers only 21 (the minor 
diastereomer) was reactive and 22 (the major diastereomer) had to be epimerized and recycled. 
As shown in Scheme 3, the C1-C6 and C7-C15 segments 23 and 21/22, respectively were both 
synthesized from a common carbohydrate, levoglucosan (1, 6-anhydro-β-D-glucose) 25. The 
bicyclic nature of levoglucosan was exploited to introduce the methyl groups at C2 and C10 with 
high regio and stereooselectivity. However introduction of the other methyl group at C4 via a 
Barton deoxygenation of the corresponding tert-alcohol was not selective and gave a 1:1 mixture 
of diastereomers 26 and 28. After separation, each acetal was converted into the open chain 
dithiane derivatives 27 and 29 respectively. The epimerization at C5 of 27 and elaboration of 29 
to a mixture of sulfoxide diastereomers 21 and 22 in a ratio of 22:74 completed the synthesis of 
the two key fragments. 
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Scheme 3. Kochetkov’s synthesis of key fragments 
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 In Martin’s synthesis5d of the C1-C10 fragment of the erythronolide B seco-acid, the furan 
30 prepared by an Evans aldol condensation was treated with bromine in aqueous acetonitrile to 
provide an intermediate that underwent acid-catalyzed cyclization to the ketal 31 (Scheme 4). 
The two methyl groups at C8 and C6 were added to 31 from the less hindered face of the bicycle 
to afford 32 which was then opened up to its acyclic form and subjected to a Lewis acid 
catalyzed crotylation reaction to introduce the C2 and C3 centers, finally providing the key ketone 
fragment 33 in 4:1 diastereoselectivity. The seco acid was formed in an aldol coupling reaction 
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of 33 with an aldehyde constituting the C11-C14 segment (which was prepared by an Evans aldol 
reaction with propionaldehyde).  
 
Scheme 4: Martin’s synthesis of C1-C10 fragment of the erythronolide B seco-acid 
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 In Mulzer’s synthesis5c the molecule was disconnected at the C6-C7 bond and involved 
the addition of the conjugated anion of 34 to the ketone 35 (eq 3). The fragments were prepared 
from a common chiral building block 37 via the stereotriads 38 and 39 in which the C11/C12 and 
C2/C3 centers were set by stereo and regioselective opening of an epoxide derived from 37 
(Scheme 5). Conversion to aldehyde followed by stereoselective addition of Grignard reagents 
installed the desired C13 and C5 chiral centers in 40 and 41 respectively.  A trans-selective Wittig 
resulted in sulfide fragment 34, which was coupled with the C1-C6 ketone fragment 35. The C8 
and C9 centers in the aglycone seco-acid 36 were later set via hydroboration oxidation. 
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Scheme 5: Mulzer’s synthesis of fragments 
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Woodward’s landmark synthesis of erythronolide A illustrated some of the inherent 
problems associated with macrocyclization strategies for this family of macrolides and 
demonstrated that the conformational flexibility of the seco-acid backbone should be reduced in 
order to achieve successful lactonization.8
                                                 
8 Woodward, R. B.; Logusch, E.; Nambiar, K. B.; Sakan, K.; Ward, D. E.; Au-Yeung, D. W.; Balaram, P.; Browne, 
L. J.; Card, P. J.; Chen, C. H.; Chênvert, R. B.; Fliri, A.; Frobel, K.; Gais, H. J.; Garrat, D. G.; Hayakawa, K.; 
Heggie, W.; Hesson, D. P.; Hoppe, D.; Hoppe, I.; Hyatt, J. A.; Ikeda, D.; Jacobi, P. A.; Kim, K. S.; Kobuke, Y.; 
Kojima, K.; Krowicki, K.; Lee, V. J.; Leutert, T.; Malchenko, S.; Martens, J.; Matthews, R. S.; Ong, B. S.; Press, J. 
B.; Rajan Babu, T. V.; Rousseau, G.;Sauter, H. M.; Suzuki, M.; Tatsuta, K.; Tolbert, L. M.; Truesdale, E. A.; J. Am. 
Chem. Soc. 1981, 103,  3213-3215. 
 In his pioneering studies he identified a number of 
structural features that must be incorporated in the seco-acid precursor for successful 
lactonization; (1) S configuration at C9 and (2) dioxolane protecting groups at C3/C5 and C9/C11-
hydroxyl groups are required for efficient lactonization. Only the seco-acid intermediate 42 
possessing a (9S)-configuration and containing two dioxolane protecting groups masking C3/C5-
OHs and C9/C11-OHs successfully underwent macrocyclization to give 43 in 70% yield. Various 
other lactonization precursors 44, 45 and 46 either possessing the epimeric (R)-configuration at 
C9, or lacking the dioxolane protecting groups failed to undergo macrocyclization (Figure 4). 
Accordingly, the most common strategy for rigidification has been the incorporation of six-
membered cyclic acetal groups on the C3/C5 hydroxyls as well as on the C9/C11 hydroxyls.4c, 5b, 6b, 
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7b Another method of rigidification that has been used is the insertion of double bonds in the 
framework as in Mulzer’s synthesis.5c 
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Figure 4. Macrolactonization studies by Woodward 
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1.3 SYNTHESIS OF POLYPROPIONATE UNITS  
Due to their fascinating biological activities and low natural abundance, the total synthesis of 
polyketides has been of immense importance to the synthetic community. Nevertheless, it is the 
complexity of their molecular architecture that has attracted organic chemists the most and no 
doubt, polyketides have become one of the most extensively investigated groups of natural 
products. Polypropionate natural products are characterized by structure with alternating methyl 
groups and oxygen functionalities (alcohol, ketone and/or carboxyl) along a contiguous carbon 
chain (Figure 5). Among the approximately 5000-10000 known polypropionates, only 1% 
possess biological activity. Despite this rather low value, it surprisingly represents five times the 
average for natural products.9
 
 
OH
R R R O
MeMeMeMe
n
***
* = stereogenic center
R = O, OH/H, H/H
n = 0, 1, 2, ....integer
 
Figure 5. General structure of polypropionate natural products 
 
 During the past three decades, synthetic chemists have made significant contributions to 
the development and advancement of asymmetric synthetic methodologies.10
                                                 
9 Koskinen, A. M. P.; Karisalmi, K. Chem. Soc. Rev. 2005, 34, 677-690. 
 The inherent 
challenge for the synthesis of polypropionates derives from the long sequence of stereocenters. 
For example, a dipropionate can have up to four different stereoisomers, a tripropionate (16), a 
10 Paterson, I.; Cowden, C. J.; Wallace, D. J. In Modern Carbonyl Chemistry; Otera, J., Ed.; Wiley-VCH: Weinheim, 
2000; pp 249-297. (b) Hoffmann, R. W. Angew. Chem. Int., Ed. Engl. 1987, 26, 489-503. 
 16 
tetrapropionate (64), a pentapropionate (256), a hexapropionate (1024) and a heptapropionate 
(4096) (Figure 6). While the alternating incorporation of acetate or propionate in their 
biosynthesis has been paralleled by aldol or aldol-type reactions in the syntheses of these 
compounds, the formation of the different and specific stereochemical arrays of these subunits at 
will, still poses a significant challenge for the synthetic chemist. 
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Figure 6. Possible number of stereoisomers for polypropionates 
 
 In polyketides, the stereotetrad is a common substructure which consists of four 
stereogenic centers, next to each other, resulting in eight possible diastereomeric combinations: 
anti, anti, anti (47a); anti, anti, syn (47b); anti, syn, anti (47c); syn, anti, anti (47d); syn, syn, 
anti (47e); syn, anti, syn (47f); anti, syn, syn (47g) and syn, syn, syn (47h) (Figure 7). The 
coupling of chiral stereotetrad fragments in a stereocontrolled fashion allows the construction of 
more elaborate polypropionate structures. However, this union can be complicated by double 
stereodifferentation and introduces a major obstacle to be overcome in any total synthesis. As a 
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result, numerous reactions have been developed for the synthesis of polypropionate structures. 
For example, aldol,11 crotylation,12 Diels-Alder,13 Wittig,14 alkylation,15 and allylstannation16
 
 
reactions are only a few of the numerous methods that have been applied for the synthesis of 
polypropionates. Despite the plethora of approaches available, the asymmetric synthesis of 
polypropionate compounds continues to be a synthetic challenge because very few methods can 
be generally applied for the iterative preparation of the numerous polypropionate motifs found in 
various natural products. 
                                                 
11 (a) Yeung, K.–S.; Paterson, I. Chem. Rev. 2005, 105, 4237-4313. (b) Schetter, B.; Mahrwald, R. Angew. Chem., 
Int. Ed. 2006, 45, 7506-7525. 
12 (a) Hoffmann, K. W.; Dresely, S.; Hildebrandt, B. Chem. Ber. 1988, 121, 2225-2230. (b) Brown, H. C.; Bhat, K. 
S. J. Am. Chem. Soc. 1986, 108, 5919-5923. (c) Roush, W. R.; Walts, A. E.; Hoong, L. K. J. Am. Chem. Soc. 1985, 
107, 8186-8190. (d) Roush, W. R.; Ando, K.; Powers, D. B.; Palkowitz, A. D.; Halterman, R. L. J. Am. Chem. Soc. 
1990, 112, 6339-6348. 
13 (a) Myles, D. C.; Danishefsky, S. J. J. Org. Chem. 1990, 55, 1636-1648. (b) Arjona, O.; Menchaca, R.; Plumet, J. 
J. Org. Chem. 2001, 66, 2400-2413. (c) Vogel, P.; Sevin, A.-F.; Kernen, P.; Bialecki, M. Pure & Appl. Chem. 1996, 
68, 719-722. 
14 Hanessian, S.; Wang, W.; Gai, Y.; Eric, O. J. Am. Chem. Soc. 1997, 119, 10034-10041. 
15 (a) Oppolzer, W.; Moretti, R.; Thomi, S. Tetrahedron Lett. 1989, 30, 5603-5606. (b) Evans, D. A.; Ennis, M. D.; 
Mathre, D. J. J. Am. Chem. Soc. 1982, 104, 1737-1739. (c) Mulzer, J.; Schollhorn, B. Angew. Chem., Int. Ed. 1990, 
29, 1476-1478. 
16 Marshall, J. A. Chem. Rev. 1996, 96, 31-47. 
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Figure 7. Stereotetrads 
  
1.3.1  Iterative Strategies for Polypropionate Synthesis 
Many of the iterative strategies for polypropionate synthesis developed to date involve the 
reaction of chiral (non-racemic) or achiral aldehydes with chiral (non-racemic) or achiral 
reagents generating one to two new stereocenters for each step. For an iterative strategy, the 
aldehyde must be prepared from the product resulting from the preceding chain elongating step 
(Scheme 6). There are two major obstacles for an iterative strategy: 1) the number of synthetic 
manipulations required for re-introduction of aldehyde and, 2) the enantio- and 
diastereoselectivities of the chain elongation steps. In Nature, as few as two steps are performed 
for each iteration and the enantio- and diastereoselectivities are controlled by enzymes. As was 
discussed earlier (Figure 6), the number of possible stereoisomers increases exponentially with 
 19 
the number of stereogenic centers. Often, the major challenge faced by synthetic chemists 
involves establishing the desired configurations of the polypropionate compound. Over the past 
three decades, several iterative strategies for polypropionate synthesis have emerged and have 
found various applications for the synthesis of polypropionate compounds. The following 
examples are presented to provide a representation of iterative approaches. All of the examples 
have shown the capacity to control the stereochemical outcome of different reactions by 
exploiting substrate- and/or reagent-control. 
  
Scheme 6. An iterative strategy 
+ reagent
OH
R
FG
chain 
elongation
aldehyde
re-introduction
OH
R
O
H
repeat
R-CHO
 
 
 In 1990, Danishefsky and co-workers disclosed a Lewis acid catalyzed diene aldehyde 
cyclocondensation (LACDAC) reaction that was applied in an iterative fashion for the synthesis 
of racemic 6-deoxyerythronolide B (Figure 8).13a The strategy exploited substrate-controlled 
Diels-Alder reactions of diene 48 with various aldehydes in the presence of different Lewis acids 
(e.g. ZnCl2 or BF3⋅OEt2) to produce dihydropyrones. Processing the dihydropyrones into their 
corresponding aldehydes (6 steps) permitted iteration of the sequence. Although the approach 
was iterative, a major limitation was the 6 steps (ca. 35-41% yields) required before the next 
iteration.  
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Figure 8. Iterative Lewis acid catalyzed Diene aldehyde cyclocondensation sequence for the synthesis of 6-
deoxyerythronolide B 
 
In a related synthesis, Roush and co-workers presented an impressive asymmetric 
synthesis of the C19-C29 polyketide segment 49 of Rifamycin S (Figure 9).17 The strategy 
employed four reagent-controlled crotylboration/allylboration reactions utilizing chiral tartarate 
ester-derived crotyl/allyl boronates 50, 51 and 52 with chiral aldehydes, where after the first 
iteration, only 2 steps were required to prepare the aldehyde for iterative chain elongation. 
Similar strategies developed by Panek18 and Marshall19
                                                 
17  Roush, W. R.; Palkowitz , A. D.  J. Am. Chem. Soc. 1987, 109, 953-955.  
 employing chiral crotylsilanes and chiral 
allenylmetal reagents were used in the syntheses of polypropionates oleandolide and 
discodermolide, respectively. 
18 Jain, N. F.; Takenaka, N.; Panek, J. S. J. Am. Chem. Soc. 1996, 118, 12475-12475. For a recent example of this 
strategy in total synthesis, see: Hu, T.; Takenaka, N.; Panek, J. S. J. Am. Chem. Soc. 1999, 121, 9229-9230. 
19 Marshall, J. A.; Perkins, J. F.; Wolf, M. A. J. Org. Chem. 1995, 60, 5556-5559. For a recent example of this 
strategy in total synthesis, see: Marshall, J. A.; Johns, B. A. J. Org. Chem. 1998, 63, 7885-7892. 
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Figure 9. Iterative crotyboration (Roush). 
 
Hanessian and co-workers utilized a Wittig methodology for building the same segment 
of Rifamycin S. The approach involved substrate-controlled methyl cuprate additions to 
protected chiral γ-alkoxy-α,β-unsaturated esters followed by a Davis α-hydroxylation to 
complete the installation of a propionate fragment (Figure 10).20
                                                 
20 Hanessian, S.; Wang, W.; Gai, Y.; Eric, O. J. Am. Chem. Soc. 1997, 119, 10034-10041. 
 Iteration was achieved by a 
three step sequence that provided the next aldehyde to be used for chain elongation. Unlike the 
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previous examples, this approach sequentially installed the desired stereocenters after chain 
elongation. 
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Figure 10. Iterative Wittig methodology 
 
Although Diels-Alder, crotylation, Wittig reactions and many others have impacted the 
synthesis of polypropionates to a large extent, the aldol reaction presents the most important and 
general method for the stereocontrolled formation of polypropionates by directly mimicking the 
biosynthetic pathway. Under the iterative aldol-based strategies Paterson’s chiral ketone 
methodology and the auxiliary based approaches are the most popular. 
Paterson reported a boron-mediated aldol reaction strategy for the synthesis of 
polypropionate compounds. The strategy exploited substrate-controlled aldol reactions of 
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preformed chiral (E)-enol borinate (R)-53 [or (S)-53] with various aldehydes.21
 
 The sequence 
was made iterable by a 4 step protocol that provided the desired aldehydes for subsequent 
iterations.  The idea for this methodology was based on the polyketide biosynthesis where each 
chain extension unit introduced was correctly functionalized prior to the addition of the next. 
Aldol reaction of propionaldehyde and (R)-53 provided the anti aldol adduct from which the 
aldehyde 54 was afforded in 4 steps. Repetition of this procedure followed by hydrolysis 
afforded 55 (97% ds) and 56 (97% ds). Thus, the introduction of twelve contiguous stereocenters 
in an eleven step protocol was accomplished in 41% yield with >88% diastereoselectivity.  
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Figure 11. Iterative aldol condensation with Paterson’s chiral ketone (R)-12 
 
                                                 
21 (a) Paterson, I.; Scott, J. P. Tetrahedron Lett. 1997, 38, 7445-7448. (b) Paterson, I.; Scott, J. P. Tetrahedron Lett. 
1997, 38, 7441-7444. (c) Gennari, C.; Ceccarelli, S.; Piarulli, U.; Aboutayab, K.; Donghi, M.; Paterson, I. 
Tetrahedron 1998, 54, 14999-15016. 
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 Frequently, auxiliary-controlled aldol reactions have proven to be a reliable method to 
install repeating polypropionate units (Scheme 7). While additional steps in a synthetic sequence 
are needed for the installation and removal of the chiral auxiliary, this drawback is outweighed 
by the benefit gained from the high diastereoselective reliability of these auxiliary-based aldol 
 
Scheme 7: Auxiliary-mediated aldol reactions 
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reactions. Evans22 and Crimmins23
 
 have both used their respective chiral auxiliaries for the 
formal synthesis of 6-deoxyerythronolide B. While Evans’ synthesis was based on a more 
convergent approach, Crimmins utilized a linear approach where the sequence was iterated five 
times during a 23 step synthesis. This was an excellent example where a chiral auxiliary was 
used for an iterative approach to a polypropionate natural product (Figure 12). 
  
  
                                                 
22 Evans, D. A.; Kim, A. S.; Metternich, R.; Novack, V. J. J. Am. Chem. Soc. 1998, 120, 5921-5942. 
23 Crimmins, M. T.; Slade, D. J. Org. Lett. 2006, 8, 2191-2194. 
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Figure 12. Iterative auxiliary based aldol sequence in Crimmins’ synthesis of 6-deoxyerythronolide B 
  
 Although the aforementioned approaches presented very interesting and unique features 
that were exploited for the synthesis of various polypropionate compounds, many strategies 
required access to expensive chiral starting materials and/or reagents. As a result, there is a 
continuous demand for effective protocols that are both highly efficient and cost-effective with 
controllable access to chiral polypropionate compounds. The catalytic aldol reaction has always 
been the goal of many researchers, including our group.  Even though many catalytic asymmetric 
aldol reactions have been successfully developed to form a single propionate unit,24
1.3.2 The Cinchona Alkaloid-Catalyzed AAC Reaction for the Efficient Formation of 
Polypropionate Units 
 too few 
examples have been used to set repeating networks of acetate or propionates.  
In 2004, our research group developed an alternative method for the production of propionate 
units by employing substoichiometric amounts of cinchona alkaloids in the acyl halide-aldehyde 
                                                 
24 (a) Mukaiyama, T.; Kobayashi, S.; Uchiro, H.; Shiina, I. Chem. Lett. 1990, 19, 129-132. (b) Kobayashi, S.; 
Mukaiyama, T. In Stereocontrolled Organic Synthesis, Trost, B. M., Ed; Blackwell, Cambridge, 1994, pp. 37–65. 
(c) Shibasaki, M.; Kanai, M.; Funabashi, K. Chem. Commun. 2002, 1989-1999 and references therein. (d) Notz, W.; 
Tanaka, F.; Barbas III, C. F. Acc. Chem. Res. 2004, 37, 580-591. (e) Northrup, A. B.; Macmillan, D. W. C. J. Am. 
Chem. Soc. 2002, 124, 6798-6799. 
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cyclocondensation (AAC) reaction (Figure 13).25
 
  The transformation of the enantioriched β-
lactone product of the reaction to aldehyde allows the iterative use of the reaction for 
polypropionate synthesis. 
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Figure 13. Iterative application of AAC reaction. 
  
 In 1982, Wynberg reported the formation of β-lactones via nucleophilic catalysis by 
alkaloid bases. β-Lactone 57 was obtained in excellent yield and optical purity by the [2+2] 
cycloaddition of ketene (58) with chloral (59) promoted by 1-2 mol% quinidine (eq 4).26 This 
was the first time that an asymmetric and catalytic synthesis of optically pure β-lactones was 
demonstrated. Either enantiomer of the lactone could be obtained by the judicious choice of the 
alkaloid catalyst-quinidine (60) or quinine (61). The reaction was thought to proceed via an 
aldol-lactonization pathway involving an acyl-ammonium enolate intermediate 62 (Figure 14). 
Later, Wynberg investigated other carbonyl compounds but found that only highly activated 
aldehydes or ketenes participate in this reaction, severely limiting the scope of the 
methodology.27
 
  
                                                 
25 Zhu, C.; Shen, X.; Nelson, S. G. J. Am. Chem. Soc. 2004, 126, 5352-5353. 
26 Wynberg, H.; Staring, E. G. J. J. Am.Chem. Soc. 1982, 104, 166-168. 
27 Wynberg, H.; Staring, E. G. J. J. Org. Chem. 1985, 50, 1977-1979.  
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Figure 14. Mechanism proposed by Wynberg. 
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Subsequent developments of Wynberg’s ketene-chloral addition led to reports of 
asymmetric alkaloid-catalyzed ketene-amine cycloadditions (Leckta),28 ketene dimerizations 
(Calter)29 and intramolecular ketene-aldehyde cycloadditions (Romo).30
 
 But intermolecular cross 
aldol type cycloadditions were limited to only highly activated aldehydes, suggesting that the 
acylammonium enolate intermediate 62 had limited nucleophilicity. In 2004, our research group 
developed the chiral cinchona alkaloid catalyzed acyl halide-aldehyde cyclocondensation (AAC) 
reaction (Scheme 8)24 where both a Lewis acid and a Lewis base were incorporated within the 
reaction manifold, providing a dually activated system. While Lewis base catalysis (as with the 
Wynberg system) allowed for formation of a specific enantiomer of the optically active 2-
oxetanone, the Lewis acid provided aldehyde activation, successfully extending the scope of the 
Wynberg ketene-aldehyde cycloaddition. 
                                                 
28 (a) Taggi, A. E.; Hafez, A. M.; Wack, H.; Young, B.; Drury, W. J., III; Lectka, T. J. Am. Chem. Soc. 2000, 122, 
7831-7832. (b) Taggi, A. E.; Hafez, A. M.; Wack, H.; Young, B.; Ferraris, D.; Lectka, T. J. Am. Chem. Soc. 2002, 
124, 6626-6635. 
29 Calter, M. A. J. Org. Chem. 1996, 61, 8006-8007. 
30 Cortez, G. S.; Tennyson, C. L.; Romo, D. J. Am. Chem. Soc. 2001, 123, 7945-7946. 
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Scheme 8. Acyl halide-aldehyde cyclocondensation reaction 
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The mechanism postulated for the transformation is shown in Figure 15.24 In this Lewis-
base catalyzed AAC reaction, propionyl chloride undergoes a dehydrohalogenation reaction in 
the presence of Hünig’s base to generate methyl ketene in situ.  Methyl ketene is then intercepted 
by a catalytic amount of either TMS-quinine or the pseudoenantiomeric TMS-quinidine to 
produce exclusively a chiral (Z)-enolate.  Subsequently, this chiral nucleophile reacts with an 
aldehyde via Zimmerman-Traxler chair transition state to yield a syn-disubstituted β-lactone 
product in good yield and in essentially enantio- and diastereomerically pure form. Thus, in 
addition to activating the aldehyde, the metallic Lewis acid also serves the dual role of stabilzing 
the ammonium-enolate 63 to afford the metalloenolate 64. The metalloenolate then, adds to the 
aldehyde via a 6-membered closed transition state 65, which is reminiscent of traditional aldol 
reactions. The cyclization of the resulting ammonium aldolate then produces the β-lactone, 
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releasing both the alkaloid and Lewis acid catalysts, completing the reaction cycle. 
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Figure 15. Postulated mechanism for the alkaloid catalyzed AAC reactions 
 
 Due to the highly efficient nature of this transformation, our research group began 
exploring the further potentials of this cinchona alkaloid-catalyzed AAC reaction.  More 
specifically, we became interested in the effect double diastereoselection would have on the 
AAC reaction when α- and/or β-substituted enantioenriched aldehydes were used (Figure 16).  If 
the cinchona alkaloid-catalyzed AAC reaction were amenable to these more elaborate aldehydes 
it would provide us with an avenue to form polypropionate units in an efficient and iterative 
fashion. 
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Figure 16. Formation of polypropionate units via cinchona alkaloid-catalyzed AAC 
 
 31 
 Cyclocondensation reactions with chiral aldehydes were thus investigated and the 
diastereoselectivities were interpreted using the well-known models that accurately predict and 
rationalize the stereochemical outcome of analogous aldol additions. The syn, anti, syn lactone 
66 was formed from aldehyde 67 in the O-trimethylsilylquinidine (TMSQd) (68a) catalyzed 
AAC whereas the quinine-derived catalyst 69b yielded the anti, anti, syn lactone 70 (Figure 
17),31
 
 providing a convenient and efficient iterative method for polypropionate assembly. 
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Figure 17. Iterative applications of AAC 
 
Of the two possible chair transition states for the TMSQd catalyzed reaction leading to 
66, the Felkin transition state 71 was disfavored by the syn-pentane interaction (Figure 18). 
Therefore to avoid this interaction the aldehyde underwent anti-Felkin type addition via 
transition state 72. Also since the enolate face reacting in 72 was the favored enolate face for 
                                                 
31 Shen, X.; Wasmuth, A. S.; Zhao, J.; Zhu, C.; Nelson, S. G. J. Am. Chem. Soc. 2006, 128, 7438-7439.  
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quinidine (Re face), the quinidine catalyzed AAC with aldehyde 67 constituted the matched case 
providing the syn, anti, syn lactone 66.  For the quinine catalyzed reaction, to accommodate the 
aldehyde’s anti-Felkin preference, the reaction proceeded through a boat transition state 73 
affording the anti, anti, syn lactone 70. 
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Figure 18. Transition states for the mismatched AAC reaction 
 
The cinchona-alkaloid catalyzed AAC reaction provides an efficient and elegant 
alternative method for the production of polypropionate units for the following reasons.  
i) The reaction can affect a rapid increase in structural and stereochemical complexity using only 
catalytic sources of chirality utilizing a “direct” aldol approach where the pregeneration of the 
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enolate is unessential; the activated enolate equivalent (the N-acylammonium enolate) is 
generated in situ. 
ii) Use of a catalyst that is prepared easily in one step from the commercially available cinchona 
alkaloids quinine or quinidine, is an immensely enticing feature of this reaction, as the use of 
stoichiometric amounts of auxiliaries or expensive transition metal catalysts is avoided.  
iii) Flexibility in reaction conditions allow for optimization of the AAC reaction for specific 
aldehydes. 
iv) The stereochemical outcome of the the diastereoselective AAC reactions can be accurately 
predicted by the same Zimmermann-Traxler type models that are commonly used to predict 
stereoselectivities in aldol reactions.  Predictability is a desired quality that determines the choice 
of a reaction in complex target oriented synthesis. 
v) The β-lactone product of the AAC reaction is amenable to easy functional group 
transformations leading back to an aldehyde that can act as substrate in a subsequent AAC 
reaction. Iterative application of AAC followed by functional group transformations to aldehyde 
will enable rapid and efficient synthesis of valuable polyketide structures. 
The potential of this cyclocondensation for the iterative synthesis of polypropionate units will 
be further demonstrated in this thesis through its application in the synthesis of erythronolide B. 
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2.0  APPLICATION OF AAC TO THE SYNTHESIS OF ERYTHRONOLIDE B: THE 
FIRST GENERATION APPROACH 
2.1.1 Retrosynthetic Analysis 
Ketene-aldehyde cycloadditions represent surrogates for catalytic asymmetric aldol additions 
exploiting ketenes as enolate equivalents. Extrapolating this reaction design to iterative catalyst-
controlled couplings with methyl ketene for propionate chain elongation would provide the basis 
for our erythronolide B synthesis (Figure 19). Disconnection of the erythronolide B aglycone 
across the C1-O and the C7-C8 bonds revealed two modified propionate trimer equivalents 74 and 
75. The syn, anti, syn synthon 74 could be accessed through two successive iterations of the 
alkaloid-catalyzed AAC reaction between propionaldehyde and methylketene using the alkaloid 
catalysts TMSQd (68a) and TMSQn (69a) respectively. The all-syn synthon 75 would be derived 
from the alkaloid catalyzed cyclocondensation of methacrolein with methylketene; ensuing 
homologation of the resulting C4-C5 via an alkaloid-catalyzed cyclocondensation reaction was 
unsuccessful at providing the desired C3-C4 syn arrangement. Therefore while our research group 
was still working on the identification of new catalysts for the synthesis of syn, syn, syn 
polypropionate segment, we would use Crimmins’ chiral auxiliary-based method32
                                                 
32 Crimmins, M. T.; King, B. W.; Tabet, E. A.; Chaudhary, K.; J. Org. Chem. 2001, 66, 894-902. 
 to gain access 
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to this fragment in order to explore the feasibility of the route. The tertiary alcohol center at C6 in 
75 could be efficiently incorporated using Sharpless’ asymmetric dihydroxylation reaction. 
Subsequent coupling of the key fragments would be realized through a ring-opening of epoxide 
75 with a 74-derived enolate. Submitting the coupled C1-C13 seco-acid to macrolactonization 
would provide the aglycone in its cyclized form.  
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Figure 19. Catalytic asymmetric synthesis of erythronolide B. 
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 With the extensive amount of literature that already exists on macrolactonization studies 
of 14-membered erythromycin analogues (discussed previously in Figure 4), we anticipated that 
the macrolactonization of the seco-acid would be relatively free of problems, if the reacting ends 
of the seco-acid could be constrained through careful choice of cyclic acetal protecting groups on 
the designated hydroxyls. The key C7-C8 fragment coupling reaction of keto-enolate with 
epoxide however, presented considerable uncertainities due to the lack of related literature 
precedents involving complex substrates. Examples in the literature where ketone enolates have 
been used to open sterically hindered epoxides are rare.33
2.1.2 Synthesis of Ketone Fragment 84 
 Due to the limited nucleophilicity of 
ketone enolates compared with esters and amides, the ring opening of epoxides with the former 
presented a challenge, that we thought was worthy of exploring. We therefore proceeded for the 
synthesis of fragment 75. 
According to our reaction design, the first propionate unit would be derived from an alkaloid 
catalyzed cyclocondensation reaction between methyl ketene and propionaldehyde. The resulting 
β-lactone would be refunctionalized to the corresponding aldehyde and this aldehyde would be 
subjected to another round of alkaloid-catalyzed cyclocondensation reaction with methyl ketene 
to produce the second propionate unit. Thus the synthesis of the C8-C13 ketone fragment 75 
commenced with an AAC reaction of propionaldehyde, using TMSQd as catalyst to provide the 
desired enantiomer of the syn β-lactone 76 in 74% yield and 98% ee (cis:trans = >99:1) (Scheme 
                                                 
33 For epoxide opening with ketone enolates see: (a) Crotti, P.; Di Bussolo, V.; Favero, L.; Pineschi, M.; Pasero, M. 
J. Org. Chem. 1996, 61, 9548–9552. (b) Crotti, P.; Di Bussolo, V.; Favero, L.; Macchia, F.; Pineschi, M.; 
Napolitano, E. Tetrahedron 1999, 55, 5853–5866 and references cited therein. 
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9, eq 5). The lactone was then ring opened to the Weinreb amide 77 (92%). TBS protection of 
the secondary alcohol group provided 78 (97%), which upon reduction with DIBAL-H led to 
aldehyde 79 in quantitative yield (Scheme 9). 
 
Scheme 9: Synthesis of lactone 76 and refunctionalization to aldehyde 
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 Subjecting the aldehyde 79 to a second round of AAC resulted in the formation of β-
lactone 80 with the required syn, anti, syn arrangement of substituents (eq 6). Because the 
aldehyde was structurally more hindered, the second round AAC reaction required a stronger 
Lewis acid compared with the first round. At –78 °C, using the stronger Lewis acid, LiI, and 
TMSQn as catalyst, lactone 80 was obtained in excellent yield (95%) and as a single 
diastereomer. The diastereoselectivity could be explained through the chair type transition state 
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81 where the aldehyde underwent a preferred anti-Felkin attack and the TMSQn-derived 
metalloenolate reacted with its favored Si face (Figure 20).  
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Figure 20. Transition state for formation of 80 
 
 With all the four stereocenters in the C9-C13 fragment installed, the only thing remaining 
was to convert the β-lactone to the ketone functionality. This was achived by subjecting β-
lactone 80 to ring opening with N,O-dimethylhydroxylamine hydrochloride to provide Weinreb 
amide 82 (Scheme 10). Subsequent protection of the C11-OH in 82 with a methyloxymethylene 
(MOM) protecting group followed by addition of ethyl magnesium bromide to 83 completed the 
synthesis of the ethyl ketone fragment 84. For successful macrolactonization of the seco-acid at 
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the end of the synthesis, a p-methoxybenzyl (PMB) protecting group at the C11-OH group would 
have been ideal as it could be tied up with the C9-OH prior to macrolactonization to provide the 
required C9/C11 cyclic acetal for efficient macrolactonization.6b However, we obtained 
consistently low yields (<40%) while attempting to protect the C11-OH in 82 or in the 
corresponding ethyl ketone 85 with the PMB protecting group by reaction with p-methoxybenzyl 
trichloroacetimidate in presence of various Brønsted acid catalysts, as both the starting materials 
and the products were sensitive to acid and underwent decomposition in the reaction mixture. 
Therefore, we decided to temporarily use the MOM group in order to quickly gather material for 
the key coupling reaction.  
 
Scheme 10. Synthesis of ketone 84 
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2.1.3 Synthesis of Epoxide 99 
The synthesis of the all-syn fragment 75 commenced with a TMSQn-catalyzed AAC reaction on 
the commercially available α,β-unsaturated aldehyde, methacrolein (Scheme 11). α,β-
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Unsaturated aldehydes, in general, are not great substrates for the AAC reaction due to the 
conjugation which makes them less reactive. As expected, under the standard reaction conditions 
(LiClO4, −78 °C) the reaction of methyl ketene with methacrolein showed negligible conversion. 
The stronger Lewis acid LiI (5 equiv) and a higher temperature of −40 °C were required for 
complete conversion to the lactone 86. The isolated yield of the product was however, lower 
(62%) because of high volatility of the product. Ring opening of lactone with N,O-
dimethylhydroxylamine to Weinreb amide 87 (85%) followed by protection of the resulting 
secondary alcohol as the trimethylsilyl (TMS) ether provided 88 (94%), which upon subsequent 
reduction with iBu2AlH provided aldehyde 89 in 94% yield, ready for another iteration of the 
AAC reaction. 
 
Scheme 11. Synthesis of the C3-C7 segment 
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The 2nd iteration of the AAC reaction on aldehyde 89, however, failed to provide the 
desired syn, syn, syn lactone 90 due to the unfavorable syn pentane interactions in the Felkin 
transition state 91 (Figure 21).  The undesired anti, anti, syn product 92 was formed under the 
 41 
TMSQn-catalyzed reaction conditions via boat transition state 93 where anti-Felkin attack on the 
aldehyde through the favored enolate face occurred.  
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Figure 21. Transition state for TMSQn catalyzed AAC on aldehyde 89 
 
Due to our inability to access the all-syn propionate fragment via the AAC reaction, we resorted 
to Crimmin’s chiral auxiliary based aldol reaction to obtain the stereochemically analogous 
compound 94. The development of a successful protocol for the synthesis of this fragment was 
still required. Enolization of N-propionyloxazolidinethione with TiCl4 (1 equiv) and sparteine 
(2.5 equiv) followed by addition of the aldehyde 89 produced the Evan’s syn aldol product 94 in 
90% yield and as a single diastereomer (dr > 97:3). Acid-mediated deprotection of the TMS 
group provided the diol 95. In order to facilitate macrolactonization at a later stage, a cyclic 
dimethylacetal protecting group was incorporated across the C3-C5 hydroxyl groups of the diol 
95 to provide compound 96 (Scheme 12). The syn stereochemistry across C3/C5-OHs in the 
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acetonide 96 was ascertained from the 13C-shift values of the two methyl groups of the acetal 
using Rychnovsky’s 13C NMR acetonide method of assigning relative configuration.34
 
 
Rychnovsky’s group has shown that the 13C NMR signals of the methyl groups in syn-1,3-diol 
acetonides occur at 19 and 30 ppm, whereas the 13C NMR signals of the methyl groups in anti-
1,3-diol acetonides occur at 25 ppm. The syn-l,3-diol acetonides adopt a chair conformation with 
one methyl axial (19 ppm) and one methyl equatorial (30 ppm). The anti-1,3-diol acetonides 
adopt a twist-boat conformation with “local” C2 symmetry, and thus both methyl groups have the 
same chemical shift at about 25 ppm. For 96, the 13C shifts of the two methyl groups were 19 and 
30 ppm, confirming the syn relative stereochemistry of the 1,3-diol. 
Scheme 12. Auxiliary-mediated synthesis of all-syn segment 
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 With the C2-C5 all syn array in place, the next challenge was to install the tertiary 
hydroxyl-center at C6 of erythronolide B. Catalytic asymmetric dihydroxylation (AD), using 
                                                 
34 Rychnovsky, S. D.; Rogers, B.; Yang, G. J. Org. Chem. 1993, 58, 3511-3515. 
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cinchona alkaloid-derived catalysts developed by Sharpless and co-workers35 was used to install 
this tertiary alcohol center at C6. The mnemonic proposed by Sharpless and co-workers is 
generally predictive for the sense of facial selectivity in dihydroxylations of a wide range of 
prochiral alkenes, and can be rationalized in most cases by consideration of the mechanistic 
model proposed by the Sharpless group.36
 
 Using enantiopure substrates in the Sharpless 
asymmetric dihydroxylation (SAD) reaction offers the prospect of matching and mismatching 
diastereomeric outcomes for AD reactions, depending on the substrate facial selectivity for 
dihydroxylation and the catalyst-mediated facial selectivity related to the substituents on the 
double bond. Applying the Sharpless mnemonic on the 1,1-disubstituted alkene 96 would predict 
that AD-mix α would favor formation of  the desired C6-stereocenter as in 97. AD-mix β and 
AD-mix α are reagents for asymmetric dihydroxylation which contain potassium osmate, 
potassium ferricyanide, potassium carbonate and the chiral ligands dihydroquinidine 1,4-
pthalazinediyl diether [(DHQD)2PHAL, in AD-mix β] or dihydroquinine 1,4-pthalazinediyl 
diether [(DHQ)2PHAL, in AD-mix α]. Accordingly, 96 was subjected to Sharpless asymmetric 
dihydroxylation with AD-mix α, which produced a single diastereomer of the diol in excellent 
yield (96%) suggesting a matched double diastereoselective reaction. The resulting primary 
alcohol function in 97 was then selectively tosylated (TsCl, DMAP) to give 98 (85%), which 
underwent elimination to epoxide upon treatment with base (K2CO3/MeOH) with concominant 
substitution of the chiral auxiliary to afford the methyl ester 99 in 63% yield (Scheme 13). 
                                                 
35 (a) Kolb, H. C.; VanNieuwenhze, M. S.; Sharpless, K. B. Chem. Rev. 1994, 94, 2483-2547. (b) Sharpless, K. B.; 
Amberg, W.; Bennani, Y.; Crispino, G. A.; Hartung, J.; Jeong, K.-S.; Kwong, H.-L.; Morikawa, K.; Wang, Z.-M.; 
Xu, D.; Zhang, X.-L. J. Org. Chem. 1992, 57, 2768-2771. 
36 (a) Norrby, P.-O.; Kolb, H. C.; Sharpless, K. B. J. Am. Chem. Soc. 1994, 116, 8470-8478. (b) Norrby, P.-O.; 
Becker, H.; Sharpless, K. B. J. Am. Chem. Soc. 1996, 118, 35-42. (c) Nelson, D. W.; Gypser, A.; Ho, P.-T.; Kolb, H. 
C.; Kondo, T.; Kwong, H.-L.; McGrath, D. V.; Rubin, A. E.; Norrby, P.-O.; Gable, K. P.; Sharpless, K. B. J. Am. 
Chem. Soc. 1997, 119, 1840-1858. 
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Scheme 13: Synthesis of epoxide fragment 99 
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2.1.4 Coupling Studies on Fragments 84 and 99 
From a preliminary survey of the literature, we found that epoxides undergo ring opening 
reactions with various types of organometallic nucleophiles such as alkynyl metals, Grignard 
reagents, etc. when suitably activated by a Lewis acid and BF3·Et2O was found to be a very 
commonly used Lewis acid for this purpose.33 Therefore, in order to achieve coupling of our two 
fragments 84 and 99, we decided to use BF3·Et2O as the Lewis acid for activating epoxide 99 
toward ring-opening with the enolate of ketone 84. The lithium enolate of 84 was generated 
using LDA and the epoxide was added to it at –78 °C, followed by addition of the Lewis acid. 
However, ring opening of the epoxide did not take place even after raising the temperature to –
30 °C. After quenching the reaction mixture, the epoxide was found to be intact and none of the 
coupled material 100 was observed in the crude 1H NMR (eq 7).  
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Lithiated hydrazones 101 are highly nucleophilic species compared to simple enolates 
due to the lower electronegativity of nitrogen and due to the α-lone pair effect (lone pairs on the 
adjacent nitrogen strongly destabilize the negative charge through electronic repulsion).37
 
 To test 
whether the epoxide could be opened by hydrazones, we first used a simple model N, N-
dimethylhydrazone derivative 102, prepared from 3-pentanone. Enolization of 102 was carried 
out followed by addition of the epoxide. A variety of Lewis acids were scanned in the reaction 
and the results are summarized in eq 8. In most of the cases, the epoxide was present intact even 
after prolonged reaction times (24-36 hours) at ambient temperature. For LiI and MgBr2, 
products corresponding to epoxide ring opening with I− and Br−, respectively, were obtained 
along with unreacted epoxide, but the desired coupled product 103 was not observed in any of 
these reactions. 
N
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Me
NMe2O
R
Me
LDAO
R
Li
Me
N
R
Me
NR2Li
LDA
ketone hydrazone"less reactive" "more reactive"
101  
                                                 
37 (a) Smith, A. B.; Doughty, V. A.; Sfouggatakis, C.; Bennett, C. S.; Koyanagi, J.; Takeuchi, M. Org. Lett. 2002, 4, 
783–786. (b) Smith, A. B.; Kanoh, N.; Minakawa, N.; Rainier, J. D.; Blase, F. R.; Hartz, R. A. Org. Lett. 1999, 1, 
1263–1266.  
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 To confirm that the lithium hydrazoate was being generated under our reaction 
conditions, we carried out a control experiment using MeI as the electrophile instead of the 
epoxide, and in this case, complete conversion to the methylated product took place within an 
hour. Assuming that the hydrazoate was not sufficiently reactive, we tried several reactions using 
different chelating agents such as N,N,N′,N′-tetramethylethylenediamine (TMEDA), N,N′-
dimethylpropyleneurea (DMPU) and hexamethylphosphoric triamide (HMPA)38
  
 (no Lewis acids 
were used in these cases) to the reaction, in order to enhance the reactivity of the anion, but 
without any success. The lack of reactivity was attributed to the highly sterically hindered nature 
of the two substrates.  
 
                                                 
38 (a) Bernstein, M. P.; Romesberg, F. E.; Fuller, D. J.; Harrison, A. T.; Collum, D. B.; Liu, Q. Y.; Williard, P. G. J. 
Am. Chem. Soc. 1992, 114, 5100–5110. (b) Reich, H. J.; Goldenberg, W. S.; Sanders, A. W.; Jantzi, K. L.; 
Tzschucke, C. C. J. Am. Chem. Soc. 2003, 125, 3509–3521. (c) Reich, H. J.; Green, D. P.; Medina, M. A.; 
Goldenberg, W. S.; Gudmundsson, B. Ö.; Dykstra, R. R.; Phillips, N. H. J. Am. Chem. Soc. 1998, 120, 7201–7210. 
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3.0  THE SECOND GENERATION APPROACH  
3.1.1 Revised Aldol Strategy 
Due to the problems encountered in the enolate-mediated ring opening of epoxide in the earlier 
synthetic route, our strategy for fragment coupling had to be revised. To couple the two 
fragments, the well-known aldol reaction39
 
 was adopted not only because of its greater reliability 
in complex substrates but also because the stereochemistry in an aldol reaction can be easily 
predicted and controlled. Thus, disconnecting the C7-C8 bond of erythronolide B provided the 
ketone and aldehyde fragments 84 and 104, respectively as shown in Figure 22.  Synthesis of the 
aldehyde 104 required a few simple functinal group manipulations on an advanced intermediate 
94 that was already used in the synthesis of the epoxide fragment 99 in the earlier route. 
Erythronolide B lacks oxygenation at C7 and, as a result, the C7 hydroxyl resulting from the aldol 
reaction between 84 and 104 would be removed by a Barton radical deoxygenation later in the 
synthesis. However the C7 alcohol would serve an essential role in the synthesis as the 
stereochemistry at the C7 hydroxyl emerging from the aldol coupling would be translated to the 
desired (S)-stereochemistry of the C9-hydroxyl group via some sort of a directed reduction.  
                                                 
39 Paterson, I. Pure & Appl. Chem. 1992, 64, 1821-1830. 
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Figure 22. The proposed aldol disconnection 
 
3.1.2 Introduction of the O11-PMB Protecting Group in the Ketone Fragment 
For efficient macrocyclization of the eryhronolide B seco-acid, cyclic acetal protecting groups 
across the C3/C5 and C9/C11-hydroxyl groups would play an extremely important role. In order to 
protect the C9/C11-OH groups with a cyclic p-methoxyphenyl (PMP)-acetal, we had planned to 
install a PMB protecting group on the C11-OH. However, as discussed earlier, protecting 82 with 
p-methoxybenzyl trichloroacetimidate had proved to be problematic in presence of various 
Brønsted acids such as triflic acid, camphor sulfonic acid, and PPTS as catalysts, resulting in 
exceptionally low yields (<40%) with decomposition of starting material.  Repeated addition of 
reagents or the use of longer reaction times (>12 h) to drive the reaction to completion resulted in 
more extensive decomposition of the acid sensitive substrate 82. Fortunately, an effective 
solution to this problem was reached when a Lewis acid catalyst BF3·Et2O was used. Reaction of 
hydroxy-ketone 85 with PMB-trichloroacetimidate in presence of 15 mol% of BF3·Et2O at −78 
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˚C provided the PMB-protected product 105 cleanly within 4 h in 90% yield (Scheme 14).40
  
 
Using BF3·Et2O in combination with the lower reaction temperature of −78 ˚C instead of 
ambient temperature which was necessary in reaction with the Brønsted acids, prevented 
decomposition of the acid-sensitive β-hydroxy ketone substrate under the reaction conditions and 
allowed its efficient conversion to the product.  
Scheme 14.  Synthesis of ketone 105 
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3.1.3 Synthesis of Aldehyde 110 
With the synthesis of the ketone fragment 105 in place, the next goal was to synthesize the 
aldehyde coupling partner 104. Synthesis of the aldehyde fragment 110 commenced from the 
common intermediate 94 prepared during the synthesis of epoxide fragment 99. Conversion of 
imide 94 to the corresponding Weinreb amide by treatment with N, O-dimethylhydroxylamine 
hydrochloride and Me3Al, followed by removal of the TMS group (1N HCl, 68% over two steps) 
provided the diol 106. Protecting the C3/C5 hydroxyl groups in 106 with the PMP acetal 
protecting group using p-anisaldehyde dimethylacetal and a catalytic amount of PPTS provided 
107 in 94% yield. Upon subjecting 107 to Sharpless asymmetric dihydroxylation with AD-mix 
                                                 
40 Li, D. R.; Zhang, D-H.; Sun, C-Y.; Zhang, J-W.; Yang, L.; Chen, J.; Liu, B.; Su, C.; Zhou, W-S.; Lin, G-Q. Chem. 
Eur. J. 2006, 12, 1185-1204. 
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α, diol 108 was produced in 93% yield and as a single diastereomer. Oxidizing the resulting 
primary alcohol was initially attempted with Dess-Martin periodinane41 but a 60:40 mixture of 
the aldehyde and the methyl ketone resulting from cleavage of the diol, was obtained. However, 
under SO3-pyridine-DMSO42
 
 conditions, the desired aldehyde 109 was obtained as the sole 
product (93%). The free tertiary alcohol α to the aldehyde carbonyl was then protected with a 
triethylsilyl (TES) group to yield aldehyde 110 (87%), completing the synthesis of the aldehyde 
fragment (Scheme 15). 
Scheme 15. Synthesis of aldehyde 110 
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41 Dess, D. B.; Martin, J. C. J. Org. Chem. 1983, 48, 4155-4156. 
42 Parikh, J. R.; Doering, W. v. E. J. Am. Chem. Soc. 1967, 89, 5505-5507. 
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3.1.4 The Problem of Diastereoselectivity in the Aldol Coupling 
With the requisite streocenters established in the ketone and aldehyde fragments 105 and 110, 
respectively, the next goal was to unite the the two fragments in a highly convergent aldol bond 
construction. Due to the large amount of existing literature on aldol bond construction using 
Z(O)-enolates, our preliminary preference was a Z(O)-enolate mediated aldol reaction to couple 
105 and 110. The projected coupling reaction would thus be a syn aldol construction. The 
reaction should be double diastereodifferentiating43
 
 in nature with both partners being chiral and 
must result in an anti relationship between the C8 and C10 methyl groups as shown in Figure 23.  
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Figure 23. The projected fragment coupling and the requisite stereochemistries 
 
                                                 
43 Roush, W. R. J. Org. Chem. 1991, 56, 4151-4157. 
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A C7-C8 aldol bond disconnection has been precedented in Evans’ synthesis of 6-
deoxyerythronolide B where the C7-C8 bond was formed in the key fragment coupling step 
between aldehyde 111 and enol silane 112 via a BF3-mediated double-diastereodifferentiating 
Mukaiyama aldol reaction (Scheme 16). While adopting the C7-C8 aldol bond construction for 
the fragment coupling, we were aware that the major uncertainty associated with the successful 
execution of this reaction concerned the influence that the chiral partners might have on the 
stereochemical outcome of this double diastereodifferentiating process. In the aldol reaction 
between two complex fragments, it has often been found that the high facial selectivity 
associated with the enolates of chiral ketones provides the controlling influence.44 Frequently 
both the selection of the metal in the enolate, and the protecting groups on the adjacent alkoxides 
has significant effect on the stereochemical course of the aldol reaction. In order to obtain useful 
levels of stereoselectivities in substrate-controlled aldol couplings involving α-methyl aldehydes, 
it is usually necessary to impart stereocontrol from the enolate, as the asymmetric induction from 
the chiral aldehyde alone is insufficient. Although α-methyl aldehydes exhibit high 
diastereofacial preferences in Mukaiyama aldol reactions with enol silanes,6b addition of other 
metal enolates such as Ti, B, Sn and Li show considerable variability.45
 
 
 
                                                 
44 For selected references of aldol additions of chiral ethyl ketones in polypropionates, see: (a) McCarthy, P.; 
Kageyama, M. J. Org. Chem. 1987, 52, 4681-4686. (b) Evans, D. A.; Rieger, D. L.; Bilodeau, M. T.; Urpi, F. J. Am. 
Chem. Soc. 1991, 113, 1047-1049. (c) Gustin, D. J.; VanNieuwenhze, M. S.; Roush, W. R. Tetrahedron Lett. 1995, 
36, 3447-3450. (d) Evans, D. A.; Dart, M. J.; Duffy, J. L.; Rieger, D. L. J. Am. Chem. Soc. 1995, 117, 9073-9074. 
(e) Martin, S. F.; Lee, W-C. Tetrahedron Lett. 1993, 34, 2711-2714. 
45 Arikan, F.; Li, J.; Menche, D. Org. Lett. 2008, 10, 3521-3524. 
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Scheme 16. Evans’ C7-C8 Mukaiyama aldol coupling for 6-deoxyerythronolide B 
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 The aldehyde partner in our synthesis is an α-tertiary alkoxy aldehyde and complex aldol 
reactions of such aldehyde substrates with chiral ethyl ketones are rare in the literature. As a 
result, in order to gain an idea about the type of reaction conditions to be employed for obtaining 
the desired stereoselectivities (choosing out of the wide variety of aldol reaction conditions 
available), we performed a preliminary survey of the literature. Aldol reactions of chiral α-
methyl and α-methyl-β-alkoxy aldehyde substrates are the most common.44a-d The reaction of α-
methyl aldehydes 113 with achiral E-enolates usually gives adducts 114 predicted by Felkin-Anh 
model whereas additions to achiral Z-boron, lithium and titanium enolates exhibit anti-Felkin 
facial selectivity, providing 115, with an increase in selectivity observed for larger R.43  In the 
chair transition state model for the Z-enolate leading to the unobserved Felkin product 116, the 
methyl groups on the enolate and the aldehyde undergo a disfavoring syn-pentane interaction 
which is removed when the aldehyde reacts via the anti Felkin face. Thus the anti-Felkin syn 
aldol diastereomer 115 is commonly formed as the major product from Z(O)-enolates when α-
methyl aldehydes are used (Figure 24).43 
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Figure 24. Roush’s model for explaining the anti-Felkin preference of α-methyl aldehydes with Z-enolates 
 
High anti-Felkin selectivity is also observed in the reactions of α-methyl-β-alkoxy 
aldehydes (similar to α-methyl aldehydes) with achiral Z-enolates. However, in reactions with 
“chiral” Z-enolates this intrinsic anti-Felkin bias of the aldehyde is overridden by the high π-
facial selectivity of the enolate. For example the aldol reaction of the Z-chlorotitanium enolate 
derived from the chiral ethyl ketone 117 (structurally related to our ketone 105) and chiral 
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aldehyde 118, provided the Felkin aldol adduct 119 as the major diastereomer.  (94:6 Felkin/anti-
Felkin) (eq 9).44c  
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In three additional related examples from Martin’s studies on erythromycin B 
synthesis,44e the titanium enolates 120 and 121 underwent Felkin-selective aldol reactions with 
aldehyde 122 (eqs 10, 11). In contrast, the ketone 123 with inverted configuration at α-methyl 
center relative to 120 and 121, upon reaction with the same aldehyde, produced the anti-Felkin 
aldol adduct as the only diastereomer (eq 12). These results clearly illustrated that in the 
reactions of the titanium enolates, the stereochemical outcome was controlled by the ketone 
partner.  
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 According to the aldol transition state models 124 and 125, proposed by Paterson (tin 
enolates)46  and Evans (for titanium and boron enolates)47
 
  respectively, it was anticipated that in 
our system, the ketone would exert the controlling influence and direct attack on the Si face of 
the aldehyde (110) leading to the undesired diastereomer 126 where the required 8,10-anti 
relationship was not satisfied (Scheme 17). Thus, the chiral elements in the aldehyde and enolate 
fragments of our projected aldol coupling reaction were stereochemically "mismatched" in the 
desired bond construction for Ti, B or Sn enolates because such enolates would exert the 
controlling influence. In such scenario there were two ways in which the desired 
diastereoselectivity could be obtained: (1) if the aldehyde exerted very strong Felkin bias; and/or 
(2) if the enolate facial selectivity was substantially lower than the aldehyde. 
                                                 
46 Paterson, I.; Tillyer, R. D. Tetrahedron Lett. 1992, 33, 4233-4236. 
47 Evans, D. A.; Rieger, D. L.; Bilodeau, M. T.; Urpi, F. J. Am. Chem. Soc. 1991, 113, 1047-1049. 
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Scheme 17. Expected formation of undesired 8,10-syn relationship with Ti, B and Sn enolates 
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 α-Alkoxy aldehydes are expected to possess very strong intrinsic Felkin-bias in their 
reactions with nucleophiles, much stronger than that of  α-methyl aldehydes due to the presence 
of the heteroatom. Although there are no well known models to predict the selectivities of aldol 
reactions of α-tertiary alkoxy aldehydes, we were encouraged by the following results obtained 
by Martin in his erythromycin A synthesis. The reaction of lithium enolate of the chiral ethyl 
ketone 127 ketone with the α-methyl aldehyde 122 (eq 13) provided the aldol adduct 129 with 
opposite diastereoselectivity (anti-Felkin) compared to the titanium enolate reaction in eq 10. To 
explain the change in distereoselectivity on going from Ti to Li, the authors suggested that in the 
lithium enolate aldol, the chirality of the aldehyde became the dominant controlling element and 
a different transition state was operative. When the α-tertiary alkoxy aldehyde 128 was used in 
the aldol reaction with the Li-enolate of the same ketone, the stereoisomer 130 predicted by 
Felkin-Anh model was produced (eq 14). 
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 The result of the aldol reaction of 127 with the α-tertiary alkoxy aldehyde 128 suggested 
that the aldehyde possessed a strong intrinsic preference for Felkin selection. In this system the 
preference of the ketone reinforced the Felkin bias of the aldehyde in leading to the syn 
relationship of the methyl groups across the carbonyl. However, in our system the aldehyde 
Felkin bias would have to override the ketone’s anti-facial selectivity in order to obtain the 
desired 8,10-anti stereochemistry  in the coupled product (eq 15).  
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A very recent study by Menche and co-workers compared the effect of various metal 
enolate counterions (Ti, Sn, B and Li) on the diastereoselectivity in the aldol reactions of ethyl 
ketones 131 and 132 with α-methyl aldehyde 133. The results clearly demonstrated that out of all 
the Z-enolate forming metals, only Li-enolates allow the aldehyde’s preferred anti-Felkin 
addition (products 134 and 135) whereas Ti and Sn enolates exhibit dominant controlling 
influences in the aldol additions giving the Felkin addition products 136 and 137, respectively, as 
the major products (Figure 25).45 In view of the above results, it appeared that a possibility of 
overriding the intrinsic facial bias of the ketone (for producing the undesired 8,10-syn 
relationship) existed if Li was used as the enolate-counterion. In that case, the aldehyde control 
would dominate and result in the requisite 8,10-anti stereochemistry.  
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Figure 25. Metal-dependent aldol diastereoselectivities of Z-enolates 
 
3.1.5 Enolization of Ketone 105   
For ketone enolization the LiHMDS/THF system usually results in the formation of the kinetic 
Z-enolate.48 In the Ireland transition state model 138 for the formation of Z-enolate, despite the 
nearly equal A values for TMS (2.5) and the iPr (2.2) group, LHMDS (L1 = TMS) gives better Z-
selectivities compared to LDA (L1 = iPr) (Figure 26). An interesting observation was made by 
Masamune49
                                                 
48 (a) House, H. O.; Kramar, V. J. Org. Chem. 1963, 28, 3362-3379. (b) Bohlmann, F.; Arndt, C.; Starnick, J. 
Tetrahedron Lett. 1963, 4, 1605-1610. (c) House, H. O.; Gall, C. M.; Olmstead, H. D. J. Org. Chem. 1969, 34, 
2324-2336.  (d) Munchhof, M. J.; Heathcock, C. J. Tetrahedron Lett. 1992, 33, 8005-8006.  (e) Xie, L.; Isenberger, 
K. M.; Held, G.; Dahl, L. M. J. Org. Chem. 1997, 62, 7516-7519. 
 who showed that the use of the highly hindered base lithium bis-
(dimethylphenyl)silazide 139, led to exclusive formation of the Z-enolate (Z:E > 99:1) from ethyl 
cyclohexyl ketone.  To explain why Z-enolate is more favored by lithium disilylamides [such as 
LHMDS and lithium bis-(dimethylphenyl)silazide] than lithium dialkylamides (such as LDA), 
49 Masamune, S.; Ellingboe, J. W.; Choy, W. J. Am. Chem. Soc. 1982, 104, 5526-5528. 
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the Xie group undertook a detailed study of the steric vs. electronic effects of the base in 
controlling ketone enolization geometry and concluded that the electronic nature of the base is 
also a dominant factor in the enolization.50
 
 Replacing both isopropyl groups in LDA with 
electron-withdrawing TMS groups significantly reduces the electron density (and the basicity) on 
the nitrogen in LHMDS. As a result, the electrostatic interaction between the less basic nitrogen 
and the lithium ion and the proton in the transition state 138 is much weaker, leading to a later 
transition state. Consequently, the Me↔L1 interaction is significantly weakened and the 
transition state leading to the Z-enolate is favored. Similarly introducing a phenyl group on the 
silicon makes the nitrogen in lithium bis-(dimethylphenyl)silazide even less basic which explains 
the high selectivities for Z-enolate formation with this bulky base. Accordingly, we used the base 
139 for enolization of 105. In order to determine the enolate geometry, the resulting enolate from 
105 was trapped with trimethylsilyl trifluoromethanesulfonate (TMSOTf) at 0 °C to give the 
corresponding Z-enol silane 112 exclusively (eq 16).6b  
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Figure 26. Ireland transition state leading to Z-enolate 
 
                                                 
50 Xie, L.; Isenberger, K. M.; Held, G.; Dahl, L. M. J. Org. Chem. 1997, 62, 7516-7519. 
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3.1.6 Strategy for Assigning Stereochemistries in the Aldol Products  
With a high Z:E enolate geometry established for ketone 105, the next goal was to engage the 
enolate in a  syn-selective aldol coupling reaction with aldehyde 110. In order to determine the 
relative and absolute stereochemistries at the C7 and C8 centers that would be newly created in 
this aldol coupling reaction, the following strategy was designed (Scheme 18). After the aldol 
coupling between 105 and 110, a chelating metal hydride reduction of the C9 ketone in the 
resulting aldol adduct would be performed using Zn(BH4)2 to give the corresponding C9-alcohol 
having the same stereochemistry as the directing C7 hydroxyl. Next the C11-PMB protecting 
group would be converted to the cyclic p-methoxybenzylidene (PMP)-acetal protecting group 
under oxidative DDQ conditions to provide the bezylidine acetal 140 or 141. The cyclic p-
methoxybenzilidene acetal moiety on the C9 and C11 hydroxyls would exist in the chair form and 
the stereochemistry of the substituents on the chair would be easily determined from nOe 
correlations. Depending on the stereochemistry of the C9 hydroxyl and hence the C7 hydroxyl 
resulting from aldol, either a cis or a trans acetal ring would be formed. In the desired 
stereoisomer 140, the p-methoxybezylidine acetal ring would be trans, and the acetal proton 
would show only one nOe correlation with H11. In the undesired stereoisomer 141 resulting from 
the wrong syn aldol adduct, the p-methoxybezylidine acetal would be cis and the acetal proton in 
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this isomer would show correlations with both H9 and H11. Thus the stereochemistries at the C7 
and C8 centers resulting from the aldol reaction would be easily determined.  
 
Scheme 18. Strategy for assignment of aldol stereochemistry 
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3.1.7  Aldol Coupling of Fragments 105 and 110    
With fragments 105 and 110 in place, the aldol fragment coupling reaction was attempted. The 
lithiated base was first generated from (dimethylphenyl)disilazide 139 and nBuLi at 0 ˚C 
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followed by addition of ketone at −78 ˚C to generate the lithium enolate. The resulting solution 
was allowed to warm to 0 ˚C for an hour before it was recooled to −78 ˚C and aldehyde 110 was 
added. The reaction worked cleanly providing a single diastereomer of a new product. However 
the mysterious absence of a keto signal in the 13C NMR of this new compound and the presence 
of two distinct signals instead of one, in the range of 95-105 ppm led us to suspect that the 
ketone had probably undergone hemiketal formation under the reaction conditions. Based on this 
assumption, we considered the formation of hemiketal 142 in the reaction (Figure 27).  
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Figure 27. Hemi-ketal formation to explain the absence of the keto signal and presence of an extra acetal 
signal in 13C NMR of aldol adduct 
 
Formation of hemiketal 142 could occur if the lithium alkoxide 143 generated by the 
aldol reaction triggered a 1,4-migration of the triethylsilyl group from the C6-tertiary alcohol to 
the adjacent secondary C7 alcohol center of the aldol adduct to produce 144 (Scheme 19). 
Subsequent cyclization of this resulting C6 lithium alkoxide intermediate 144, on to the ketone 
carbonyl would then result in the formation of the five-membered hemiketal 142. The migration 
of trialkylsilyl protecting groups (TBS, TBDPS, TIPS, TMS etc.) from oxygen to oxygen is a 
well-known phenomenon in organic chemistry. Usually, these rearrangements occur in a 1, 4 or 
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1, 5 fashion, and 1, n (n = 6–11 etc.) type silyl migration has also been observed.51
 
 The release of 
steric strain in going from 143 to 144 as well as the formation of a stable tetrahydrofuran ring 
provided an enhanced driving force for the reaction. 
Scheme 19. Formation of cyclized product 142 
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 The structure of 142 was determined by detailed 1H-COSY, HMQC and HMBC NMR 
analysis. Using ROESY correlations (Figure 28), the relative stereochemistries of the C6-C9 
substituents on the tetrahydrofuran ring were determined.  The stereochemistry of the C6-tertiary 
alcohol center was used to determine the absolute stereochemistries of the remaining C7-C9 
centers in the tetrahydrofuran ring of 142 which to our satisfaction, matched completely with the  
                                                 
51 (a) Still, W. C.; Macdonald, T. L. J. Org. Chem. 1976, 41, 3620-3622. (b) Yamazaki, T.; Mizutani, K.;  Takeda, 
M.; Kitazume, T. J. Chem. Soc., Chem. Commun. 1992, 55-57. (c) Yamazaki, T.; Oniki, T.; Kitazume, T. 
Tetrahedron 1996, 52, 11753-11762. (d) Rücker, C. Chem. Rev. 1995, 95, 1009-1064. (e) Zhao, Z. Q.; Peng, L. Z.; 
Li, Y. L. Chin. Chem. Lett. 2005, 16, 290-292.  
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respective stereochemistris in the desired open chain diastereomer 145 suggesting that the 
desired Felkin diastereoselection was obtained in the coupling reaction. 
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Figure 28. Determination of stereochemistry at C6-C9 by ROESY correlations and comparison with desired 
diastereomer 
 
Despite the excellent Felkin selectivity achieved in the aldol coupling reaction between 
105 and 110, the irreversible cyclization of the lithium aldolate 143 to the tetrahydrofuran 142 
posed a serious problem in its further elaboration toward erythronolide B synthesis. We believed 
that this problem could be solved by eliminating the triethylsilyl group on the C6-hydroxyl and 
replacing it with a different protecting group that would not undergo transfer under the basic 
conditions of the aldol reaction. However, another point of concern in this aldol reaction was its 
low conversion and unfortunately, all attempts to improve the yield e.g. longer reaction times, 
increasing the overall concentration of the reaction or increasing the equivalents of the aldehyde 
were unsuccessful and the conversion remained in the modest 50-55% range. We also attempted 
a BF3·Et2O mediated Mukaiyama aldol reaction (see Scheme 16). When preformed enol silane 
112 and aldehyde 110 were subjected to the Lewis acid, no reaction occurred at −78 ˚C and the 
starting materials were recovered intact (Scheme 20). The lack of reactivity was presumably 
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caused by the hindered quarternary center α to the reacting carbonyl in the aldehyde, as would be 
expected. We therefore continued with the lithium enolate aldol reaction. Our next goal was to 
stop the cyclization by using a non-migratory protecting group at C6-OH. 
 
Scheme 20. Attempted Mukaiyama aldol reaction 
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3.1.8 Change in Protecting Group on Aldehyde 110 
We substituted the silyl protecting group on the C6 hydroxyl in 110 with an alkyl protecting 
group such as benzyl in order to prevent in situ hemi-ketal formation by the lithium aldolate. The 
nature of protecting group on the α-hydroxyl center of a reacting aldehyde plays an important 
role in defining the diastereoselection of the aldol reaction. Based on Martin’s precedent of 
erythromycin A synthesis (see eq 14) where they obtained Felkin diatereoselection in a related 
system, we proceeded to synthesize the benzyloxy group containing aldehyde 146 for the aldol 
coupling reaction.  
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3.1.8.1 Synthesis of α-Benzyloxy Aldehyde 146 and the Aldol Coupling of Fragments 105 
and 146 
For the synthesis of α-benzyloxy aldehyde 146, the diol 106 was first protected as the acetonide 
147 (100%) and dihydroxylated with AD mix α to provide diol 148 in 91% yield and as a single 
diastereomer.  The primary alcohol group in 148 was then selectively protected with a 
triisopropylsilyl (TIPS) group. This was followed by benzyl protection of the C6 tertiary alcohol 
(74%) with NaH and BnBr in presence of tert-butyl ammonium iodide (TBAI). The sterically 
bulky TIPS protecting group on the C7 primary hydroxyl group was necessary as the alternative 
TES and TBS groups were labile under the basic NaH conditions of the subsequent reaction and 
resulted in multiple product formation (both mono- and di-benzylated products were isolated). 
Deprotection of the TIPS group using HF.py provided 149 in 95% yield. Subsequent oxidation of 
the free alcohol with Dess-Martin’s reagent provided the requisite aldehyde 146 in 83% yield 
(Scheme 21).  
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Scheme 21. Synthesis of α-benzyloxy aldehyde 146 
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With aldehyde 146 in hand, the coupling reaction was attempted anticipating that the 
uncyclized aldol adduct would be obtained. Indeed, when 105 and 146 were subjected to the 
previously used aldol reaction conditions using 139 as the base, the acyclic aldol adduct 150 was 
obtained in excellent diastereoselectivity in 56% yield (Scheme 6). The absence of the hemiketal 
carbon signal in the 13C NMR of the product along with the presence of a keto signal confirmed 
that the acyclic product was isolated. Incomplete conversion was observed once again and the 
product was isolated in 55% yield along with unreacted starting materials (eq 17).  
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3.1.8.2 Stereochemistry Determination of the Aldol Product  
To determine the stereochemistries at the C7 and C8 centers generated in the aldol reaction (eq 
17), the aldol adduct 150 was subjected to a syn-selective chelate controlled reduction of the C9-
ketone with Zn(BH4)2. The major product 151 (90% yield, 86:14 dr) was subjected next to 
oxidation with DDQ to provide the O9/O11 p-methoxybenylidine acetal. The 1H NMR of this 
compound contained overlapping peaks in the carbinol region, so in order to facilitate 
unambiguous structure analysis it was futher converted to the deoxygenated product 152 via 
Barton’s deoxygenation protocol. In subsequent ROESY NMR analysis of 152, the acetal proton 
Ha was, unexpectedly, found to show correlations with both H9 and H11, which suggested a syn 
relationship between the two hydroxyls at C9/C11 and hence C9-OH having the undesired (R)-
stereochemistry. To be sure, the minor product of the Zn(BH4)2 reduction 153 was also converted 
to the corresponding cyclic acetal 154, whose C9/C11–anti stereochemistry was similarly 
confirmed from ROESY NMR analysis which showed a single correlation of the acetal proton 
with C11. A summary of the above results along with the observed ROESY correlations are 
outlined in Scheme 22 (stereochemistries of all compounds are drawn to represent the 
information obtained from the ROESY data of the homologous compounds 152 and 154).  
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Scheme 22. Stereochemistry determination of aldol adduct 150 
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To explain the selective formation of the anti-Felkin product 150 in the aldol reaction, 
Cram chelation of the α-benzyloxy substituent in the aldehyde 146 may be invoked (Figure 29), 
although this would be in disagreement with Martin’s precedent where the Felkin diastereomer 
was formed as the major product.  
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Figure 29. Possibility of Cram-chelation in transition state leading to 150 
3.1.9 The Aldolate-Ketalization Problem Revisited: Use of TBS Group 
The undesired stereochemical outcome in the aldol reaction of ketone 105 with aldehyde 146 (eq 
17) led us to return to the α-triethylsilyloxy aldehyde 110 which provided the desired Felkin 
selective aldol with competing hemi-ketal formation (Scheme 23). We began to search for a 
suitable modification that would prevent the unwanted cyclization in this system. We 
hypothesized that a more bulky silicon-based protecting group such as TBS or TIPS would 
alleviate attack of the C7-alkoxide and prevent the silyl transfer process at low temperatures, as 
formation of the five-coordinated silicon species required in the transition state of such a process 
would become unfavorable due to steric crowding. To test this hypothesis, the α-tert-
butylsilyoxy aldehyde 155 was quickly synthesized from aldehyde 109 using TBSOTf and 2,6-
lutidine. Aldehyde 155 was then subjected to the usual aldol conditions, which to our 
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disappointment, led to the exclusive formation of the corresponding cyclized hemi-ketal product 
156 (Scheme 24).  
 
Scheme 23. The problem of cyclization in the aldol reaction of 110 
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Scheme 24. Formation of ketalized product 156 from aldehyde 155 
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Although this result was very disappointing, an interesting observation was made during 
this aldol reaction which ultimately led us to the solution. During TLC monitoring of the 
reaction, it was observed that the reaction mixture looked quite different before and after the 
aqueous NH4Cl quench. In the post-quench (sat. aqueous NH4Cl) TLC of the organic layer, the 
product (156) spot was visible as the only major spot other than those of the two unreacted 
starting materials. However, in the TLC of the reaction mixture immediately before quench, a 
significantly polar spot was found to be present as the major spot along with a tiny spot 
corresponding to 156 suggesting that the cyclized product 156 was being formed during or after 
the aqueous quench and that the compound corresponding to the significantly polar spot was 
leading to the cyclized product 156 upon quench (Figure 30).  
 
•
•
NH4Cl quench
156
 ?
 
Figure 30. TLCs of the aldol reaction between 105 and 155 (startng material spots have not been shown for clarity) 
 
If the aldol adduct existed as the aldolate 157 until the quench, it would, at first, seem 
unlikely that the addition of a proton source (NH4Cl) would result in its cyclization to 156 in 
preference to the faster process of protonation which would lead to 158 (Scheme 25). However, 
in the event of addition of aqueous NH4Cl solution into the reaction mixture at −78˚C, the 
aqueous phase was caused to freeze leading to a heterogeneous system where the organic and 
aqueous phases remained separated. As the reaction was then allowed to warm up, the rise of 
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temperature triggered the aldolate 157 in the organic phase to undergo silyl transfer and 
cyclization to 156. Thus, completely protonating the aldolate at low temperatures should lead 
exclusively to the acyclic product 158. To achieve complete protonation of 157 at low 
temperature, we proposed to use a homogeneous quench of the aldol reaction in place of an 
aqueous quench.  
 
Scheme 25. Competing reaction pathways for the lithium aldolate  
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 To test this, the α-triethylsilyloxy aldehyde 110 was subjected to the aldol reaction 
conditions and after 30 minutes the reaction was quenched with 1 N solution of acetic acid (4 
equiv) in THF. The resulting homogeneous solution was allowed to stir for 20 min at the same 
temperature to allow for complete protonation and then the excess acid was quenched with 
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aqueous NaHCO3 solution whereupon it was allowed to warm to room temperature. After 
workup, the acyclic adduct 145 was isolated in 51% yield and as a single diastereomer, along 
with unreacted starting materials. None of the cyclized adduct 142 was formed (eq 18).  
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3.1.10 On the Way to Erythronolide B from Aldol Adduct 145: An Unexpected Problem 
After having successfully synthesized the desired aldol adduct 145, we began its elaboration into 
erythronolide B. To establish the (9S)-hydroxyl configuration in 159 required for 
macrocyclization, the aldol adduct 145 was subjected to chelate controlled reduction with 
Zn(BH4)2 which proceeded in excellent yield and selectivity (94% yield, >85:15 
diastereoselection). p-Methoxybenzylidene acetal 160 was then formed as a single isomer 
through an anhydrous DDQ oxidation in 96% yield, differentiating the C7 and C9 alcohols and 
constraining the C9 and C11 hydroxyls in a dioxolane ring required for macrocyclization (Scheme 
26).  
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Scheme 26. Synthesis of the PMP acetal 160 from the aldol adduct 145 
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At this point, all the stereocenters in the target had been installed, leaving only final 
refunctionalizations and macrocyclization to complete the synthesis. Before proceeding with the 
deoxygenation of the C7-hydroxyl group in 160 via the Barton McCombie protocol, we wanted 
to verify the stereochemistry of the C9/C11 acetal and came upon an unexpected problem. As 
shown below, in the ROESY NMR of compound 160, the acetal proton Ha showed correlations 
to both protons H9 and H11 suggesting a cis benzylidine acetal which was very difficult to 
reconcile with the previous stereochemical assignment of the cyclized aldol adduct 142 which 
should have produced the trans benzylidene acetal depicted by the structure 160 (Figure 31).  
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Figure 31. ROESY correlations of 160 
 
While searching for the source of this discrepancy, we became suspicious of the 
possibility of an erroneous assignment of the stereochemistry of the C6-quaternary center. This 
center was constructed through a highly selective Sharpless asymmetric dihydroxlation reaction 
of olefin 107 (see Scheme 15). Sharpless’s general mnemonic rule for predicting dihydroxylation 
stereochemistry in prochiral terminal olefins was used in the selection of AD-mix α as the chiral 
ligand in our system to obtain the desired dihydroxylation stereochemistry. Consequently, the 
unusually high selectivity achieved in the formation of diol 108, convinced us that the 
stereochemical preferences of the chiral substrate and catalyst were matched in this case and 
hence the reaction proceeded with very high selectivity in providing the desired diastereomer 
108. However, since no other confirmatory evidence existed to support this assignment, let us 
assume that the C6-epimer 108' was formed in the Sharpless asymmetric dihydroxylation (SAD) 
reaction. Depending on Felkin or anti-Felkin selectivity in the aldol reaction, 160′ and 161′ 
should represent the two benzylidene acetal isomers that could be possibly formed from 
aldehyde precursor 108′. Similarly, 160 and 161 represent the two possible stereoisomers that 
could result from the aldehyde precursor 108 (Scheme 27).  
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Scheme 27. Possible stereoisomers from 107 depending on the stereochemistry of its dihydroxylation 
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Only the Felkin diastereomers 160 and 160′ have the relative stereochemistry at the C6-
C8 centers predicted by the ROESY correlations observed in the cyclized aldol product (shown in 
red, Scheme 28). However out of the two, only the diastereomer 160′ possesses the requisite 
O9/O11 cis benzylidene acetal stereochemistry established by ROESY correlations in the actual 
benzylidene acetal (shown in blue, Scheme 28).  Thus 142' (and not 142) must be the hemiketal 
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formed in the aldol reaction and 160′ (and not 160) must be the corresponding benzylidene 
acetal.  
 
Scheme 28. 160' (not 160) is found to match the relative and absolute setereochemistries predicted by ROESY data 
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The preceding analysis suggested that the C6-epimeric diol 108′ (and not 108) was 
formed in the SAD reaction. In order to unambiguously confirm this, we obtained crystals of the 
homologous epoxide fragment 99 previously prepared from alkene 96. The X-ray structure of the 
epoxide revealed that the absolute configuration at the C6 center, was indeed the opposite of what 
had been presumed thus far (Scheme 29).  
 
Scheme 29: Stereochemical proof of SAD product  
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3.1.11 Dihydroxylation of 147 Using AD-mix β 
As the Sharpless asymmetric dihydroxylation of 147 using AD-mix α provided the wrong 
stereochemistry at C6, we anticipated that switching to the pseudoenantiomeric ligand in AD-mix 
β would reverse the selectivity. Upon subjecting 147 to catalytic dihydroxylation with AD-mix β, 
the corresponding diol was produced cleanly and with excellent diastereoselectivity (>95:5). The 
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diol product isolated in the dihydroxylation reaction, however, was found to possess the incorrect 
C6 stereochemistry. Proof of stereochemistry was obtained by derivatization of the diol to 
epoxide 147a whose structure was confirmed by X-ray crystallography (Scheme 30). 
 
Scheme 30: Dihydroxylation of 147 with pseudoenantiomeric ligand AD-mix β 
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 Dihydroxylations of 147 with the diastereomeric cinchona alkaloid catalysts AD-mix α 
and AD-mix β provided the same sense of diastereoselectivity. Therefore it was clear that the 
allylic alkoxy substituents in the substrate 147, was providing a strong stereodirecting influence 
in the dihydroxylation reaction in favor of the undesired diastereomer. These results are in 
agreement with Kishi’s dihydroxylation model52 as well as the “inside alkoxy effect”, which was 
first proposed by Stork53 and later supported by Houk54
                                                 
52 Cha, J. K.; Christ, W. J.; Kishi, Y. Tetrahedron Lett. 1983, 24, 3943-3946.  
 to explain the inherent stereoselectivity 
53 Stork, G.; Kahn, M. Tetrahedron Lett. 1983, 24, 3951-3954. 
54 Haller, J.; Strassner, T.; Houk, K. N. J. Am. Chem. Soc. 1997, 119, 8031-8034. 
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of dihydroxylation reactions for allylic alkoxy substrates. This model predicts that the allylic 
alkoxy substituent prefers to align parallel to the olefin in the reacting conformation due to 
stereoelectronic effects. This alignment is believed to minimize the destabilizing electron-
withdrawing interaction between the C-O σ* orbital and the C=C π bond orbital within the 
transition state. Reaction with the electrophilic osmium tetroxide reagent would then be expected 
to favor approach of the olefin face opposite the more sterically demanding alkyl substituent as 
shown in Figure 32. This model supports the results of the dihydroxylation selectivity; however, 
it is surprising that, even under reagent-controlled conditions, the inherent diastereoselectivity 
could not be overridden.  
 
Me
RO
H
R
OsO4
N
OMe
HO
MeHO
O O
Me Me
O
Me
Me Me
 
Figure 32. Inside-alkoxy effect in the substrate-controlled dihydroxylation of 147 
 
3.1.12 Stereochemical Reassignment of C6-OH Containing Structures 
With this stereochemical proof, it now became necessary to look back and reassign the 
stereochemistries of all compounds where the C6 center was present i.e all the post-
dihydroxylation compounds whose C7-C9 stereochemistries had been predicted based on the 
misassigned C6-stereochemistry.  The corrected sequence of compounds for the TES and Bn 
protected α-tertiary alkoxide series have been redrawn in Schemes 31 and 32, respectively.  For 
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the purpose of clarity, all structures with the corrected stereochemistries are numbered as N′, 
where N is the number that represented the compounds with presumed wrong stereochemistries. 
Thus the aldol reaction of the α-triethylsolyloxy aldehyde 110′ produced the aldol diastereomer 
145′, via Felkin selection which ultimately provided the cis benzylidene acetal 160′ (Scheme 
31).  
 
Scheme 31. Corrected stereochemistries and modified numbering sequences for the TES series 
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 Also in the aldol reaction of the α-benzyloxy aldehyde 146′, instead of presumed aldol 
adduct 150 (initially proposed to form via a 5-membered chelate-Cram model), the Felkin 
product 150′ was formed selectively, which led to the cis benzylidene acetal 152′ (Scheme 32).  
 
Scheme 32. Corrected stereochemistries and modified numbering sequences for the Bn series 
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3.1.13 Conclusion 
In conclusion, an unexpected outcome of diastereoselective SAD reaction of the chiral 1,1-
disubstituted alkenes 107 and 147 was observed where both pseudo-enantiomeric PHAL series 
AD ligands catalyzed the AD reactions giving the same sense of enhanced diastereoselectivity, 
one thus consistent (β) and one inconsistent (α) with the mnemonic for predicting selectivity 
preferences. Similar unexpected diastereomeric outcomes in SAD reactions of chiral 
monosubstituted and trans-disubstituted alkene substrates have been reported previously by the 
groups of Smith55 and Carreira56
Also in the aldol reactions of α-tertiary-alkoxy aldehydes (e.g. 110′ and 146′), it was 
found that the Felkin diastereoselection model was favored, irrespective of the type of protecting 
group on the alkoxide. This observation would be useful in predicting aldol stereoselection in the 
actual erythronolide B system.   
 in their respective syntheses of calyculin and zaragozic acids. 
 
                                                 
55 Iwashima, M.; Kinsho, T.; Smith, A. B., III Tetrahedron Lett. 1995, 36, 2199-2202. 
56 Carreira, E. M.; Du Bois, J. J. Am. Chem. Soc. 1994, 116, 10825-10826. 
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4.0  CORRECTION OF C6-STEREOCHEMISTRY AND SYNTHESIS OF SYN, SYN, 
SYN POLYPROPIONATE UNIT 
So far, the synthesis of the left hand fragment 74, which contained the syn, anti, syn 
polypropionate segment has been accomplished by using the cinchona alkaloid catalyzed AAC 
chemistry. The right hand fragment 75 has been synthesized with a wrong stereochemistry at C6 
center and Crimmins’ auxiliary mediated aldol reaction has been utilized for synthesizing the 
syn, syn, syn-C2-C5 segment. The aldol coupling of α-tertiary-alkoxy aldehyde substrate 75 with 
ketone substrate 74 has also been performed affording the desired Felkin diastereoselection. This 
result provided useful insight into the type of diastereoselection (Felkin) that should be expected 
in future aldol reactions of substrate 75 with the correct C6-stereochemistry. Thus, 1) installation 
of the correct C6-stereochemistry and 2) an efficient catalytic synthesis of the syn, syn, syn-C2-C5 
segment were the two remaining major tasks required to complete our synthesis (Figure 33). 
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Figure 33. Required tasks for completion of the synthesis 
4.1 SYNTHESIS OF THE SYN, SYN, SYN-POLYPROPIONATE UNIT 
Our next target was to synthesize the C2-C5 syn, syn, syn-polypropionate unit of erythronolide B. 
As discussed previously, of the four diastereomers possible for a bispropionate, the syn, anti, 
syn-bispropionate precursor 66 and the anti, anti, syn-bispropionate precursor 70 can be prepared 
by AAC chemistry starting from aldehyde 67.  Bispropionate precursors 162 and 163 possessing 
C3-C4-syn stereochemistry cannot be made by AAC chemistry, since the inherent anti-Felkin 
bias of the aldehyde cannot be overridden by catalyst stereocontrol in the closed transition states 
associated with these reactions (Figure 34).  
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Figure 34. Felkin products unaccessible in diastereoselective AAC reactions 
 
 Despite the propensity of α-substituted aldehydes to express anti-Felkin 
diastereoselection in aldol additions with enolates, Evans and Crimmins have each developed 
auxiliary-controlled enolate additions that are uniquely effective at overriding this 
stereoelectronic bias. Evans’ oxazolidinone57 and Crimmins’ thiazolidinethione-derived58
                                                 
57 Evans, D. A.; Clark, J. S.; Metternich, R.; Novack, V. J.; Sheppard, G. S. J. Am. Chem. Soc. 1990, 112, 866-868. 
 
metalloenolates mediate stereoselective aldol additions to chiral α-substituted aldehydes wherein 
58 Crimmins, M. T.; King, B. W.; Tabet, E. A.; Chaudhary, K. J. Org. Chem. 2001, 66, 894-902. 
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stereoselection is derived exclusively from the chiral auxiliary. However, these methods for 
synthesizing the all-syn polypropionate unit suffer from the drawback of using a stoichiometric 
amount of chiral auxiliary. Our group was interested to develop a catalyst-controlled reaction 
methodology for the synthesis of all-syn polypropionate unit which would eliminate the 
requirement for stoichiometric chiral auxiliary. For successfully designing reactions to access 
polypropionate architecture complementary to that obtained from the AAC chemistry so far, a 
catalyst that would override the dominant anti-Felkin facial bias expressed by α-chiral aldehydes 
was necessary. The anti-Felkin aldehyde facial bias is generally associated with C−C bond 
constructions proceeding via closed, metal-templated transition states.59 Therefore, identifying 
reaction conditions that would enforce the enolate-aldehyde addition through an open transition 
state (e.g., 164) should result in the α-chiral aldehydes expressing more typical Felkin facial bias 
due to relief of the syn pentane interaction incurred in the closed transition state 165.60 Catalyst-
based stereocontrol in conjunction with Felkin-selective aldehyde addition would afford highly 
diastereoselective access to β-lactone propionate dimers 162 possessing C3-C4-syn relationships. 
Toward that end, significant efforts were directed on the identification of suitable catalysts and 
non-coordinatve Lewis acids for the AAC reaction, but when this approach did not lead to the 
desired results, the Nelson group turned toward the Lewis base catalyzed Mukaiyama aldol 
reaction, and finally succeeeded at providing a solution (Figure 35).61
 
 
                                                 
59 Zimmerman, H. E.; Traxler, M. D. J. Am. Chem. Soc. 1957, 79, 1920-1923. 
60 (a) Roush, W. R. J. Org. Chem. 1991, 56, 4151-4157. (b) Evans, D. A.; Dart, M. J.; Duffy, J. L.; Yang, M. G.; 
Livingston, A. B. J. Am. Chem. Soc. 1995, 117, 6619-6620. (c) Evans, D. A.; Dart, M. J.; Duffy, J. L.; Rieger, D. L. 
J. Am. Chem. Soc. 1995, 117, 9073-9074. (d) Evans, D. A.; Siska, S. J.; Cee, V. J. Angew. Chem., Int. Ed. 2003, 42, 
1761-1765. 
61 The reaction development and optimization studies in this project were all done by Dezhi Fu in the Nelson group. 
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Figure 35. Relief of the syn-pentane interaction in open transition state should allow Felkin addition 
 
4.1.1 Lewis Base-Catalyzed Mukaiyama Aldol Reaction: Contributions of the Nelson 
Group 
Activation of simple silyl enolates such as trimethylsilyl enolates 166, via Lewis base 
catalysis was first performed by Mukaiyama with Lewis base catalysts such as lithium 
diphenylamide,62 lithium 2-pyrrolidone,63 lithium acetate,64 lithium phenoxide and ammonium 
phenoxides65
                                                 
62 Fujisawa, H.; Mukaiyama, T. Chem. Lett. 2002, 182. 
 to obtain good yields and syn selectivities (eq 19). However, these Lewis base-
catalyzed Mukaiyama aldol reactions had only been performed on achiral aldehydes providing 
racemic aldol products. Our group became strongly intrigued by the possibility of application of 
63 Fujisawa, H.; Mukaiyama, T. Chem. Lett. 2002, 858. 
64 Nakagawa, T.; Fujisawa, H.; Nagata, Y.; Mukaiyama, T. Bull. Chem. Soc. Jpn. 2004, 77, 1555-1567. 
65 Fujisawa, H.; Nagata, Y.; Sato, Y.; Mukaiyama, T. Chem. Lett. 2005, 34, 842-843. 
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the aformentioned chemistry on chiral aldehyde substrates as it came to our realization that the 
high propensity of syn aldol formation in these reactions, combined with Felkin addition on α-
chiral aldehydes via open transition states 167 can provide an avenue for the synthesis of syn, 
syn, syn-bispropionates 168 (Figure 36).    
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Figure 36. Felkin addition via open transition state will lead to syn, syn, syn-bispropionates 
 
Building on this hypothesis, we soon identified the optimum reaction conditions for the 
diastereoselective Lewis base catalyzed Mukaiyama aldol reaction. In presence of 20 mol% of 
the tetrabutylammonium 4-nitrophenoxide catalyst, in THF at −70 ˚C, the propionyl pyrrole 
derived enol silane 169 reacted with chiral aldehydes to provide the all-syn bispropionates 170a 
(96%, syn:anti = >99:1)  and 170b (62%, syn:anti = 99:1) (Table 1). Control experiments 
revealed that the p-nitrophenoxide catalyst expressed the correct Lewis basicity to promote 
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efficient enol silane addition without affecting base-promoted epimerization of the α-substituted 
aldehydes. The pyrrole functionality in the enol silane 169 enhanced nucleophilicity of the donor 
and also prevented epimerization of the products via deprotonation possible under the basic 
conditions of the reaction due to developing A1,3 strain in the enolate anion (Figure 37).    
 
Table 1. Selected examples of Lewis base-catalyzed Mukaiyama aldol reaction on chiral aldehydes   
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Figure 37. Advantages of the pyrrole functionality 
 
The relative stereoselection emerging from open transition state silyl enolate-aldehyde 
additions are governed by developing gauche interactions in the competing anti or synclinal 
transition states.66
 
 Steric demands of the hypervalent silicate 171 should render the enolate 
uniquely disposed toward C−C bond construction via the  anti transition state 172. Among the 
competing anti transition states 172 and 173 (Figure 38), a significant developing gauche 
interaction between the enolate methyl and the α-methyl group in the aldehyde would destabilize 
transition state 173. Enolate approach through transition state 172 would orient the enolate 
methyl substituent to minimize developing non-bonded interactions with the aldehyde alkyl 
chain while providing for Felkin aldehyde selectivity. Ensuing C−C bond construction would 
afford the all-syn propionate dimer 170. 
                                                 
66 Denmark, S. E.; Almstead, N. G. J. Org. Chem. 1994, 59, 5130-5132. 
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Figure 38. Competing anti transition states 
 
4.1.2 Synthesis of the All Syn C2-C5 Bispropionate of Erythronolide B 
Using the p-nitrophenoxide catalyzed Mukaiyama aldol protocol, the requisite syn, syn, syn-
bispropionate 174 was prepared from aldehyde 89 and enol ether 169 in 73% yield and as a 
single diastereomer (Scheme 33). The all-syn stereochemistry of 174 was confirmed from the X-
ray crystal structure of the TMS-deprotected diol 176. The Lewis base catalyzed Mukaiyama 
aldol reaction proved to give superior diastereoselectivity when compared to the corresponding 
BF3·Et2O catalyzed reaction which provided only a moderate 66:33 dr for the diastereomeric 
products 174 and 175. To confirm the stereochemistry of 175, it was deprotected to the diol 
which was then reprotected as an acetonide. The syn stereochemistry of this acetonide was 
confirmed via Rychnovsky’s protocol providing the stereochemical proof for distereomer 175 
(anti aldol, Felkin). The more sterically encumbered silicon center of the enolate involved in the 
Lewis base catalyzed process caused a much greater steric difference between the two competing 
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Felkin transition states 172 and 173 (see Figure 38). Therefore the syn aldol diastereomer 174 
was formed more preferentially in this case than in the Lewis acid (BF3·Et2O) catalyzed reaction.    
 
Scheme 33. Synthesis of 174 and its stereochemical proof 
 
 20 mol%
N
OTMS
Me
THF, −70 °C
5 equiv.
O
H
OTMS
Me
O-NBu4+
Me
O
Me
O OTMS
Me
N
O
Me
O OTMS
Me
N
MeMe
+
99:1 (73%)
NO2
169 89 174 175
O
Me
OH OH
Me
N
Me
X-ray
176
1N HCl
(97%)
66:33 (BF3⋅Et2O)
TMSTMS
 
4.2 INSTALLATION OF THE C6-STEREOCENTER  
4.2.1 Correction of C6 Stereochemistry 
Recognizing the strong stereochemical bias of 147 to undergo dihydroxylation via the inside 
alkoxy conformation, we decided to obtain the desired C6 stereochemistry via an inversion 
mechanism. The preference for allylic ethers to adopt the inside alkoxy conformation holds 
 97 
generally for any sort of electrophilic additions.67
 
 Specifically, we envisioned that in the 
iodination of 177, the double bond would present the inside alkoxy face for the approach of the 
electrophilic iodinating agent, as the alkoxy oxygen would provide a stabilizing electrostatic 
interaction with the partially positive charge on the developing halonium ion in the transition 
state.  If the resulting halonium ion could be trapped with an external oxygen nucleophile such as 
water or an alkoxide, an inversion would result at C6 leading to the desired diastereomer 178 
(Scheme 34).    
Scheme 34: Halonium ion formation followed by inversion with O-nucleophile could lead to desired C6-
stereochemistry 
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With this in mind, acetonide 177 was first prepared by protection of the diol 176 
(Me2C(OMe)2, cat. CSA, 88%) and then subjected to iodohydrin formation via a 
diphenyldiselenide-catalyzed protocol68
                                                 
67 Houk, K. N.; Moses, S. R.; Wu, Y. D; Rondan, N. G.; Jager, V.; Schohe, R.; Fronczek, F. R. J. Am. Chem. Soc. 
1984, 106, 3880-3882. 
 using NIS as the iodinating agent in presence of water as 
the nucleophile (using either molecular I2 or NIS alone in the absence of the selenium catalyst 
resulted in substantially slower reaction rates). Although the reaction proceeded cleanly to 
provide a single product, the 1H and 13C NMR of the isolated compound indicated absence of the 
acetonide ring. The compound formed in the reaction was presumably the tetrahydrofuran 179 
68 Carrera, I; Brovetto, M. C.; Seoane, G. A. Tetrahedron Lett. 2006, 47, 7849-7852. 
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which should result if the iodonium ion is intramolecularly trapped by the C3-alkoxy oxygen 
followed by hydrolytic cleavage of the acetonide protecting group (Scheme 35). 
 
Scheme 35: Attempted selenium catalyzed iodohydrin formation reaction of 177 
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Clearly, the installation of the desired C6 center by using the alkene as a nucleophile was 
turning out to be problematic. In order to provide a solution to this problem, we adopted a 
different strategy as shown in Figure 39.  Nucleophilic addition to ketones can provide tertiary 
alcohols and in case of chiral α-alkoxy ketones, the stereochemistry of addition is determined by 
the stereochemistry and nature of the alkoxy residue. In order to apply this strategy in our system 
the terminal alkene in 177 should be first converted to the ketone 180. Vinyl addition to this 
ketone via a Cram chelate transition state 181 should lead to the tertiary alcohol product 182 with 
the desired stereochemistry at C6.  
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Figure 39. Nucleophilic addition to ketone to set the C6-stereocenter 
 
The propensity of the ketone substrate 180 to participate in chelation would depend on 
the choice of the protecting group on the α-oxy group. In that respect, the acetal protecting group 
in our substrate would be optimal.  The nature of the cation participating in chelate formation is 
also important. Pioneering studies conducted by Still on the chelate-controlled additions of 
carbanions to ketones for the synthesis of simple vicinal diols demonstrated that Mg(II) is 
superior to Li(I) for the formation of chelates and THF is the optimal solvent.69 Earlier, Kishi 
had applied this strategy to synthesize 183, an important intermediate in his synthesis of 
lasalocid A. The stereoselective addition of ethylmagnesium bromide to ketone 184 proceeded 
through the chelate 185 to provide a single diastereomer of the tertiary alcohol product (eq 20).70
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69 Still, W. C.; McDonald, J. H. Tetrahedron Lett.  1980, 21, 1031-1034. 
70 Nakata, T.; Schmid, G.; Vranesic, B.; Okigawa, M.; Smith-Palmer, T.; Kishi, Y. J. Am. Chem. Soc. 1978, 100, 
2933-2935. 
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In order to synthesize ketone 180, the alkene 177 was subjected to standard ozonolysis 
conditions, which unfortunately led to a complex mixture of products due to the decomposition 
of the pyrrole moiety under those conditions. Therefore, 177 was converted first to the methyl 
ester 186 (96%) using sodium methoxide in MeOH and then ozonolyzed to provide the ketone 
187 (Scheme 36). Subsequent addition of vinylmagnesium bromide to 187 at −78 ˚C in THF 
provided 188 cleanly in high yield (99% over two steps) and as a single diastereomer.  
 
Scheme 36. Installation of C6-tertiary alcohol center 
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For stereochemical proof, 188 was converted to epoxide 189 (Scheme 37, eq 21) and its  
NMR spectra was compared to that of epoxide 99′ which possessed the incorrect stereochemistry 
at C6. A complete mismatch of the NMR spectra was observed, suggesting that 188 indeed 
possessed the correct C6 stereochemistry. With the correct C6 stereocenter finally in place, 188 
was converted to the aldehyde 191 via a two-step sequence involving ozonolysis of the vinylic 
double bond to provide the α-hydroxy aldehyde 190 (92%) followed by TES-protection of the 
C6-oxygen (81%) (Scheme 37).  
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Scheme 37: Stereochemical proof for 188 and synthesis of aldehyde 191 
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5.0  COMPLETING THE SYNTHESIS OF ERYTHRONOLIDE B 
5.1 ALDOL COUPLING OF FRAGMENTS 105 AND 191 
With the correct C6-stereochemistry and the all-syn propionate successfully established in the 
aldehyde fragment 191, the next goal was to engage it in the aldol coupling reaction with ketone 
105. The enolization of 105 was performed with lithium hexamethyldisilazide (LHMDS) at 0 ˚ C 
for 2 h and the resulting enolate was cooled to −78 ˚C before the aldehyde solution was 
cannulated.  The aldol product 192 was afforded in 51% yield as a single observable 
diastereomer along with recovery of unreacted starting materials (eq 22). The anticipated Felkin 
selectivity in the aldol reaction was confirmed later from the ROESY spectra of the ensuing 
benzylidene acetal intermediate 194.   
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5.2 SYNTHESIS OF MACROLACTONE 198 
Chelate controlled reduction of the aldol adduct 192 with Zn(BH4)271
 
 afforded diol 193 (95% 
yield, >95:5 diastereoselection), thereby establishing the desired (9S)-hydroxyl configuration 
required for macrocyclization. Benzylidene acetal 194 was then formed as a single isomer 
through an anhydrous DDQ oxidation (94%), differentiating the C7 and C9 alcohols and 
constraining the C9 and C11 hydroxyls for macrocyclization. Stereochemical characterization of 
the acetal 194 based on its ROESY spectrum clearly established the (R)-configuration of trans 
acetal (the acetal proton Ha showed correlation with H11 but not with H9) while also confirming 
the (9S)-hydroxyl configuration resulting from a Felkin selective aldol reaction (Scheme 38). 
Scheme 38: Stereochemistry verification of benzylidene acetal 194 
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71 Oishi, T.; Nakata, T. Acc. Chem. Res. 1984, 17, 338-344. 
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In the DDQ mediated formation of the acetal ring in 194, a new stereocenter was created. 
However, out of the two possible isomers, only the R-configured acetal isomer was formed 
selectively (from ROESY). The selective formation of this isomer over the undesired S-
configured acetal and the importance of this R-configured acetal isomer in the macrocyclization 
deserve some comment here. Conformational analysis of the two isomeric acetals shows that the 
alternative S-configured acetal suffers from a syn-pentane interaction between the C10 and C12 
methyl substituents. Therefore, even though the the R-configured acetal isomer contains greater 
number of axial substituents, minimization of syn-pentane interactions within its structure leads 
to the remarkable selectivity found for this acetal isomer. Similarly, in case of the cis benzylidine 
acetals 152′ and 160′ made previously, the R-configured acetal isomers were formed selectively. 
In Woodward’s erythromycin synthesis, the critical function of the C9/C11 cyclic acetal in the 
preorganization of the seco acid was revealed. In those studies, only the R-configured isomer was 
found to undergo successful lactonization. The spatial orientation of the extending arms R1 and 
R2 determine the ease of lactone formation in each of the acetal isomers. In the R-configured 
isomer of trans benzylidine acetal, the R1 and R2 groups (shown in red) are closer together 
making this isomer predisposed toward macrolactonization. On the other hand the reacting 
centers in the S-configured isomer are farther apart, preventing successful macrolactonization in 
this isomer (Figure 40).   
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Figure 40. Rationale for selective formation of the R-configured acetal 
 
At this point, all the stereocenters in the target had been installed, leaving only the final 
functional group manipulations and macrolactonization to complete the synthesis. First of all, the 
C7-OH in 194 needed to be removed through a radical deoxygenation process. In order to 
circumvent the problem of silyl-group migration, formation of xanthate was achieved at low 
temperature (−78 ˚C) using KHMDS as the base and the resulting naked C7-alkoxide was trapped 
at the same low temperature with excess CS2 present in the reaction mixture. This was followed 
by addition of MeI affording the desired methyl xanthate 195 in 90% yield.  The reduction of the 
xanthate via Barton radical deoxygenation72
                                                 
72 (a) Barton, D. H. R.; McCombie, S. W. J. Chem. Soc., Perkin Trans. 1 1975, 1574-1585. (b) Barton, D. H. R.; 
Dorchak, J.; Jaszberenyi, J. Cs. Tetrahedron 1992, 48, 7435-7446. 
 under Evan’s modified conditions6b using neat 
Bu3SnH was accompanied by epimerization of the acetal stereocenter providing a 2.4:1 mixture 
of deoxygenated R- and S-benzylidene acetals 196.  A similar problem had been encountered in 
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Evans’ synthesis of 6-deoxyerythronolide B, where the 3.3:1 mixture of deoxygenated 
benzylidene acetals was converted to the desired R-acetal isomer by equilibration with CSA. 
When 196 was subjected to similar conditions (cat. CSA in CH2Cl2), equilibration occurred to 
provide the desired isomer but extensive decomposition due to PMP-acetal deprotection was also 
observed in the reaction. To circumvent this problem equilibration was performed in presence of 
an excess of the acetal forming reagent (4-MeOC6H4CH(OMe)2). This allowed reprotection of 
the deprotected product in the reaction mixture to provide a single isomer of the deoxygenated 
product 197 (71% over two steps) (Scheme 39). 
 
Scheme 39. Xanthate formation and deoxygenation/equilibration 
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In preparation for macrocyclization, ester hydrolysis from the carboxyl terminus and 
cleavage of the C13-TBS protecting group was required to afford the seco acid. Hydrolysis of the 
methyl ester 197 to the free acid was achieved with aq. LiOH in THF/MeOH (1:1 v/v) at a 
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slightly elevated temperature of 50 ˚C (Scheme 40).   The C13-TBS group was then removed with 
TBAF in refluxing THF to afford the seco acid. Macrolactonization was successfully performed 
by Yonemitsu’s modified Yamaguchi lactonization protocol73
                                                 
73 (a) Hikota, M.; Sakurai, Y.; Horita, K.; Yonemitsu, O. Tetrahedron Lett. 1990, 31, 6367-6370. (b) Hikota, M.; 
Tone, H.; Horita, K.; Yonemitsu, O. J. Org. Chem. 1990, 55, 7-9. (c) Inanaga, J.; Hirata, K.; Saeki, H.; Katsuki, T.; 
Yamaguchi, M. Bull. Chem. Soc. Jpn. 1979, 52, 1989-1993. 
 which does not involve the high 
dilution conditions which are generally required in the conventional Yamaguchi macrolactonization 
to prevent intermolecular reactions. This interesting and highly efficient modification of Yamaguchi 
macrolactonization was reported in 1990 by Yonemitsu in the total synthesis of erythronolide A.
73a 
The 14-membered erythronolide A macrocycle was formed by treating a concentrated benzene 
solution of the mixed anhydride of the seco acid with excess DMAP at ambient temperature to afford 
the lactone in near quantitative yield. The success of this method had been attributed to the favorable 
conformation adopted by the seco acid, which greatly enhanced its propensity for cyclization. We 
incorporated similar lactonization conditions into our own synthetic strategy and obtained the 
protected erythronolide B macrocycle 198 in good yield (79% from 197) (Scheme 40). The 
subsequent conversion of 198 into erythronolide B has been reported previously5b and was hence 
not pursued. 
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Scheme 40. Macrolactonization of the seco-acid 197 
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5.3 CONCLUSION 
This synthesis, involving 19 steps in the longest linear sequence upto 198, constitutes the first 
catalytic asymmetric formal synthesis of erythronolide B. In pursuit of the synthesis, the 
integration of two different catalytic asymmetric processes of polypropionate synthesis has been 
elegantly achieved. The iterative cinchona alkaloid catalyzed AAC method of β-lactone synthesis 
is nicely showcased in the synthesis of six key stereochemical relationships in the two 
polypropionate fragments. The need to synthesize the syn propionate dimer in a “catalytic 
asymmetric” fashion inspired the development of the Lewis-base catalyzed Mukaiyama aldol 
reaction in our group. This methodology was successfully applied for the installation of the C3-
C4 and C4-C5 syn stereochemical relationships. This formal erythronolide B synthesis highlights 
the efficient access to complex polypropionate architecture through asymmetric catalysis. 
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5.4 EXPERIMENTAL 
General Information: Optical rotations were measured on a Perkin-Elmer 241 digital 
polarimeter with a sodium lamp at ambient temperature and are reported as follows: [α]λ (c 
g/100mL, solvent). Infrared spectra were recorded on a Nicolet Avatar 360 FT-IR spectrometer. 
NMR spectra were recorded on a Bruker Avance-300 (1H: 300 MHz; 13C: 75 MHz), 500 (1H: 
500 MHz; 13C: 125 MHz) or 600 (1H: 600 MHz; 13C: 150 MHz) spectrometers with chemical 
shifts reported relative to residual CHCl3 (7.26 ppm) for 1H and CDCl3 (77.0 ppm) for 13C NMR 
spectra or residual CH2Cl2 (5.32 ppm) for 1H and CD2Cl2 (53.8 ppm) for 13C NMR spectra. 
Unless otherwise stated, all reactions were carried out in flame-dry glassware under a nitrogen 
atmosphere using standard inert atmosphere techniques for the manipulation of solvents and 
reagents. Anhydrous solvents (CH2Cl2, THF and diethyl ether) were obtained by passage through 
successive alumina and Q5 reactant-packed columns on a solvent purification system. N, N-
Diisopropylethylamine and triethylamine were distilled under nitrogen from CaH2. 
Commercially available propionyl chloride was redistilled under N2. All the commercial 
chemicals are purchased from Aldrich Chemical Co. Anhydrous LiI, LiClO4 (ReagentPlus) and 
N,O-dimethylhydroxylamine hydrochloride were weighed out in a N2-filled glovebox. O-
Trimethylsilylquinidine (TMSQd) and O-trimethylsilylquinine (TMSQn) were prepared 
according to the literature procedure.74 Flash chromatography was performed on EM silica gel 
60 (230-240 mesh) unless noted otherwise.75
 
 If the reaction was worked up with aqueous 
extraction, d.r. (diastereomer ratio) was determined from crude NMR.  
                                                 
74 Calter, M. A. J. Org. Chem. 1996, 61, 8006-8007.  
75 Still, W. C.; Kahn, M.; Mitra, A. J. Org. Chem. 1978, 43, 2923-2925. 
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(3S,4R)-4-Ethyl-3-methyloxetan-2-one (76).  TMSQd (0.476 g, 1.20 
mmol) and LiClO4 (0.638 g, 6.00 mmol) were dissolved in 12 mL diethyl 
ether and 24 mL CH2Cl2 at room temperature and the solution was cooled to 
−78 °C.  N, N-Diisopropylethylamine (5.22 mL, 30.0 mmol) was added and the reaction was 
stirred 15 min at −78 °C.  Freshly distilled propanal (0.696 g, 0.870 mL, 12.0 mmol) was added 
whereupon a solution of propionyl chloride (1.08 mL, 24.0 mmol) in 6 mL CH2Cl2 was then 
added over 2 h by syringe pump.  Once addition was complete, the reaction was stirred 14 h at 
−78 °C.  The reaction was quenched at the reaction temperature by adding 10 mL Et2O and sat. 
aqueous NH4Cl solution and the resulting mixture was allowed to warm to ambient temperature.  
The layers were separated and the aqueous portion was extracted with ether (3×25 mL).  The 
organic extracts were combined, washed with brine, dried (Na2SO4) and concentrated.  The 
resulting crude product mixture was purified by flash chromatography (2.5% ether in pentane) 
affording 1.05 g (74%) of the title compound as a colorless liquid.  Separating the enantiomers 
by chiral GLC [Chirasil-dex CB  25 m x 0.25 mm column, flow rate 0.6 mL/min, method: 60 °C 
for 5.0 min, ramp @ 5.0 °C/min to 140 °C for 10.0 min, Tr: 18.0 min (3S,4R), Tr: 18.3 min 
(3R,4S)] provided the enantiomer and diastereomer ratios: (S,R):(R,S) = 1:99 (98% ee), cis:trans 
= >99:1 (>99% de). [α]D +30.0 (c 1.04, CH2Cl2);  IR νmax(thin film) cm-1: 2975, 1820, 1461, 1386, 
1119, 1044, 958, 845; 1H NMR (300 MHz, CDCl3): δ 4.49 (ddd,  J = 8.7, 6.3, 6.3 Hz, 1H), 3.74 
(dq,  J =7.8, 7.5 Hz, 1H), 1.89-1.65 (m, 2H), 1.28 (d,  J =7.5 Hz, 3H), 1.05 (t,  J =7.2 Hz, 3H); 
13C NMR (75 MHz, CDCl3): δ 172.6, 76.9, 47.1, 23.3, 9.7, 8.0. HRMS (EI) m/z calcd for 
C6H10O2: 114.0681; found: 114.0676. 
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(2S,3R)-3-Hydroxy-N-methoxy-N, 2-dimethylpentanamide (77). To 
a 0 °C stirred solution of N,O-dimethylhydroxylamine hydrochloride 
(1.11 g, 11.389 mmol) in 20 mL CH2Cl2, Me2AlCl (11.4 mL, 1.0 M in 
hexane, 11.389 mmol) was added dropwise and the resulting solution was warmed to ambient 
temperature. After stirring for 2 hours, a solution of lactone 76 (0.65 g, 5.695 mmol) in 5 mL 
CH2Cl2 was added. The resulting mixture was stirred overnight whereupon it was diluted with 15 
mL pH=7 phosphate buffer. The resulting biphasic mixture was stirred vigorously for an hour. 
Then the organic layer was separated and the aqueous layer was extracted with CH2Cl2 (3×25 
mL). The organic extracts were combined, dried (Na2SO4), and concentrated. The resulting crude 
oil was then purified by flash chromatography (35% ethyl acetate in hexanes) affording 0.92 g 
(92.0%) of the title compound as a clear colorless oil. [α]D +16.5 (c 1.01, CHCl3); IR νmax(thin film) 
cm-1: 3432, 2971, 2938, 1638, 1461, 1388, 1180, 1114, 993; 1H NMR (300 MHz, CDCl3): δ 3.76 
(ddd,  J = 8.1, 5.4, 2.7 Hz, 1H), 3.69 (s, 3H), 3.18 (s, 3H), 3.00-2.80 (m, 1H), 1.65-1.47 (m, 1H), 
1.45-1.30 (m, 1H), 1.15 (d,  J = 7.2 Hz, 3H), 0.95 (t,  J = 7.5 Hz, 3H); 13C NMR (75 MHz, 
CDCl3): δ 178.3, 73.1, 61.5, 38.1, 31.9, 26.7, 10.3, 10.0. HRMS (EI) m/z calcd for C8H17NO3: 
175.1208.; found: 175.1207. 
 
(2S,3R)-3-(tert-Butyldimethylsilyloxy)-N-methoxy-N,2-
dimethylpentanamide (78). To a solution of 77 (0.445 g, 2.541 mmol) 
in 20 mL CH2Cl2 at −78 °C, TBSOTf (0.88 mL, 3.811 mmol) was added and the reaction 
mixture was stirred for ten minutes whereupon Et3N (0.89 mL, 6.353 mmol) was added. After 
addition was complete, the reaction mixture was warmed to 0 °C and stirred for 30 minutes, then 
warmed to ambient temperature. After stirring for additional 3 h, the reaction was quenched by 
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adding a saturated aqueous solution of NaHCO3 (50 mL) and the resulting mixture was extracted 
with CH2Cl2 (3×30 mL). The combined organic extracts were combined, washed with brine, 
dried (Na2SO4), and concentrated. The resulting crude oil was purified by flash chromatography 
(30-35% ethyl acetate in hexanes), affording 0.71 g (97%) of the title compound as clear 
colorless oil. [α]D +4.17 (c 1.34, CHCl3); IR νmaxneat cm-1 2959, 1665, 1463, 1383, 1254, 1114, 
1048, 999, 835, 774; 1H NMR (300 MHz, CDCl3): δ  3.87 (dt, J = 8.7, 4.8 Hz, 1H), 3.68 (s, 3H), 
3.16 (s, 3H), 3.10-2.91 (m, 1H), 1.60-1.40  (m, 2H), 1.13 (d, J = 7.2 Hz, 3H), 0.88 (s. 9H), 0.86 
(t, J = 7.5 Hz, 3H), 0.04 (s, 3H), 0.04 (s, 3H); 13C NMR (75 MHz, CDCl3): δ 176.7, 74.1, 61.4, 
39.9, 32.0, 28.1, 25.9, 18.1, 14.6, 8.4, −4.3, −4.5. HRMS (EI) m/z calcd for C14H31NO3Si: 
289.2073; found: 289.2067. 
 
(2S,3R)-3-(tert-Butyldimethylsilyloxy)-2-methylpentanal (79).  To a 
solution of 78 (1.88 g, 6.51 mmol) in 50 mL THF at −78 °C, iBu2AlH (13.0 
mL, 1.0 M in hexane, 13.0 mmol) was added dropwise. The reaction was stirred until complete 
as monitored by TLC (1.5 h) and quenched by adding a saturated aqueous solution of Rochelle 
salt solution (30 mL) at −78 °C. The resulting gel-like mixture was warmed to ambient 
temperature, stirred vigorously until clear and extracted with ether (2 × 50 mL). The combined 
organic extracts were washed with brine, dried (Na2SO4) and concentrated. The crude oil was 
purified by flash chromatography (2% ether in pentane), affording 1.50 g (100%) of the title 
compound as colorless oil.  [α]D +58.5 (c 1.10, CH2Cl2); IR νmax(thin film) cm-1: 2958, 2708, 1726, 
1463, 1361, 1254, 1103, 1047, 1029, 837, 775; 1H NMR (300 MHz, CDCl3): δ 9.76 (d, J = 0.9 
Hz, 1H), 4.02 (dt, J = 6.6, 3.6 Hz, 1H), 2.45 (tq, J = 6.9, 3.6, 0.9 Hz, 1H), 1.58-1.42 (m, 1H), 
1.04 (d, J = 6.9 Hz, 3H), 0.87 (t, J = 7.2 Hz, 3H), 0.84 (s, 9H), 0.05 (s, 3H), 0.02 (s, 3H); 13C 
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NMR (75 MHz, CDCl3): δ 205.4, 73.4, 50.8, 27.4, 25.8, 18.0, 10.1, 7.6, −4.2, −4.7. HRMS (EI) 
m/z calcd for C12H26O2Si: 230.1702; found: 230.1691. 
 
(3R,4S)-4-[(2R,3R)-3-(tert-Butyldimethylsilyloxy)pentan-2-yl]-3-
methyloxetan-2-one (80).  To a suspension of TMSQn (0.069 g, 0.17 
mmol) and LiI (1.16 g, 8.68 mmol) in 0.85 mL ether was added 8 mL 
CH2Cl2 and the reaction mixture was cooled to −78 °C.  To this mixture was added N, N-
diisopropylethylamine (0.76 mL, 4.34 mmol) followed by a solution of the aldehyde 79 (0.400 g, 
1.74 mmol) in 1 mL CH2Cl2.  A solution of propionyl chloride (0.300 mL, 3.47 mmol) in 2 mL 
CH2Cl2 was then added over 3 h by syringe pump.  After addition was complete, the reaction 
was stirred an additional 17 h at –78 °C whereupon the reaction was quenched at the reaction 
temperature by adding ether (20 mL) and a saturated aqueous solution of NH4Cl (20 mL).  The 
resulting mixture was warmed to ambient temperature and extracted with ether (3×20 mL).  The 
combined organic extracts were washed with brine, dried (Na2SO4), and concentrated.  The crude 
product mixture was then purified by flash chromatography (2.5% ethyl acetate in hexanes) 
giving 0.470 g (95%) of the title compound as clear colorless oil.  Analysis of the crude product 
mixture by 1H/13C NMR indicated a single product diastereomer.  [α]D –30.1 (c 1.26, CH2Cl2); 
IR νmax
(thin film) cm-1: 2958, 2857, 1828, 1463, 1386, 1256, 1149, 1093, 1051, 876, 833, 775; 1H 
NMR (300 MHz, CDCl3): δ 4.43 (dd, J = 11.1, 6.3 Hz, 1H), 3.81 (ddd, J = 8.7, 5.7, 1.5 Hz, 1H), 
3.76 (dq, J = 7.8, 7.5 Hz, 1H), 1.93-1.80 (m, 1H), 1.60-1.40 (m, 2H), 1.32 (d, J = 7.5 Hz, 3H), 
0.88 (s, 9H), 0.83 (t, J = 7.5 Hz, 3H), 0.80 (d, J = 6.9 Hz, 3H), 0.05 (s, 3H), 0.04 (s, 3H); 13C 
NMR (75 MHz, CDCl3): δ 172.9, 76.2, 71.2, 46.4, 36.0, 27.7, 25.9, 18.1, 10.1, 8.5, 7.2, −4.2, 
−4.9; HRMS (EI) m/z calcd for C11H21SiO3 [(M – tBu)•+]: 229.1259; found: 229.1255. 
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(2R,3S,4R,5R)-5-(tert-Butyldimethylsilyloxy)-3-hydroxy-N-
methoxy-N,2,4-trimethylheptanamide (82). To a 0 °C stirred 
solution of N,O-dimethylhydroxylamine hydrochloride (0.283 g, 2.93 mmol) in 10 mL CH2Cl2, 
Me2AlCl (2.93 mL, 1.0 M in hexane, 2.93 mmol) was added dropwise and the resulting solution 
was warmed to ambient temperature. After stirring for 2 h, the reaction mixture was recooled to 
0 °C and a solution of 80 (0.420 g, 1.46 mmol) in 2 mL CH2Cl2 was added.  The reaction was 
stirred for 12 h at ambient temperature whereupon the reaction mixture was diluted with pH = 7 
phosphate buffer (15 mL) at 0 °C. The resulting biphasic mixture was stirred vigorously for 1 h.  
The layers were separated and the aqueous portion was extracted with CH2Cl2 (3×25 mL).  The 
organic extracts were combined, dried (Na2SO4), and concentrated. The resulting crude oil was 
purified by flash chromatography on SiO2 (7% ethyl acetate in hexanes) to afford 0.500 g (98%) 
of the title compound as a clear colorless oil.  [α]D –1.4 (c 0.30, CHCl3); IR νmax(thin film) cm-1: 
3465, 2959, 2856, 1641, 1462, 1387, 1251, 1061, 999, 834, 774; 1H NMR (300 MHz, CDCl3): δ 
4.11 (d, J = 1.8 Hz, 1H), 4.03 (dt, J = 7.8, 1.5 Hz, 1H), 3.76 (td, J = 9, 2.4 Hz, 1H), 3.70 (s, 3H), 
3.20 (s, 3H), 3.07-2.95 (m, 1H), 1.70 -1.58 (m, 1H), 1.60-1.42 (m, 2H), 1.15 (d, J = 6.9 Hz, 3H), 
0.87 (s, 9H), 0.84 (t, J = 7.5 Hz, 3H), 0.79 (d, J = 6.9 Hz, 3H), 0.08 (s, 3H), 0.06 (s, 3H);  13C 
NMR (75 MHz, CDCl3): δ 178.3, 73.3, 72.6, 61.4, 38.1, 36.4, 32.1, 27.5, 26.0, 18.1, 10.6, 9.9, 
9.3, −4.2, −4.6; HRMS (EI) m/z calcd for C17H37NO4Si: 347.2492; found: 347.2490.  
 
(2R,3S,4R,5R)-5-(tert-Butyldimethylsilyloxy)-N-methoxy-3- 
(methoxymethoxy)-N,2,4-trimethylheptanamide (83). To an 
ice-cold solution of the alcohol 82 (0.250 g, 0.719 mmol) and N, 
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N-diisopropylethylamine (0.378 mL, 2.16 mmol) in 10 mL CH2Cl2, MOMCl (0.109 mL, 1.44 
mmol) was added and the reaction mixture was warmed to 70 °C. Additional 3 equivalents of the 
base and 2 equivalents of MOMCl were added in two separate batches after a gap of 8 hours 
each and the reaction mixture was stirred until TLC monitoring showed complete consumption 
of the starting alcohol (if required, excess reagents were added). The reaction was then cooled to 
ambient temperature, diluted with ether (20 mL) and a saturated aqueous solution of NaHCO3 
(30 mL) and the layers were separated. The organic layer was washed with brine, dried 
(Na2SO4), and concentrated. The resulting crude oil was purified by flash chromatography (6% 
ethyl acetate in hexanes), affording 0.24 g (85% yield) of the title compound as a pale yellow oil. 
[α]D −24.51 (c 1.33, CH2Cl2); IR νmax(thin film) cm-1: 2936, 2885, 1672, 1463, 1379, 1251, 1145, 
1095, 1037, 835, 774; 1H NMR (300 MHz, CDCl3): δ 4.61 (d,  J = 6.6 Hz, 1H), 4.51 (d,  J = 6.6 
Hz, 1H), 3.94 (dd,  J = 8.4, 3.3 Hz, 1H), 3.80 (ddd,  J = 8.1, 4.8, 2.4 Hz, 1H), 3.67 (s, 3H), 3.35 
(s, 3H), 3.18 (s, 3H), 3.00 - 2.90 (m, 1H), 1.72-1.62 (m, 1H), 1.58-1.44 (m, 2H), 1.13 (d,  J = 6.9 
Hz, 3H), 0.87 (s, 9H), 0.83 (d,  J = 6.9 Hz, 3H),  0.83 (t,  J = 7.5 Hz, 3H), 0.05 (s, 6H); 13C 
NMR (75 MHz, CDCl3): δ 176.4, 97.8, 80.5, 72.4, 60.9, 55.9, 39.3, 37.6, 32.5, 28.3, 25.8, 18.2, 
10.2, 9.7, 9.4, −3.8, −4.7.  
 
(4R,5S,6R,7R)-7-(tert-Butyldimethylsilyloxy)-5-
(methoxymethoxy)-4,6-dimethylnonan-3-one (84). To a 
solution of 83 (0.235 g, 0.600 mmol) in 10 mL Et2O, ethyl 
magnesium bromide (0.50 mL, 3.0 M solution in hexanes, 1.5 mmol) was added and the reaction 
mixture was allowed to stir at ambient temperature until complete as monitored by TLC (3 h). 
The reaction was quenched by adding a saturated aqueous solution of NH4Cl (20 mL) and 
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extracted with ether (2×20 mL). The organic extracts were combined, dried (Na2SO4), and 
concentrated. The crude oil was purified by flash chromatography (5% ethyl acetate in hexane), 
affording 0.212 g (98% yield) of the title compound as colorless oil. [α]D −63.6 (c 0.11, CHCl3); 
IR νmax
neat cm-1 2936, 1716, 1462, 1382, 1251, 1144, 1039, 834, 773; 1H NMR (300 MHz, 
CDCl3): δ 4.58 (d,  J = 6.6 Hz, 1H), 4.49 (d,  J = 6.6 Hz, 1H), 4.03 (dd,  J = 9.0, 1.8  Hz, 1H), 
3.84 (ddd,  J = 8.4, 5.1, 1.8  Hz, 1H), 3.25 (s, 3H), 2.72-2.56 (m, 2H), 2.49-2.35 (m, 1H), 1.73-
1.62 (m, 1H), 1.64-1.42 (m, 2H), 1.09 (d,  J = 6.9 Hz, 3H), 1.06 (t,  J = 7.5 Hz, 3H), 0.9 (s, 9H), 
0.83 (t,  J = 7.5 Hz, 3H), 0.8 (d,  J = 6.9 Hz, 3H), 0.07 (s, 6H); 13C NMR (75 MHz, CDCl3): δ 
212.9, 97.9, 80.8, 72.7, 55.9, 48.4, 39.4, 33.8, 28.4, 26.0, 18.3, 10.1, 9.4, 8.6, 8.0, −3.4, −4.4.  MS 
(ESI): m/z 383.3 (M++Na); HRMS (EI) m/z calcd for C19H40SiO4: 360.2696. Found: 360.2692. 
 
(4R,5S,6R,7R)-7-(tert-butyldimethylsilyloxy)-5-hydroxy-4,6-
dimethylnonan-3-one (85).  To a solution of 82 (0.390 g, 1.12 
mmol) in 15 mL Et2O, ethyl magnesium bromide (1.12 mL, 3.0 M 
solution in hexanes, 3 equiv, 3.37 mmol) was added and the reaction mixture was allowed to stir 
at ambient temperature for 1 h during which time, the reaction mixture became cloudy with a 
white precipitate.  Another portion of ethyl magnesium bromide (1.12 mL, 3.0 M solution in 
hexanes, 3 equiv, 3.37 mmol) was added and stirred until the reaction was complete (as 
monitored by TLC). The reaction was quenched by adding a saturated aqueous solution of 
NH4Cl solution (30 mL) and the resulting mixture was extracted with ether (2×20 mL).  The 
combined organic extracts were dried (Na2SO4) and concentrated. The resulting crude oil was 
purified by flash chromatography (4% ethyl acetate in hexanes) to afford 0.330 g (93%) of the 
title compound as a clear colorless oil.  [α]D +10.3 (c 1.18, CH2Cl2); IR νmax(thin film) cm-1: 3481, 
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2959, 2937, 2883, 2858, 1704, 1462, 1382, 1253, 1047; 1H NMR (300 MHz, CDCl3): δ 4.03 (dt, 
J = 9.9, 2.1 Hz, 1H), 3.87 (d, J = 1.8 Hz, 1H), 3.82 (ddd, J =  7.8, 5.5, 2.4 Hz, 1H), 2.60-2.50 (m, 
3H), 1.80-1.67 (m, 1H), 1.65-1.48 (m, 2H), 1.10 (d, J = 6.9 Hz, 3H), 1.06 (t, J = 7.5 Hz, 3H), 
0.90 (t, J = 7.5 Hz, 3H), 0.89 (s, 9H), 0.77 (d, J = 6.9 Hz, 3H), 0.10 (s, 3H), 0.07 (s, 3H); 13C 
NMR (75 MHz, CDCl3): δ 215.0, 76.9, 72.9, 48.4, 39.2, 34.0, 25.9, 25.4, 18.0, 11.7, 11.1, 8.2, 
7.8, −4.5, −4.6. MS (ESI): m/z 339.2 (M ++ Na); HRMS (ESI) m/z calcd for C17H36O3SiNa 
[(M+Na)+]: 339.2331; found: 339.2360. 
 
(3R,4R)-3-Methyl-4-(prop-1-en-2-yl)oxetan-2-one (86). TMSQn (0.565 g, 
1.43 mmol) and LiI (3.800 g, 28.53 mmol) were dissolved in 5 mL diethyl 
ether and 45 mL CH2Cl2 at room temperature and then cooled to −40 °C.  To 
this solution was added N, N-diisopropylethylamine (6.25 mL, 35.7 mmol) and the mixture was 
stirred 15 min whereupon freshly distilled methacrolein (1.000 g, 1.180 mL, 14.27 mmol) was 
added.  A solution of propionyl chloride (2.730 mL, 31.39 mmol) in 2.3 mL CH2Cl2 was then 
added over 2 h by syringe pump.  The reaction was stirred 16 h then at –78 °C by adding 60 mL 
Et2O and 60 mL sat. NH4Cl solution.  The resulting mixture was warmed to ambient 
temperature, the layers were separated and the aqueous portion was extracted with ether (3×25 
mL).  The combined organic extracts were washed with brine, dried (Na2SO4) and concentrated.  
The resulting crude product was purified by flash chromatography (pentane followed by 1-2.5% 
ether in pentane) giving 0.92 g (62%) of the title compound as a colorless, highly volatile liquid.  
Crude NMR of the reaction mixture showed the conversion was 80-85%.  Separation of the 
enantiomers by chiral GLC [Chirasil-dex CB  25 m x 0.25 mm column, flow rate 0.5 mL/min, 
method: 80 °C for 5.0 min, ramp @ 5.0 °C/min to 100 °C for 10.0 min, ramp @ 5.0 °C/min to 
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130 °C for 5.0 min, Tr: 23.5 min (3S,4S), Tr: 24.3 min (3R,4R)] provided the enantiomer and 
diastereomer ratios: (S,S):(R,R) = 1:99 (98% ee), cis:trans = >99:1 (>99% de). [α]D +10 (c 0.92, 
CHCl3);  IR νmax(thin film) cm-1: 2981, 2947, 1829, 1455, 1378, 1262, 1008, 993, 922, 730; 1H NMR 
(300 MHz, CDCl3): δ  5.18 (br s, 1H), 5.15 (br s, 1H), 4.92 (d, J = 6.6 Hz, 1H), 3.85 (dq, J = 7.8, 
6.6 Hz, 1H), 1.73 (s, 3H), 1.22 (d, J = 7.5 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 171.9, 138.2, 
113.3, 75.9, 48.8, 19.0, 8.5; HRMS (EI) m/z calcd for C7H10O2: 126.0681; found 126.0677. 
 
(2R,3R)-3-Hydroxy-N-methoxy-N,2,4-trimethylpent-4-enamide (87). 
To a 0 °C stirred solution of N,O-dimethylhydroxylamine hydrochloride 
(1.00 g, 10.3 mmol) in 40 mL CH2Cl2, Me2AlCl (10.31 mL, 1.0 M in hexane, 10.31 mmol) was 
added dropwise and the resulting mixture was warmed to ambient temperature. After the reaction 
was stirred for 2 hours, a solution of lactone 86 (0.650 g, 5.15 mmol) in 5 mL CH2Cl2 was added. 
The resulting mixture was stirred overnight, then quenched with 15 mL of pH = 7 phosphate 
buffer. The resulting biphasic mixture was stirred vigorously for an hour. Then the organic layer 
was separated and the aqueous layer was extracted with CH2Cl2 (3×25 mL). The combined 
organic extracts were dried (Na2SO4) and concentrated. Purification by flash chromatography 
(20% ethyl acetate in hexanes) afforded 0.82 g (85%) of the title compound as a white solid. m.p. 
73-75 ˚C;   [α]D +15.5 (c 1.19, CHCl3); IR νmax(thin film) cm-1: 3434, 3054, 2986, 1632, 1422, 1265, 
994; 1H NMR (300 MHz, CDCl3): δ 5.18 (t, J = 2.4 Hz, 1H), 4.99 (app sextet, J = 1.8 Hz, 1H), 
4.34 (s, 1H), 4.08 (br s, 1H), 3.71 (s, 3H), 3.20 (s, 3H), 3.10-3.00 (m, 1H), 1.70 (s, 3H), 1.09 (d, J 
= 6.9 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 178.1, 143.1, 111.8, 74.1, 61.5, 36.5, 32.0, 19.5, 
9.9; HRMS (EI)  m/z calcd for C9H17NO3: 187.1208; found: 187.1204. 
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(2R,3R)-N-Methoxy-N,2,4-trimethyl-3-(trimethylsilyloxy)pent-4-
enamide (88). To a solution of 87 (0.758 g, 4.05 mmol) in 20 mL 
CH2Cl2 at room temperature, Et3N (0.960 mL, 6.88 mmol) was added and the reaction was 
stirred for 5 min. The reaction mixture was then cooled to 0 °C and TMSCl (0.770 mL, 6.70 
mmol) was added dropwise. The reaction was stirred for an additional 4 h, then quenched by 
adding a saturated aqueous solution of NaHCO3 (50 mL) and extracted with CH2Cl2 (2×30 mL). 
The combined organics were washed with brine, dried (Na2SO4) and concentrated. The resulting 
crude oil was purified by flash chromatography (5% ethyl acetate in hexanes) affording 0.94 g 
(94%) of the title compound as colorless oil. [α]D −11.2 (c 1.70, CHCl3); IR νmax(thin film) cm-1: 
3076, 2959, 1665, 1459, 1383, 1251, 1082; 1H NMR (300 MHz, CDCl3): δ 4.87 (s, 1H), 4.77 (s, 
1H), 4.23 (d, J = 8.7 Hz, 1H), 3.64 (s, 3H), 3.15-3.05 (m, 1H), 3.11 (s, 3H), 1.70 (s, 3H), 1.17 (d, 
J = 6.6 Hz, 3H), 0.10 (s, 9H); 13C NMR (75 MHz, CDCl3): δ 175.7, 145.6, 112.5, 78.1, 61.2, 
40.2, 31.9, 17.0, 14.2, −0.2. HRMS (EI) m/z calcd for C12H25NO3Si: 259.1604; found: 259.1614. 
 
(2R,3R)-2,4-Dimethyl-3-(trimethylsilyloxy)pent-4-enal (88). To a 
solution of Weinreb amide 12 (2.12 g, 8.17 mmol) in 50 mL THF at − 78 
°C, iBu2AlH (16.34   mL, 1.0 M in hexane, 16.34 mmol) was added dropwise. After being stirred 
for another 1 h at the same temperature, the reaction was quenched with 50 mL sat. aqueous 
Rochelle salt solution at –78 °C. The gel-like mixture was warmed to ambient temperature and 
stirred vigorously until clear. 50 x 2 mL Et2O was then added for extraction and the organic 
layers were combined and washed with brine, dried (Na2SO4) and concentrated. The crude oil 
was purified with flash column (2.5% ethyl acetate in hexanes), affording 1.54 g (94%) of the 
title compound as a colorless oil.  [α]D +10 (c 0.23, CHCl3); IR νmax(thin film) cm-1: 3095, 2959, 
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2715, 1727, 1452, 1252, 1113, 1036, 872, 843, 752; 1H NMR (300 MHz, CDCl3): δ  9.66 (d, J = 
1.8 Hz, 1H), 4.97 (s, 1H), 4.91 (s, 1H), 4.41 (d, J = 5.1 Hz, 1H), 2.54-2.43 (m, 1H), 1.69 (s, 3H), 
1.03  (d,  J = 6.6 Hz, 3H),  0.08 (s, 9H); 13C NMR (75 MHz, CDCl3): δ 204.5, 144.7, 112.7, 75.5, 
50.0, 18.4, 8.1, −0.1; HRMS (EI) m/z calcd for C10H20O2Si: 200.1233; found: 200.1233. 
 
(2R,3S,4S,5R)-1-[(R)-4-Benzyl-2-thioxooxazolidin-3-yl]-3-
hydroxy-2,4,6-trimethyl-5-(trimethylsilyloxy)hept-6-en-1-one 
(94). To an ice-cold solution of N-propionyloxazolidinone 
(0.408 g, 1.63 mmol) in 10 mL of CH2Cl2, titanium (IV) 
chloride (0.188 mL, 1.72 mmol) was added dropwise and the solution was stirred for 5 min 
whereupon a thick yellow slurry was formed. (-)-Sparteine (0.938 mL, 4.08 mmol) was added 
and the resulting dark red enolate solution was stirred for 20 min at 0 °C. The reaction mixture 
was then cooled to −78 °C and a solution of aldehyde 89 (0.360 g, 1.80 mmol) in 1 mL CH2Cl2 
was added dropwise. After addition was complete, the reaction was warmed to 0 °C and stirred 
for another 1 h. The reaction was quenched with half-saturated ammonium chloride solution (10 
mL) and the layers were separated. The organic layer was dried over sodium sulfate, filtered, and 
concentrated. Purification by flash chromatography (2.5% ethyl acetate in hexanes) afforded 
0.661 g (90%) of the title compound as a single diastereomer as determined by 1H NMR analysis 
of the crude product mixture. [α]D −88.9 (c 0.56, CHCl3); IR νmax(thin film) cm-1: 3501, 2962, 1693, 
1454, 1366, 1315, 1192, 1154, 1052, 957, 841, 747 ; 1H NMR (300 MHz, CDCl3): δ 7.33-7.20 
(m, 5H), 4.95 (s. 1H), 4.92 (s, 1H), 4.85-4.95 (m, 1H), 4.87-4.76 (m, 1H), 4.35-4.23 (m, 2H), 
4.10 (d,  J = 5.7 Hz, 1H), 4.00 (ddd,  J = 8.4, 3.9, 2.7 Hz, 1H), 3.21 (dd,  J = 13.2, 3.3 Hz, 1H), 
2.75 (dd,  J = 13.2, 9.9 Hz, 1H), 2.49 (d,  J = 2.9 Hz, 1H), 1.69 (s, 3H), 1.67-1.62 (m, 1H), 1.39 
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(d,  J = 6.6 Hz, 3H), 0.89 (d,  J = 6.6 Hz, 3H),  0.11 (s, 9H); 13C NMR (75 MHz, CDCl3): δ 
184.7, 177.1, 145.8, 135.1, 129.4, 129.1, 127.5, 112.5, 80.1, 74.3, 70.1, 59.9, 41.5, 38.8, 37.5, 
18.1, 14.6, 7.9, 0.13; MS (EI, 70 eV): m/z  449, 431, 416, 398, 194, 143, 117, 102, 91, 73; 
HRMS (EI) m/z calcd for C23H33NO3SSi [(M+–H2O)•+]: 431.1950; found: 431.1937. 
 
(R)-1-[(R)-4-Benzyl-2-thioxooxazolidin-3-yl]-2-[(4S,5S,6R)-
2,2,5-trimethyl-6-(prop-1-en-2-yl)-1,3-dioxan-4-yl]propan-1-
one (96). To a stirred solution of the aldol product 94 (0.638 g, 
1.42 mmol) in 10 mL MeOH at room temperature, was added a few drops (12-15) of 1 N 
aqueous HCl solution and the reaction mixture was stirred until complete as monitored by TLC 
(~15 min). The reaction was diluted with saturated aqueous NaHCO3 solution (50 mL) and 
extracted with EtOAc (2×50 mL). The combined organic extracts were dried (Na2SO4) and 
concentrated. The resulting crude diol product 95 was carried to the next step without further 
purification. 
  To a solution of the diol (prepared above) in 2,2-dimethoxypropane (10 mL) was added a 
catalytic amount of camphor sulfonic acid (2.3 mg, 0.010 mmol) and the reaction was stirred for 
4.5 h at ambient temperature. Et3N (2 mL) was added to quench the reaction and the reaction 
mixture was concentrated. The resulting oil was purified by flash chromatography (5% ethyl 
acetate in hexanes) to afford the 0.512 g (87% over two steps) of the title compound as a viscous 
yellow oil. IR νmax(thin film) cm-1: 3028, 2990, 1694, 1454, 1365, 1194, 1156, 1018, 968; 1H NMR 
(300 MHz, CDCl3): δ 7.35-7.20 (m, 5H), 5.03 (s, 1H), 5.00-4.90 (m, 1H), 4.89 (s, 1H), 4.80-4.66 
(m, 1H), 4.44-4.22 (m, 4H), 3.21 (dd,  J = 13.5, 3.6 Hz, 1H), 2.76 (dd,  J = 13.2, 10.2 Hz, 1H), 
1.70-1.65 (m, 1H), 1.64 (s, 3H), 1.48 (s, 3H), 1.45 (s, 3H), 1.37 (d,  J = 6.9 Hz, 3H), 0.68 (d,  J = 
O
Me
O
Me
Me
O
N O
S
Bn
Me Me
 122 
6.9, 3H); 13C NMR (75 MHz, CD2Cl2): δ 184.8, 175.6, 142.9, 135.4, 129.5, 128.9, 127.4, 109.9, 
99.2, 74.8, 74.7, 70.4, 59.8, 40.4, 37.5, 31.1, 29.7, 19.4, 19.1, 15.5, 5.8; MS (EI, 70 eV): m/z 
417, 402, 359, 342, 276, 249, 194, 117, 102; HRMS (ESI) m/z calcd for C23H31NO4S (M+): 
417.1974; found: 417.1989.  
 
(R)-1-[(R)-4-Benzyl-2-thioxooxazolidin-3-yl]-2-{(4S,5S,6R)-6-
[(S)-1,2-dihydroxypropan-2-yl]-2,2,5-trimethyl-1,3-dioxan-4-
yl}propan-1-one (97′).  To the acetonide 96 (1.015 g, 2.431 
mmol) in tBuOH/H2O (1: 1 v/v, 50 mL total), was added methanesulfonamide (0.231 g, 2.43 
mmol) followed by AD-mix α (3.646 g). The yellow reaction mixture was allowed to stir at 
ambient temperature for 20 h whereupon it was diluted with 20 mL EtOAc followed by the 
addition of Na2SO3 (0.919 g, 7.29 mmol). The resulting heterogeneous mixture was stirred for 20 
min. The layers were then separated and the aqueous layer was extracted with EtOAc (2×50 
mL). The combined organic extracts were washed with 1M NaHSO4 solution (1×50 mL), sat. 
NaHCO3 solution (1×50 mL) and brine, dried over Na2SO4 and concentrated. The resulting crude 
oil was purified by flash chromatography (60% ethyl acetate in hexanes) affording 1.04 g (96%) 
of the title compound as a colorless viscous oil. IR νmax(thin film) cm-1: 3435, 2989, 2936, 1735, 
1693, 1454, 1376, 1310, 1197, 1155, 1046, 1016, 969, 746, 702; 1H NMR (300 MHz, CDCl3): δ 
7.40-7.19 (m, 5H), 5.00-4.90 (m, 1H), 4.80-4.70 (m, 1H), 4.36-4.26 (m, 2H), 4.15 (dd,  J = 9.9, 
2.1 Hz, 1H), 3.94 (d,  J = 2.1 Hz, 1H), 3.79 (dd,  J =11.4, 3.6 Hz, 1H), 3.40 (dd,  J = 11.1, 2.7 
Hz, 1H), 3.19 (dd,  J = 13.2, 3.3 Hz, 1H), 2.87 (br s, 1H), 2.75 (dd,  J =13.5, 10.2 Hz, 1H), 2.50-
2.35 (br m,1H), 1.76-1.66 (m, 1H), 1.46 (s, 3H), 1.44 (s, 3H), 1.35 (d,  J = 6.6 Hz, 3H), 1.16 (s, 
3H), 0.94 (d,  J = 6.9 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 184.4, 175.6, 135.0, 129.3, 129.0, 
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127.5, 127.5, 99.9, 78.9, 76.0, 73.5, 70.1, 67.7, 59.7, 39.7, 37.5, 31.2, 29.8, 21.8, 19.4, 15.6, 7.4; 
HRMS (EI) m/z calcd for C23H33NO6S:  451.2029; found: 451.2007. 
 
(S)-2-{(4R,5S,6S)-6-[(R)-1-[(R)-4-Benzyl-2-thioxooxazolidin-
3-yl]-1-oxopropan-2-yl]-2,2,5-trimethyl-1,3-dioxan-4-yl}-2-
hydroxypropyl 4-methylbenzenesulfonate (98′). To a solution 
of the diol 97′ (0.840 g, 1.85 mmol) and N,N-
dimethylaminopyridine (0.340 g, 2.79 mmol), in 6 mL CH2Cl2 at 0 °C, p-toluenesulfonyl 
chloride (0.425 g, 2.23 mmol) was added. The reaction mixture was allowed to stir at ambient 
temperature for 24 h, then quenched by adding a saturated aqueous solution of NH4Cl (20 mL). 
The layers were separated and the aqueous layer was extracted with CH2Cl2 (2×20 mL). The 
organic extracts were combined, washed with brine, dried (Na2SO4) and concentrated. The 
resulting crude oil was purified by flash chromatography (30% ethyl acetate in hexanes), 
affording 0.96 g (85% yield) of the title compound as a colorless viscous oil, sometimes as a 
white foam. IR νmax(thin film) cm-1: 3501, 2990, 1694, 1455, 1365, 1310, 1190, 1176, 1097, 1018, 
975, 837; 1H NMR (300 MHz, CDCl3): δ 7.81 (d,  J = 8.4 Hz, 2H), 7.40-7.20 (m, 7H), 5.10-4.95 
(m, 1H), 4.80-4.65 (m, 1H), 4.40-4.30 (m, 2H), 4.20-4.10 (m, 1H), 3.99 (d,  J = 9.6 Hz, 1H),  
3.91 (d,  J = 9.6 Hz, 1H), 3.80 (br s, 1H), 3.25 (dd,  J = 12.9, 3.3 Hz, 1H), 2.78 (dd,  J = 13.5, 
9.9 Hz, 1H), 2.46 (s, 3H), 2.50-2.30 (m, 1H), 1.78-1.70 (m, 1H), 1.42 (s, 6H), 1.35 (d,  J = 6.6 
Hz, 3H), 1.16 (s, 3H), 0.95 (d,  J = 6.6 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 184.7, 175.8, 
145.1, 135.2, 129.9, 129.8, 129.4, 129.0, 128.0, 127.4, 100.1, 76.2, 75.3, 72.6, 70.4, 60.4, 60.1, 
39.7, 37.5, 31.1, 29.7, 23.0, 21.7, 19.5, 15.2, 7.6; HRMS (EI) m/z calcd for C30H39NO8S2: 
605.2117; found: 605.2120. 
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(R)-Methyl 2-{(4S,5S,6R)-2,2,5-trimethyl-6-[(S)-2-methyloxiran 
-2-yl]-1,3-dioxan-4-yl}propanoate (99′). To a solution of tosylate 
98′ (0.600 g, 0.990 mmol) in 10 mL MeOH, solid K2CO3 (0.137 g, 
0.990 mmol) was added. After stirring for 2 hours at ambient temperature (TLC monitoring 
indicated complete conversion of starting material), the reaction mixture was concentrated and 
extracted with ether (3×30 mL). The combined ether extracts were washed with brine, dried 
(Na2SO4) and concentrated. The resulting crude oil was purified by flash chromatography (10% 
ethyl acetate in hexanes), affording 0.170 g (63%) of the title compound as  colorless oil. [α]D 
−20.3 (c 1.33, CHCl3); IR νmax(thin film) cm-1:  2991, 2940, 1738, 1455, 1381, 1259, 1200, 1157, 
1108, 1053, 992; 1H NMR (300 MHz, CDCl3): δ 4.04 (d, J = 2.1 Hz, 1H), 3.92 (dd, J = 9.9, 2.1 
Hz, 1H), 3.71 (s, 3H), 3.05 (d, J = 5.7 Hz, 1H), 2.63 (dq, J = 9.9, 6.9 Hz, 1H), 2.55 (d, J = 5.4 
Hz, 1H), 1.55-1.66 (m, 1H), 1.43 (s, 3H), 1.38 (s, 3H), 1.28 (s, 3H), 1.23 (d, J = 6.9 Hz, 3H), 
0.89 (d, J = 6.9, 3H);  13C NMR (75 MHz, CDCl3): δ 174.9, 99.5,5.9, 74.4, 71.8, 56.7, 51.7, 50.2, 
41.9, 31.9, 29.6, 19.3, 18.4, 15.1; MS (EI): m/z  257, 185, 128, 113, 109, 102; HRMS (EI) m/z 
calcd for C13H21O5 (M+–CH3): 257.1389; found: 257.1392.  
 
(4R,5S,6R,7R)-7-(tert-Butyldimethylsilyloxy)-5-[(p-methoxybenz  
yl)oxy]-4,6-dimethylnonan-3-one (105).  To a solution of 85 (1.12 
g, 3.54 mmol) in 30 mL CH2Cl2 at −78 °C was added freshly 
prepared p-methoxybenzyl trichloroacetimidate (1.69 g, 6.00 mmol) and BF3•Et2O (0.23 mL, 1.0 
M solution in CH2Cl2, 0.23 mmol) and the reaction mixture was stirred for 2.5 h.  At this time, 
1.30 g (4.62 mmol) of p-methoxybenzyl trichloroacetimidate and 0.22 mL of BF3·Et2O (0.22 
O
Me
O
MeMe
O
OMe
Me Me
O
O
Me
O
Me
Me
OTBS
Me
PMB
 125 
mmol) were added.  After stirring for an additional 3 h (at which time the reaction was complete 
as monitored by TLC), the reaction was quenched by adding a saturated aqueous solution of 
NaHCO3 (30 mL) and extracted with CH2Cl2 (2×20 mL).  The combined organic extracts were 
dried (Na2SO4), and concentrated to provide a yellow oil that was triturated with 5% 
EtOAc/hexanes and the resulting white solid was removed by filtration.  The filtrate was 
concentrated and purified by flash chromatography (2.5-5 % ethyl acetate in hexanes) to afford 
1.38 g (90%) of the title compound as a clear colorless oil.  [α]D −57.0 (c 1.00, CH2Cl2); IR 
νmax
(thin film) cm-1: 2957, 2936, 2882, 2857, 1713, 1614, 1514, 1462, 1250, 1095; 1H NMR (300 
MHz, CDCl3): δ 7.21 (d, J = 8.7 Hz, 2H), 6.86 (d, J = 8.7 Hz, 2H), 4.35 (d, J = 10.5 Hz, 1H), 
4.27 (d, J = 10.5 Hz, 1H), 3.97 (dt, J = 6, 1.8 Hz, 1H), 3.96 (dd, J = 8.1, 2.1 Hz, 1H), 3.80 (s, 
3H), 2.69 (dq, J = 7.2, 2.4 Hz, 1H), 2.64 (app quint, J = 7.2 Hz, 1H), 2.57-2.42 (m, 1H), 1.80-
1.66 (m, 1H), 1.65-1.42 (m, 2H), 1.14 (d, J = 6.9 Hz, 3H), 1.09 (t, J = 7.2 Hz, 3H), 0.92 (s, 9H), 
0.82 (t, J = 7.2 Hz, 3H), 0.81 (d, J = 6.6 Hz, 3H),; 13C NMR (75 MHz, CDCl3): δ 212.9, 97.9, 
80.8, 72.7, 55.9, 48.4, 39.4, 33.8, 28.4, 26.0, 18.3, 10.1, 9.4, 8.6, 8.0, −3.4, −4.4. HRMS (ESI): 
m/z calcd for C25H44O4SiNa [(M+Na)+]: 459.2907; found: 459.2906. 
 
(2R,3S,4S,5R)-3,5-Dihydroxy-N-methoxy-N,2,4,6-tetramethylhe   
pt-6-enamide (106).  To an ice-cold solution of N,O-dimethylhydr- 
oxylamine hydrochloride (0.438 g, 4.49 mmol) in 9 mL CH2Cl2, 
AlMe3 (2.24 mL, 2 M solution in toluene, 4.49 mmol) was added dropwise. After addition was 
complete, the reaction mixture was stirred at room temperature for 1 hour. The reaction was then 
cooled to −20 °C and a solution of the aldol adduct 94 (0.807 g, 1.79 mmol) in 5 mL CH2Cl2 was 
added. The reaction was stirred for additional 2 hours at 0 °C and quenched by adding a saturated 
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aqueous solution of Rochelle’s salt (30 mL). The resulting biphasic mixture was stirred 
vigorously for 30 minutes at room temperature until two homogeneous layers separated. The 
aqueous layer was extracted with CH2Cl2 (2×50 mL). The combined organic extracts were 
washed with brine, dried (Na2SO4) and concentrated. Majority of the product coeluted with the 
chiral auxiliary upon flash chromatography (20% ethyl acetate in hexanes). A small amount of 
the pure material was obtained and used for characterization. [α]D –5.39 (c 1.02, CHCl3); IR 
νmax
neat cm-1 3465, 2962, 1644, 1456, 1385, 1250, 1067, 1044, 996, 901, 841, 751; 1H NMR (300 
MHz, CDCl3): δ 4.91 (s, 1H), 4.87 (s, 1H), 4.10 (d, J = 5.1 Hz, 1H), 3.84 (d, J = 8.7 Hz, 1H), 
3.69 (s, 3H), 3.15 (s, 3H), 3.15-3.00 (m, 1H), 2.86 (s, 1H), 1.80-1.60 (m, 1H), 1.64 (s, 3H), 1.23 
(d, J = 6.6 Hz, 3H), 0.87 (d, J = 6.9 Hz, 3H), 0.10 (s, 9H); 13C NMR (75 MHz, CDCl3): δ 176.7, 
145.7, 112.1, 80.5, 75.0, 61.6, 38.8, 38.1, 32.0, 18.4, 14.5, 7.5, 0.1; HRMS (EI) m/z calcd. for 
C15H31NO4Si: 317.2022; found: 307.2010. 
To a stirred solution of the crude mixture from above,  in 10 mL MeOH at room 
temperature, was added a few drops (12-15) of 1 N aqueous HCl solution and the reaction 
mixture was stirred at room temperature until TLC showed no presence of starting material (~20 
min). The reaction was quenched by adding a saturated aqueous solution of NaHCO3 (30 mL) 
and extracted with EtOAc (3 ×30 mL). The combined organic extracts were washed with water 
and brine, dried (Na2SO4) and concentrated. The crude product was purified by flash 
chromatography (40% ethyl acetate in hexanes), affording 0.300 g (68% yield over two steps) of 
the title compound as colorless oil. [α]D –29 (c 0.25, CHCl3); IR νmax(thin film) cm-1: 3396, 2976, 
2938, 1633, 1455, 1388, 1124, 990; 1H NMR (300 MHz, CDCl3): δ 4.98 (app. d,  J = <1 Hz, 
1H), 4.89 (dq, J = 1.5, 3.0 Hz,  1H),  4.20 (s, 1H), 3.97 (dd, J = 3.0, 7.5 Hz, 1H), 3.69 (s, 3H), 
3.16 (s, 3H), 3.15-3.06 (m, 1H), 2.65 (br s, 1H), 1.75 (tq, J = 7.2, 3.0 Hz, 1H), 1.64 (s, 3H), 1.23 
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(d, J = 6.9 Hz, 3H), 0.85 (d, J = 6.9 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 177.0, 145.9, 110.1, 
78.3, 76.3, 61.6, 38.2, 36.8, 32.0, 19.4, 13.7, 5.9; HRMS (Q-Tof) m/z calcd for C12H23NO4Na 
[(M+Na)+]: 268.1525; found: 268.1512. 
 
(R)-N-methoxy-2-[(2R,4S,5S,6R)-2-(4-methoxyphenyl)-5-
methyl-6-(prop-1-en-2-yl)-1,3-dioxan-4-yl]-N-methylpropanam 
ide (107). To a solution of 106 (1.05 g, 4.28 mmol) in 20 mL 
CH2Cl2, pyridinium p-toluenesulfonate (PPTS) (0.107 g, 0.428 mmol) and p-anisaldehyde 
dimethyl acetal (1.090 mL, 6.415 mmol) were added sequentially. The reaction mixture was 
allowed to stir at room temperature for 7 hours, concentrated and purified by flash 
chromatography (8% ethyl acetate in hexanes) to afford 1.457 g (94% yield) of the title 
compound in the form of a colorless oil. [α]D –43.7 (c 0.16, CHCl3); IR νmax(thin film) cm-1: 2936, 
1652, 1519, 1455, 1248, 1070; 1H NMR (300 MHz, CDCl3): δ 7.47 (d, J = 8.7 Hz, 2H), 6.90 (d, 
J = 8.7 Hz, 2H), 5.60 (s, 1H), 5.11 (s, 1H), 4.93 (s, 1H), 4.29 (d, J = 1.5 Hz, 1H), 4.07 (dd, J = 
9.9, 1.5 Hz, 1H), 3.81 (s, 3H), 3.72 (s, 3H), 1.90 (tq, J = 1.5, 6.9 Hz, 1H), 1.68 (s, 3H), 1.32 (d, J 
= 6.9 Hz, 3H), 0.84 (d, J = 6.9 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 175.5, 159.8, 142.2, 
131.6, 127.3, 113.5, 110.5, 101.1, 82.4, 82.2, 61.5, 55.2, 37.7, 32.1, 31.2, 19.2, 15.7, 6.3; HRMS 
(EI) m/z calcd for C20H29NO5: 363.2046; found: 363.2046. 
 
(R)-2-{(2R,4S,5S,6R)-6-[(S)-1,2-dihydroxypropan-2-
yl]-2-(4-methoxyphenyl)-5-methyl-1,3-dioxan-4-yl}-N-
methoxy-N-methylpropanamide (108′).  To a suspension of 
107 (0.325 g, 0.894 mmol) in tBuOH/H2O (1: 1 v/v, 18 mL total), was added 
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methanesulfonamide (0.085 g, 0.89 mmol) followed by AD-mix α (1.341 g). The yellow 
reaction mixture was allowed to stir at ambient temperature for 36 h whereupon it was diluted 
with 40 mL EtOAc followed by addition of Na2SO3 (0.338 g, 2.68 mmol). The resulting biphasic 
mixture was stirred for 20 min after which the layers were separated and the aqueous layer was 
extracted with EtOAc (2 x 30 mL). The combined organic extracts were washed with 1M 
NaHSO4 (1 × 30 mL), sat. NaHCO3 solution (1 × 30 mL), and brine, then dried over Na2SO4 and 
concentrated. The crude oil was purified by flash chromatography (80% ethyl acetate in hexanes) 
affording 0.328 g (93% yield) of the title compound as a colorless viscous oil. [α]D –16.6 (c 0.12, 
CHCl3); IR νmax(thin film) cm-1: 3427, 2972, 2937, 2877, 1639, 1517, 1460, 1391, 1248, 1171, 1107; 
1H NMR (300 MHz, CDCl3): δ 7.42 (d, J = 8.7 Hz, 2H), 6.91 (d, J = 8.7 Hz, 2H), 5.56 (s, 1H), 
3.98 (dd, J = 9.9, 1.8 Hz, 1H), 3.92 (d, J = 2.1 Hz, 1H), 3.82 (dd, J = 10.8, 3.0 Hz, 1H),3.81 (s, 
3H), 3.73 (s, 3H), 3.44 (dd, J = 11.1, 8.7 Hz, 1H), 3.25-3.18 (m, 1H), 3.20 (s, 3H), 2.78 (br s, 1H, 
OH), 2.30 (dd, J = 8.7, 3.3 Hz, 1H, OH), 1.93 (tq, J = 1.8, 6.9 Hz, 1H), 1.58 (s, 3H), 1.29 (d, J = 
6.6 Hz, 3H), 1.24 (s, 3H), 1.10 (d, J = 6.9 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 175.2, 160.0, 
131.0, 127.3, 113.6, 102.2, 86.1, 83.7, 73.8, 67.6, 61.6, 55.3, 37.1, 32.1, 31.2, 21.6, 15.7, 8.0; 
HRMS (EI) m/z calcd for C20H31NO7: 397.2101; found: 397.2096. 
 
(R)-2-{(2R,4S,5S,6R)-6-[(R)-1-formyl-1-hydroxyethyl]-
2-(4-methoxyphenyl)-5-methyl-1,3-dioxan-4-yl}-N-methoxy-N-
methylpropanamide (109′). To a solution of the diol 108′ (1.01 g, 
2.54 mmol), anhydrous DMSO (1.98 mL, 27.9 mmol) and triethylamine (1.77 mL, 12.7 mmol) 
in 10 mL dichloromethane at 0 °C, was added pyr.SO3 complex (1.617 g, 10.16 mmol). The 
yellow reaction mixture was then stirred at the same temperature for 3 hours whereupon it was 
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diluted with ether (20 mL). The ether layer was washed with water and brine, dried over Na2SO4 
and concentrated. The crude oil was purified by flash chromatography with 40% ethyl acetate in 
hexanes as eluant affording 0.767 g (77%) of the title compound as a colorless oily liquid. [α]D –
36.2 (c 0.37, CHCl3); IR νmax(thin film) cm-1: 3433, 2935, 1733, 1652, 1518, 1462, 1386, 1249, 
1171, 1114, 1068, 1030; 1H NMR (300 MHz, CDCl3): δ 9.72 (s, 1H), 7.40 (d, J = 8.4 Hz, 2H), 
6.90 (d, J = 8.7 Hz, 2H), 5.54 (s, 1H), 3.99 (d, J = 1.8 Hz, 1H), 3.98 (dd, J = 8.1, 1.5 Hz, 1H), 
3.80 (s, 3H), 3.71 (s, 3H), 3.42 (s, 1H), 3.25-3.10 (m, 1H), 3.18 (s, 3H), 1.94 (tq, J = 1.8, 6.9 Hz, 
1H), 1.35 (s, 3H), 1.28 (d, J = 6.6 Hz, 3H), 1.05 (d, J = 6.9 Hz, 3H); 13C NMR (75 MHz, 
CDCl3): δ 201.2, 174.9, 160.0, 130.6, 127.3, 113.6, 102.2, 85.2, 83.2, 78.6, 61.5, 55.3, 37.2, 32.1, 
31.1, 18.9, 15.6, 8.4; HRMS (Q-Tof) m/z calcd for C20H29NO7Na [(M+Na)+]: 418.1842; found: 
418.1878. 
 
(R)-2-{(2R,4S,5S,6R)-6-[(R)-1-(triethylsilyloxy)-1-
formylethyl)-2-(4-methoxyphenyl)-5-methyl-1,3-dioxan-4-yl}-
N-methoxy-N-methylpropanamide (110′).  To a solution of the 
aldehyde 109′ (0.767 g, 1.94 mmol) in 10 mL dichloromethane at −30 °C was added 2,6-lutidine 
(0.340 mL, 2.91 mmol). After stirring for 5 minutes, TESOTf (0.520 mL, 2.33 mmol) was added 
and the solution was allowed to stir for 2 h at −30 °C followed by 2 h at 0 °C . The reaction was 
then quenched with sat. NH4Cl solution and the two layers were separated. The aqueous layer 
was extracted with ether (2 × 15 mL) and the combined organic extracts were washed with brine, 
dried (Na2SO4) and concentrated.  The resulting crude oil was purified by flash chromatography 
(10% ethyl acetate in hexanes) affording 0.859 g (87%) of the title compound as a colorless oil. 
[α]D –21.2 (c 0.67, CHCl3); IR νmax(thin film) cm-1: 2955, 2876, 1735, 1659, 1616, 1518, 1460, 
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1384, 1248, 1168, 1111, 1013; 1H NMR (300 MHz, CDCl3): δ 9.64 (s, 1H), 7.41 (d, J = 8.7 Hz, 
2H), 6.89 (d, J = 8.7 Hz, 2H), 5.50 (s, 1H), 3.96 (dd, J = 9.9, 2.1 Hz, 1H), 3.96 (d, J = 2.1 Hz, 
1H), 3.81 (s, 3H), 3.70 (s, 3H), 3.23-3.17 (m, 1H), 3.18 (s, 3H), 1.87 (tq, J = 2.1, 6.6 Hz, 1H), 
1.33 (s, 3H), 1.28 (d, J = 6.9 Hz, 3H), 0.98 (d, J = 6.9 Hz, 3H), 0.91 (t, J = 7.8 Hz, 9H), 0.58 (q, 
J = 7.8 Hz, 6H); 13C NMR (75 MHz, CDCl3): δ 202.0, 175.2, 159.8, 131.0, 127.3, 113.4, 102.0, 
85.4, 83.5, 80.4, 61.6, 55.3, 37.1, 32.1, 31.2, 19.2, 15.6, 7.7, 6.9, 6.5; HRMS (Q-Tof) m/z calcd 
for C26H43NO7SiNa [(M+Na)+]: 532.2707; found: 532.2673. 
 
(R)-N-methoxy-N-methyl-2-[(4S,5S,6R)-2,2,5-trimethyl-6-
(prop-1-en-2-yl)-1,3-dioxan-4-yl]propanamide  (147). To a solu- 
tion of the diol 106 (0.320 g, 1.30 mmol) in 2,2-dimethoxypropane 
(10 mL) was added camphor sulfonic acid (0.030 g, 0.130 mmol) 
and the resulting solution was stirred at ambient temperature for 1 h.  The reaction was quenched 
by adding 2 mL of Et3N and the reaction mixture was concentrated and the resulting crude oil 
was purified by flash chromatography (30% ethyl acetate in hexanes) to afford the 0.370 g of the 
acetonide 147 (100%) as a colorless oil. [α]D –15 (c 0.44, CHCl3); IR νmax(thin film) cm-1: 2989, 
2938, 1661, 1459, 1384, 1254, 1200, 1160, 1104, 955; 1H NMR (300 MHz, CDCl3): δ 5.00 (app. 
s, 1H), 4.86 (m, 1H),  4.29 (d, J = <1 Hz, 1H), 4.07 (dd, J = 1.8, 9.6 Hz, 1H), 3.70 (s, 3H), 3.18 
(s, 3H), 3.14-3.00 (m, 1H), 1.73 (tq, J = 6.9, 1.8 Hz, 1H), 1.62 (s, 3H), 1.46 (s, 3H), 1.44 (s, 3H), 
1.22 (d, J = 6.9 Hz, 3H), 0.71 (d, J = 7.2 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 175.8, 142.8, 
110.1, 99.1, 75.1, 74.9, 61.5, 37.8, 32.1, 31.1, 29.9, 19.6, 19.3, 15.6, 5.4; HRMS (EI) m/z calcd 
for C14H24NO4 [(M−CH3)•+]: 270.1705; found: 270.1694. 
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(R)-2-{(4S,5S,6R)-6-[(S)-1,2-dihydroxypropan-2-yl]-2,2,5-
trimethyl-1,3-dioxan-4-yl}-N-methoxy-N-methylpropanamide   
(148′).  To a suspension of 147 (0.710 g, 2.49 mmol) in 
tBuOH/H2O (1: 1 v/v, 50 mL total), was added methanesulfonamide (0.236 g, 2.49 mmol) 
followed by AD-mix α (3.73 g). The yellow reaction mixture was allowed to stir at ambient 
temperature for 36 h whereupon it was diluted with 50 mL EtOAc followed by addition of 
Na2SO3 (0.940 g, 7.47 mmol). The resulting biphasic mixture was stirred for 20 min after which 
the layers were separated and the aqueous layer was extracted with EtOAc (2×50 mL). The 
combined organic extracts were washed with 1M NaHSO4 (1×50 mL), sat. NaHCO3 solution 
(1×50 mL), and brine, then dried over Na2SO4 and concentrated. The crude oil was purified by 
flash chromatography (60-70% ethyl acetate in hexanes) affording 0.725 g (91% yield) of the 
title compound as a colorless viscous oil. mp 102-103 °C; [α]D +0.74 (c 0.45, CHCl3); IR νmax(thin 
film) cm-1: 3427, 2989, 2938, 1638, 1459, 1389, 1200, 1050; 1H NMR (300 MHz, CDCl3): δ 3.97 
(dd, J = 9.9, 1.8 Hz, 1H), 3.92 (d, J = 2.1 Hz, 1H), 3.79 (dd, J = 10.8, 1.2 Hz, 1H), 3.71 (s, 3H), 
3.38 (dd, J = 10.8, 8.7 Hz, 1H), 3.17 (s, 3H), 3.15-3.00 (m, 1H), 2.90 (s, 1H), 2.57 (dd, J = 8.7, 
2.1 Hz, 1H), 1.80-1.68 (m, 1H), 1.44 (s, 3H), 1.43 (s, 3H), 1.21 (d, J = 6.6 Hz, 3H), 1.14 (s, 3H), 
0.97 (d, J = 6.9 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 175.4, 99.9, 79.6, 76.4, 73.5, 67.8, 61.6, 
37.1, 32.1, 31.2, 29.8, 21.6, 19.5, 15.6, 6.9; HRMS (Q-Tof) m/z calcd for C15H29NO6Na 
[(M+Na)+]: 342.1893; found: 342.1877. 
 
(R)-2-{(4S,5S,6R)-6-[(S)-2-(benzyloxy)-1-hydroxypropan-2-
yl]-2,2,5-trimethyl-1,3-dioxan-4-yl}-N-methoxy-N-methylpro-  
panamide (149′).  To a CH2Cl2 solution (5 mL) of 148′ (0.135 
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g, 0.421 mmol) at 0 °C, were added 2,6-lutidine (0.293 mL, 2.53 mmol) and TIPSOTf (0.226 
mL, 0.842 mmol). After stirring the reaction mixture for 3 h at room temperature, the reaction 
was quenched by the addition of sat. NaHCO3 solution, and the organic materials were extracted 
with CH2Cl2 (2×10 mL), then the combined organic extracts were washed with brine, dried over 
anhydrous Na2SO4, and concentrated in vacuo after filtration. Purification by flash column 
chromatography (5% ethyl acetate in hexanes) gave 0.165 g (90%) of TIPS ether.  
 To a suspension of NaH (60%, 45.6 mg, 1.15 mmol) in DMF (1.5 mL) at 0 °C was added 
a solution of the above TIPS ether(0.165 g, 0.382 mmol) in DMF (1.5 mL). After stirring the 
reaction mixture for 30 min, benzyl bromide (0.113 mL, 0.955 mmol) and TBAI (1.5 mg, 0.0040 
mmol as a solution in DMF) were added at 0 °C, and the reaction mixture was stirred at room 
temperature for 3 h. The reaction was quenched with saturated aqueous NH4Cl (10 mL) and the 
aqueous layer was extracted with ether (2×10 mL). The combined organic extracts were dried 
over Na2SO4 and concentrated. Purification by flash column chromatography (5% ethyl acetate 
in hexanes) afforded 0.160 g (74%) of the tertiary benzyl ether. 
To a solution of the compound (prepared above) in THF (5 mL) was added pyridine (3 
mL) followed by HF.pyr complex (2 mL) and the reaction mixture was allowed to stir for 36 h at 
ambient temperature.  The reaction was quenched by adding it dropwise into an ice-cold 
saturated aqueous NaHCO3 solution (30 mL) which was then extracted with ether (2×30 mL). 
The combined organic extracts were dried (Na2SO4) and concentrated. Purification by flash 
column chromatography (30% ethyl acetate in hexanes) afforded 0.116 g (95%) of the title 
compound as colorless oil. [α]D +2.31 (c 0.52, CHCl3); IR νmax(thin film) cm-1: 3435, 2989, 2937, 
2883, 1640, 1458, 1387, 1256, 1199, 1105, 1061; 1H NMR (300 MHz, CDCl3): δ 7.34-7.20 (m, 
5H), 4.67 (d, J = 11.4 Hz, 1H), 4.54 (d, J = 11.4 Hz, 1H), 4.08 (d, J = 2.1 Hz, 1H), 3.99 (dd, J = 
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9.9, 1.8 Hz, 1H), 3.77-3.68 (m, 1H), 3.71 (s, 3H), 3.51 (dd, J = 11.4, 6.9 Hz, 1H), 3.17 (s, 3H), 
3.20-3.05 (m, 1H), 2.31 (app t, J = 6.3 Hz, 1H),  1.81 (tq, J = 2.2, 6.9 Hz, 1H), 1.45 (s, 6H), 1.28 
(s, 3H), 1.21 (d, J = 6.9 Hz, 3H), 1.04 (d, J = 6.9 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 175.6, 
139.5, 128.5, 127.3, 127.2, 99.7, 78.8, 77.1, 76.8, 66.4, 64.9, 61.6, 37.2, 32.1, 31.4, 29.9, 19.4, 
17.3, 15.6, 7.1; HRMS (Q-Tof) m/z calcd for C22H35NO6Na [(M+Na)+]: 432.2362; found: 
432.2342. 
 
(R)-2-[(2R,4S,5S,6R)-6-{(2R,3S,4S, 
5R)-5-((2R,3S,4R,5R)-5-(tert-butyldimethylsi 
lyloxy)-3-(4-methoxybenzyloxy)-4-methylhe 
ptan-2-yl}-5-hydroxy-2,4-dimethyl-3-(trieth 
ylsilyloxy)tetrahydrofuran-2-yl)-2-(4-metho 
xyphenyl)-5-methyl-1,3-dioxan-4-yl]-N-methoxy-N-methylpropanamide (142′). 1H NMR 
(500 MHz, CD2Cl2): δ 7.41 (d, J = 8.5 Hz, 2H), 7.17 (d, J = 9.0 Hz, 2H), 6.86 (d, J = 9.0 Hz, 
2H), 6.82 (d, J = 9.0 Hz, 2H),  5.51 (s, 1H), 4.35 (d, J = 10.5 Hz, 1H), 4.32 (d, J = 10.5 Hz, 1H), 
3.99 (d, J = 2.0 Hz, 1H), 3.95 (ddd, J = 8.5, 5.0, 2.0 Hz, 1H), 3.92 (dd, J = 6.6, <1 Hz, 1H), 3.86 
(dd, J = 9.5, 1.5 Hz, 1H), 3.82 (d, J = 3.5 Hz, 1H),  3.77 (s, 3H), 3.76 (s, 3H), 3.68 (s, 3H), 3.24 
(dq, J = 7.0, 4.0 Hz, 1H), 3.25-3.15 (m, 1H), 3.11 (s, 3H), 2.76 (br s, 1H), 2.68 (dq, J = 7.0, 1.0 
Hz, 1H), 1.98-1.93 (app q, J = 6.6 Hz,  1H), 1.60-1.50 (m, 2H), 1.50-1.42 (m, 1H), 1.25 (s, 3H), 
1.22 (d, J = 6.5 Hz, 3H), 1.14 (d, J = 7.0 Hz, 3H), 1.08 (d, J = 7.0 Hz, 3H), 1.04 (d, J = 7.0 Hz, 
3H), 0.90 (t, J = 8.0 Hz, 9H), 0.88 (s, 9H), 0.78 (t, J = 7.5 Hz, 3H),  0.63 (q, J = 8.0 Hz, 6H), 
0.62 (d, J = 7.0 Hz, 3H), 0.05 (s, 3H), 0.05 (s, 3H); 13C NMR (75 MHz, CD2Cl2): δ 175.5, 160.4, 
159.6, 131.9, 131.4, 129.9, 128.2, 114.0, 113.7, 106.0, 102.8, 87.9, 85.5, 84.5, 79.6, 73.8, 72.4, 
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61.9, 55.6 (2C), 50.9, 44.7, 38.9, 37.6, 32.0 (2C), 30.1, 28.1, 26.3, 19.0, 18.6, 15.8, 14.6, 10.2, 
9.5, 8.8, 7.1, 5.6, –3.1, –3.9.  
 
(R)-N-Methoxy-2-{(2R,4S,5S,6R)-2-
(4-methoxyphenyl)-5-methyl-6-
[(5S,6S,7S,9R,10S,11R,12R)-3,3,12-triethyl-
6-hydroxy-10-(4-methoxybenzyloxy)-
5,7,9,11,14,14,15,15-octamethyl-8-oxo-4,13-dioxa-3,14-disilahexadecan-5-yl]-1,3-dioxan-4-
yl}-N-methylpropanamide (145′).  To a solution of 0.143 mL (0.494 mmol) of 
diphenyltetramethyldisilazine in 2.5 mL of THF at 0 °C was added a 1.55 M solution of n-
butyllithium in hexanes (0.320 mL, 0.494 mmol). After 20 min, the reaction was cooled to –78 
°C and a solution of ketone (0.196 g, 0.449 mmol) in 1.0 mL of THF was added via cannula 
(with 2 x 0.5 mL rinses). The resultant clear yellow solution was stirred at –78 °C for 20 min, 
then at 0 °C for 1 h, before the reaction was recooled to –78 °C and a solution of the aldehyde 
110′ (0.343 g, 0.673 mmol) in 2.0 mL of THF was added via cannula. The resultant solution was 
stirred for 24 h at –78 °C, then quenched by dropwise addition of precooled acetic acid (1.8 mL, 
1 N in THF, 4 equiv) at the same temperature.  After stirring for another 20 min at −78 °C, a 
saturated aqueous solution of NaHCO3 (10 mL) was added and exttracted with CH2Cl2 (3×10 
mL). The combined organic extracts were dried (Na2SO4) and concentrated to afford a yellow 
oil. Analysis of the unpurified mixture by 1H NMR revealed a single diastereomer. Purification 
by automated flash chromatography (linear gradient 0 to 50% ethyl acetate/hexanes) afforded 
0.220 g (51%) of the title compound as colorless oil. [α]D −0.91 (c 0.44, CHCl3); IR νmax(thin film) 
cm-1: 3412, 2955, 2878, 1699, 1660, 1616, 1515, 1461, 1384, 1249, 1034; 1H NMR (500 MHz, 
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CD2Cl2): δ 7.41 (d, J = 8.5 Hz, 2H), 7.17 (d, J = 9.0 Hz, 2H), 6.86 (d, J = 9.0 Hz, 2H), 6.82 (d, J 
= 9.0 Hz, 2H),  5.51 (s, 1H), 4.35 (d, J = 10.5 Hz, 1H), 4.32 (d, J = 10.5 Hz, 1H), 3.99 (d, J = 2.0 
Hz, 1H), 3.95 (ddd, J = 8.5, 5.0, 2.0 Hz, 1H), 3.92 (dd, J = 6.6, <1 Hz, 1H), 3.86 (dd, J = 9.5, 1.5 
Hz, 1H), 3.82 (d, J = 3.5 Hz, 1H),  3.77 (s, 3H), 3.76 (s, 3H), 3.68 (s, 3H), 3.24 (dq, J = 7.0, 4.0 
Hz, 1H), 3.25-3.15 (m, 1H), 3.11 (s, 3H), 2.76 (br s, 1H), 2.68 (dq, J = 7.0, 1.0 Hz, 1H), 1.98-
1.93 (app q, J = 6.6 Hz,  1H), 1.60-1.50 (m, 2H), 1.50-1.42 (m, 1H), 1.25 (s, 3H), 1.22 (d, J = 6.5 
Hz, 3H), 1.14 (d, J = 7.0 Hz, 3H), 1.08 (d, J = 7.0 Hz, 3H), 1.04 (d, J = 7.0 Hz, 3H), 0.90 (t, J = 
8.0 Hz, 9H), 0.88 (s, 9H), 0.78 (t, J = 7.5 Hz, 3H),  0.63 (q, J = 8.0 Hz, 6H), 0.62 (d, J = 7.0 Hz, 
3H), 0.05 (s, 3H), 0.05 (s, 3H); 13C NMR (75 MHz, CD2Cl2): δ 217.7, 175.5, 160.4, 159.4, 132.0, 
131.6, 129.3, 128.0, 113.9, 113.7, 102.6, 84.7, 81.9, 80.0, 78.8, 76.3, 73.3, 73.2, 61.9, 55.6 (2C), 
47.3, 43.7, 39.6, 37.4, 32.3, 31.7, 28.8, 26.2, 22.3, 18.6, 15.7, 12.7, 10.2, 9.9, 9.8, 8.8, 7.3, 7.2, –
3.2, –4.0; HRMS (Q-Tof) m/z calcd for C51H87NO11Si2Na [(M+Na)+]: 968.5715; found: 
968.5695. 
 
(R)-N-Methoxy-2-{(2R,4S,5S,6R)-2-
(4-methoxyphenyl)-5-methyl-6-[(5S,6S,7R, 
8R,9S,10R,11R,12R)-3,3,12-triethyl-6,8-
dihydroxy-10-(4-methoxybenzyloxy)-5,7,9, 
11,14,14,15,15-octamethyl-4,13-dioxa-3,14-disilahexadecan-5-yl]-1,3-dioxan-4-yl}-N-methyl 
propanamide (159′).  To a solution of aldol adduct 145′ (0.100 g, 0.106 mmol) in 2 mL of 
CH2Cl2 at 0 °C was added 3.03 mL (0.424 mmol, 0.14 M in Et2O) of Zn(BH4)2. After 9 h at 0 
°C, the reaction was quenched by adding a saturated aqueous solution of NH4Cl (5 mL) and the 
resultant mixture was extracted with CH2Cl2 (3×5 mL). The combined organic extracts were 
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washed with water, dried (Na2SO4) and concentrated. The residue was dissolved in 20 mL of 
MeOH and stirred at 23 °C for 36 h. Following concentration, the residue (80:20 mixture of 
diastereomers by crude 1H NMR) was purified by flash chromatography (10% EtOAc in 
hexanes) affording 0.085 g (82%) of the title compound as a white foam. [α]D −5.4 (c 0.93, 
CHCl3); IR νmax(thin film) cm-1: 3507, 2954, 2879, 1662, 1615, 1515, 1461, 1385, 1249, 1109, 1035; 
1H NMR (500 MHz, CD2Cl2): δ 7.41 (d, J = 9.0 Hz, 2H), 7.26 (d, J = 8.5 Hz, 2H), 6.89 (d, J = 
8.5 Hz, 2H), 6.86 (d, J = 9.0 Hz, 2H),  5.56 (s, 1H), 4.65 (d, J = 10.5 Hz, 2H), 4.57 (d, J = 10.5 
Hz, 2H), 3.99 (ddd, J = 8.5, 5.0, 2.5 Hz, 1H), 3.94 (dd, J = 10.0, 1.5 Hz, 1H), 3.83 (d, J = 1.5 Hz, 
1H), 3.80 (s, 3H), 3.78 (s, 3H), 3.71 (s, 3H), 3.69 (dd, J = 8.0, 4.0 Hz, 1H), 3.60 (dd, J = 9.0, 1.5 
Hz, 1H), 3.30-3.20 (m, 1H),  3.14 (s, 3H), 2.96-2.88 (br s, 1H), 2.30 (ddq, J = 7.5, 7.5, 1.5 Hz, 
1H),, 1.60-1.45 (m, 3H), 1.43 (s, 6H), 1.41 (s, 3H), 1.18 (d, J = 6.6 Hz, 3H), 1.12 (d, J = 6.6 Hz, 
3H), 2.23 (br s, 1H), 1.95 (tq, J = 7.0, 1.0 Hz, 1H), 1.90 (ddd, J = 6.5, 3.5, 2.0 Hz, 1H), 1.86-1.80 
(m, 1H), 1.65-1.52 (m, 3H),  1.26 (d, J = 6.5 Hz, 3H), 1.24 (s, 3H), 1.12 (d, J = 7.0 Hz, 3H), 1.03 
(t, J = 8.5 Hz, 9H), 0.95 (d, J = 7.0 Hz, 3H), 0.91 (s, 9H), 0.88 (d, J = 7.0 Hz, 3H), 0.83 (t, J = 
7.0 Hz, 3H), 0.77 (d, J = 7.0 Hz, 3H), 0.71 (q, J = 7.5 Hz, 6H), 0.09 (s, 6H); 13C NMR (75 MHz, 
CD2Cl2): δ 175.3, 160.3, 159.6, 131.9, 131.1, 129.5, 127.6, 114.1, 113.7, 102.0, 84.2, 83.9, 82.7, 
78.4, 77.3, 76.0, 73.7, 73.2, 61.9, 55.6 (2C), 39.0, 37.2, 36.9, 36.3, 32.1, 31.4, 28.6, 26.2, 21.2, 
18.6, 15.9, 11.0, 10.0, 9.5, 8.7, 7.4, 7.0, 6.1, -2.9, -4.1 ; HRMS (Q-Tof) m/z calcd for 
C51H89NO11Si2Na [(M+Na)+]: 970.5872; found: 970.5853. 
 
(R)-2-[(2R,4S,5S,6R)-6-{(2S,3S,4S)-4-
((2R,4R,5S,6R)-6-((2R,3R)-3-(tert-Butyldimet- 
hylsilyloxy)pentan-2-yl)-2-(4-methoxyphenyl) 
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-5-methyl-1,3-dioxan-4-yl}-3-hydroxy-2-(triethylsilyloxy)pentan-2-yl)-2-(4-methoxyphenyl)-
5-methyl-1,3-dioxan-4-yl]-N-methoxy-N-methylpropanamide (160′).  To a mixture of 
azeotropically dried 159' (0.080 g, 0.082 mmol) and 95 mg of activated powdered 4 Å molecular 
sieves in 2 mL of CH2Cl2 was added a solution of DDQ (0.022 g, 0.078 mmol) in 2 mL of 
CH2Cl2 at 0 °C by syringe. After stirring at 0 °C for 1 h, the reaction was filtered through celite 
and the filtrate washed with saturated aqueous NaHCO3 solution (15 mL). The aqueous layer 
was extracted with CH2Cl2 (3×10 mL). The combined organic layers were washed with brine, 
dried (Na2SO4), and concentrated. Purification by flash chromatography (10% EtOAc in 
hexanes) afforded the title compound as a clear colorless oil (0.075 g, 94%). 1H NMR (500 MHz, 
CD2Cl2): δ 7.42 (d, J = 8.5 Hz, 2H), 7.41 (d, J = 8.5 Hz, 2H), 6.89 (d, J = 8.5 Hz, 2H), 6.88 (d, J 
= 9.0 Hz, 2H),  5.56 (s, 1H), 5.44 (s, 1H), 4.03 (ddd, J = 9.5, 6.0, 1.5 Hz, 2H), 3.95 (dd, J = 9.5, 
1.5 Hz, 2H), 3.89 (d, J = 2.0 Hz, 1H), 3.80 (s, 3H), 3.80 (s, 3H), 3.75 (br s, 1H), 3.72 (s, 3H), 
3.70 (dd, J = 10.0, 1.5 Hz, 1H), 3.55 (dd, J = 10.5, 1.5 Hz, 1H), 3.31-3.23 (m, 1H),  3.14 (s, 3H), 
2.32 (dq, J = 10.5, 6.5 Hz, 1H), 1.97-1.91 (m, 1H), 1.81-1.75 (m, 1H), 1.73 (ddq, J = 10.5, 7.0, 
1.5 Hz, 1H), 1.57-1.45 (m, 2H), 1.29 (s, 3H),  1.25 (d, J = 7.0 Hz, 3H), 1.13 (d, J = 7.0 Hz, 3H), 
1.05 (d, J = 6.5 Hz, 3H), 1.03 (t, J = 8.0 Hz, 9H), 0.91 (s, 9H), 0.89 (d, J = 7.0 Hz, 3H), 0.81 (t, J 
= 7.5 Hz, 3H), 0.74 (d, J = 7.0 Hz, 3H), 0.75-0.63 (m, 6H), 0.05 (s, 3H), 0.04 (s, 3H); 13C NMR 
(75 MHz, CD2Cl2): δ 175.3, 160.4, 160.1, 132.4, 131.9, 127.8, 127.6, 113.7, 113.7, 102.2, 101.7, 
84.7, 84.2, 82.3, 81.2, 76.6, 73.9, 71.4, 61.9, 55.6 (2C), 37.4, 37.4, 34.7, 32.0, 31.6, 30.9, 28.5, 
26.1, 22.2, 18.4, 15.8, 11.2, 10.4, 8.4, 7.4, 6.6, 6.2, 5.5, –3.6, –4.5. 
 
(R)-2-{(4S,5S,6R)-6-[(R)-1-(benzyloxy)-1-
formylethyl]-2,2,5-trimethyl-1,3-dioxan-4-yl}-N-methoxy-
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N-methylpropan amide (146′).  To a stirred solution of 149′       (0.110 g, 0.269  mmol) in 
CH2Cl2 (5 mL) cooled at 0 °C was added Dess-Martin periodinane (0.194 g, 0.456 mmol). After 
being stirred at room temperature for 1 h, the reaction was quenched by the addition of a 
saturated aqueous solution of NaHCO3 (5 mL), and extracted with CH2Cl2 (2×10 mL). The 
combined organic extracts were washed with brine, dried (Na2SO4) and concentrated. 
Purification by flash column chromatography (15-20% ethyl acetate in hexanes) afforded 0.092 g 
(83%) of the title compound as colorless oil. [α]D +13 (c 0.44, CHCl3); IR νmax(thin film) cm-1: 2990, 
2938, 2888, 1737, 1659, 1460, 1386, 1200, 1157, 1109; 1H NMR (300 MHz, CDCl3): δ 9.67 (s, 
1H), 7.36-7.22 (m, 5H), 4.61 (d, J = 11.7 Hz, 1H), 4.44 (d, J = 11.7 Hz, 1H), 4.25 (d, J = 2.1 Hz, 
1H), 4.00 (dd, J = 9.9, 1.8 Hz, 1H), 3.70 (s, 3H), 3.16 (s, 3H), 3.20-3.00 (m, 1H), 1.82-1.72 (m, 
1H), 1.46 (s, 3H), 1.43 (s, 3H), 1.31 (s, 3H), 1.21 (d, J = 6.6 Hz, 3H), 0.92 (d, J = 6.9 Hz, 3H); 
13C NMR (75 MHz, CDCl3): δ 203.2, 175.3, 138.7, 128.3, 127.4, 127.0, 99.8, 82.7, 77.2, 76.2, 
65.9, 61.5, 37.2, 32.1, 31.3, 29.7, 19.3, 15.5, 14.5, 6.9; HRMS (Q-Tof) m/z calcd for 
C22H33NO6Na [(M+Na)+]: 430.2206; found: 430.2226. 
 
(R)-2-{(4S,5S,6R)-6-[(2S,3S,4S,6R,7S,8R,9R)-
2-(Benzyloxy)-9-(tert-butyldimethylsilyloxy)- 
-3-hydroxy-7-(4-methoxybenzyloxy)-4,6,8-tri 
methyl-5-oxoundecan-2-yl]-2,2,5-trimethyl-
1,3-dioxan-4-yl}-N-methoxy-N-methylpropanamide (150′).  To a solution of 0.102 mL (0.353 
mmol) of diphenyltetramethyldisilazine in 2.5 mL of THF at 0 °C was added a 1.6 M solution of 
n-butyllithium in hexanes (0.221 mL, 0.353 mmol). After 20 min, the reaction was cooled to –78 
°C and a solution of ketone (0.140 g, 0.321 mmol) in 2.0 mL of THF was added via cannula 
OO
Me
O
Me
N
OH
MeO
O
Me
Me
TBSO
Me
O
Me
OMe
Me
Bn
PMB
MeMe
 139 
(with 2 x 0.5 mL rinses). The resultant clear yellow solution was stirred at –78 °C for 20 min, 
then at 0 °C for 1 h, before the reaction was recooled to –78 °C and a solution of the aldehyde 
146′ (0.170 g, 0.417 mmol) in 2.0 mL of THF was added via cannula. The resultant solution was 
stirred for 24 h at –78 °C, then quenched by the addition of a saturated aqueous solution of 
NaHCO3 and extracted with CH2Cl2 (3×10 mL). The combined organic extracts were dried over 
anhydrous Na2SO4 and concentrated to afford a pale yellow oil. Analysis of the unpurified 
mixture revealed a >95:5 ratio of diastereomers. Purification by flash chromatography (linear 
gradient 0 to 50% ethyl acetate/hexanes) afforded 0.153 g (56%) of the title compound as a clear 
colorless oil.  [α]D −7.6 (c 0.85, CHCl3); IR νmax(thin film) cm-1: 3407, 2934, 2856, 1638, 1615, 
1513, 1461, 1381, 1250; 1H NMR (600 MHz, CDCl3): δ 7.23-7.16 (m, 5H), 7.15 (d, J = 8.4 Hz, 
2H), 6.82 (d, J = 9.0 Hz, 2H), 4.86 (d, J = 12.0 Hz, 1H),  4.52 (d, J = 11.4 Hz, 1H), 4.35 (d, J = 
11.4 Hz, 1H), 4.33 (d, J = 10.8 Hz, 1H), 4.12 (d, J = 1.2 Hz, 1H), 4.07 (app t, J = 3.6 Hz, 1H), 
3.97 (d, J = 9.6 Hz, 1H), 3.96 (dd, J = 9.6, 1.8 Hz, 1H), 3.91 (ddd, J = 8.4, 4.8, 1.2 Hz, 1H), 3.78 
(s, 3H), 3.68 (s, 3H), 3.40 (dq, J = 7.2, 4.8 Hz, 1H), 3.14 (s, 3H), 3.15-3.10 (m, 1H), 2.73 (d, J = 
3.0 Hz, 1H), 2.58-2.54 (m, 1H), 1.97-1.90 (m, 1H), 1.62-1.56 (m, 1H), 1.55-1.45 (m, 2H), 1.45 
(s, 3H), 1.44 (s, 3H), 1.33 (s, 3H), 1.20 (d, J = 6.6 Hz, 3H), 1.13 (d, J = 7.2 Hz, 3H), 1.11 (d, J = 
7.2 Hz, 3H), 1.05 (d, J = 7.2 Hz, 3H), 0.88 (s, 9H), 0.76 (t, J = 7.2 Hz,, 3H), 0.57 (d, J = 7.2 Hz, 
3H), 0.02 (s, 6H); 13C NMR (75 MHz, CDCl3): δ 217.7, 175.6, 158.8, 139.7, 131.4, 128.8, 128.1, 
127.2, 126.9, 113.6, 99.5, 80.6, 78.8, 76.5, 72.9 (2C), 72.3, 66.0, 61.5, 55.2, 47.1, 42.6, 39.4, 
37.2, 32.1, 30.9, 30.1, 29.7, 28.4, 26.1, 19.5, 18.3, 15.5 (2C), 13.0, 10.1, 9.5 (2C), 7.1, –3.4, –4.1; 
HRMS (Q-Tof) m/z calcd for C47H77NO10SiNa [(M+Na)+]: 866.5294; found: 866.5214. 
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 (R)-2-{(4S,5S,6R)-6-[(2S,3S,4R,5R, 
6S,7R,8R,9R)-2-(Benzyloxy)-9-(tert-butyldim 
ethylsilyloxy)-3,5-dihydroxy-7-(4-methoxybe 
nzyloxy)-4,6,8-trimethylundecan-2-yl]-2,2,5-
trimethyl-1,3-dioxan-4-yl}-N-methoxy-N-methylpropanamide (151′).  To a solution of aldol 
adduct 150′ (0.140 g, 0.166 mmol) in 2 mL of CH2Cl2 at 0 °C was added 4.74 mL (0.664 mmol, 
0.14 M in Et2O) of Zn(BH4)2. After 8.5 h at 0 °C, the reaction was quenched with sat. aqueous 
NH4Cl and the resultant mixture was extracted with CH2Cl2 (3 x 5 mL). The combined organic 
extracts were dried (Na2SO4), filtered, and concentrated. The residue was dissolved in 20 mL of 
MeOH and stirred at 23 °C for 24 h. Following concentration, the residue (86:14 mixture of 
diastereomers by crude NMR) was purified by flash chromatography affording 0.126 g (90%) of 
the title compound as a white foam. [α]D −19 (c 0.55, CHCl3); IR νmax(thin film) cm-1: 3437, 2935, 
2856, 1644, 1513, 1461, 1381, 1249, 1148, 1090, 1040; 1H NMR (600 MHz, CD2Cl2): δ 7.20 
(dd, J = 1.8, 6.6 Hz, 2H), 7.06-7.00 (m, 5H), 6.79 (d, J = 8.4 Hz, 2H), 4.97 (d, J = 10.8 Hz, 1H),  
4.43 (d, J = 10.8 Hz, 1H), 4.26 (s, 2H), 4.03 (d, J = 1.2 Hz, 1H), 3.93 (dd, J = 9.6, 1.2 Hz, 1H), 
3.90 (ddd, J = 8.4, 1.2 Hz, 1H), 3.78 (s, 3H), 3.75 (dd, J = 9.0, 3.0 Hz, 1H), 3.74 (d, J = 1.2 Hz, 
1H), 3.72 (s, 3H),  3.48 (d, J = 9.0 Hz, 1H), 3.15 (s, 3H), 3.10-3.03 (m, 1H), 2.45-2.40 (m, 1H), 
2.05-1.98 (m, 1H), 1.84-1.77 (m, 1H), 1.73-1.66 (m, 1H), 1.60-1.45 (m, 3H), 1.43 (s, 6H), 1.41 
(s, 3H), 1.18 (d, J = 6.6 Hz, 3H), 1.12 (d, J = 6.6 Hz, 3H), 0.98 (d, J = 7.2 Hz, 3H), 0.90 (s, 9H), 
0.85 (d, J = 6.6 Hz, 3H), 0.80 (t, J = 7.8 Hz, 3H),  0.73 (d, J = 7.2 Hz, 3H), 0.06 (s, 3H), 0.04 (s, 
3H); 13C NMR (150 MHz, CD2Cl2): δ 175.9, 159.3, 139.8, 131.6, 129.4, 128.4, 128.3, 127.2, 
113.8, 99.8, 81.0, 80.4, 80.2, 78.5, 77.4, 76.9, 73.9, 73.5, 67.3, 61.9, 55.5, 39.7, 38.0, 37.5, 34.6, 
32.3, 31.2, 30.3, 28.7, 26.2, 19.4, 18.6, 15.9, 15.8, 10.3, 9.4, 9.2, 8.1, 7.7, −3.1, −4.0; HRMS (Q-
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Tof) m/z calcd for C47H79NO10SiNa [(M+Na)+]: 868.5371; found: 868.5379. 
 
(R)-2-[(4S,5S,6R)-6-{(2S,4S)-2-
(benzyloxy)-4-((2R,4R,5S,6R)-6-((2R,3R)-3-
(tert-butyldimethylsilyloxy)pentan-2-yl)-2-
(4-methoxyphenyl)-5-methyl-1,3-dioxan-4-
yl)pentan-2-yl}-2,2,5-trimethyl-1,3-dioxan-4-yl]-N-methoxy-N-propanamide (152′).  To a 
mixture of azeotropically dried 151' (0.060 g, 0.071 mmol) and 65 mg of activated powdered 4 
Å molecular sieves in 2 mL of CH2Cl2 was added a solution of DDQ (0.018 g, 0.078 mmol) in 3 
mL of CH2Cl2 at 0 °C by syringe. After stirring at the same temperature for 1 h, the reaction was 
filtered through celite and the filtrate washed with 3 x 5 mL of sat. aqueous NaHCO3 solution. 
The aqueous layer was extracted with CH2Cl2 (2×5 mL). The combined organic extracts were 
washed with brine, dried (Na2SO4), and concentrated. Purification by flash chromatography 
(10% EtOAc in hexanes) afforded the PMP acetal as white foam (0.054 mg, 92%).  
 To a solution of the above prepared PMP acetal (0.043 g, 0.051 mmol) in 2 mL of THF at 
0 °C was added 60% NaH (16.2 mg, 0.407 mmol), followed by CS2 (0.031 mL, 0.51 mmol). The 
resultant suspension was stirred for 1 h at 0 °C and then for 1 h at ambient temperature. The 
reaction was recooled to 0 °C and methyl iodide (0.127 mL, 2.04 mmol) was added. After 
stirring for 4 h at 0 °C, the reaction was warmed to ambient temperature and allowed to stir for 
additional 16 h. The reaction was partitioned between 4 mL of CH2Cl2 and 10 mL of H2O, and 
the aqueous layer was extracted with CH2Cl2 (3×5 mL). The combined organic extracts were 
dried over Na2SO4 and concentrated. Purification by flash chromatography (linear gradient 0 to 
20% EtOAc/hexanes) yielded 0.043 g (91%) of the xanthate as a yellow oil. 
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Azeotropically dried (benzene) xanthate (0.042 g, 0.045 mmol) was taken up in 1 mL of 
tributyltin hydride and heated to 110 °C at which point a catalytic amount of AIBN (1.0 mg) was 
added. After heating for 30 min, the reaction was cooled to 23 °C and quenched by adding water 
(5 mL) and extracted with CH2Cl2 (3×5 mL). The combined organic layers were then dried 
(Na2SO4) and concentrated. The resulting colorless oil was passed through a silica column 
eluting first with hexanes followed by 20% EtOAc in hexanes to afford the deoxygenated 
product 152′ (0.030 g, 81%). 1H NMR (500 MHz, CDCl3): δ 7.42 (d, J = 8.5 Hz, 2H), 7.30-7.17 
(m, 5H), 6.88 (d, J = 9.0 Hz, 2H), 5.40 (s, 1H), 4.78 (d, J = 11.5 Hz, 1H), 4.50 (d, J = 11.0 Hz, 
1H), 4.03 (ddd, J = 8.5, 6.0, 1.5 Hz, 1H), 3.96 (dd, J = 9.5, 1.5 Hz, 1H), 3.80 (s, 3H), 3.78 (d, J = 
2.0 Hz, 1H),  3.71 (s, 3H), 3.59 (dd, J = 10.0, 1.5 Hz, 1H), 3.32 (dd, J = 10.0, 1.5 Hz, 1H), 3.17 
(s, 3H), 3.15-3.10 (m, 1H), 2.10-2.00 (m, 1H), 1.91-1.83 (m, 1H), 1.76-1.62 (m, 3H), 1.54-1.46 
(m, 2H), 1.47 (s, 3H), 1.43 (s, 3H), 1.39 (s, 3H), 1.23 (d, J = 6.5 Hz, 3H), 1.13 (d, J = 6.5 Hz, 
3H), 1.06 (d, J = 6.5 Hz, 3H), 1.05-1.00 (m, 1H),  0.89 (s, 9H), 0.79 (t, J = 7.5 Hz, 3H), 0.73 (d, 
J = 6.5 Hz, 3H), 0.67 (d, J = 7.0 Hz, 3H), 0.02 (s, 3H), 0.01 (s, 3H); 13C NMR (125 MHz, 
CDCl3): δ 175.8, 159.5, 140.1, 132.2, 127.9, 127.7, 127.2, 126.7, 113.4, 100.9, 99.4, 86.6, 80.8, 
79.0, 78.4, 71.1, 65.8, 61.6, 55.3, 38.5, 37.1, 37.1, 36.6, 32.1, 31.1, 30.3, 30.0, 29.8, 28.2, 26.1, 
20.7, 19.4, 19.2, 18.2, 15.7, 10.3, 6.8, 6.5, 5.4, –3.9, –4.4. 
 
(2R,3S,4S,5R)-2,4,6-trimethyl-1-(1H-pyrrol-1-yl)-3,5-
bis(trimethylsilyloxy)hept-6-en-1-one (174).  To a solution of 
aldehyde 89 (0.400 g, 1.99 mmol) and enolsilane 169 (1.94 g, 9.99 
mmol) in 10 mL THF, was added 0.800 mL of a 0.5 M DMF solution of tetra(n-
butyl)ammonium p-nitrophenoxide (0.399 mmol) at −70 oC.  The reaction was stirred for 6 h at 
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−70 oC then diluted with Et2O (5 mL) and the resulting mixture was filtered through a silica gel 
plug.  The crude product mixture was purified by column chromatography (3% ethyl acetate in 
hexanes) to afford 0.571 g (73%) of the title compound as a clear colorless oil.  [α]D –19 (c 0.25, 
CHCl3); IR νmax(thin film) cm-1:  2959, 1713, 1466, 1250, 1071 cm-1;  1H NMR (300 MHz, CDCl3) δ 
7.32 (s, 2H), 6.31 (t, J = 2.4 Hz, 2H), 4.98 (t, J = 1.8 Hz, 1H), 4.94 (s, 1H), 3.99 (dd, J = 8.7, 1.5 
Hz, 1H), 3.93 (d, J = 9 Hz, 1H), 3.33-3.28 (m, 1H), 1.64 (s, 3H), 1.29 (d, J = 6.9 Hz, 3H),  0.90 
(d, J = 6.6 Hz, 3 H), 0.17 (s, 9H), 0,08 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 173.2, 146.6, 
119.0, 114.3, 113.4, 79.0, 74.1, 43.2, 40.6, 16.4, 16.0, 9.9, 1.1, 0.2; HRMS (ESI) m/z calcd for 
C20H37NO3Si2Na [(M+Na)+]: 418.2210; found: 418.2190. 
 
(2R,3S,4S,5R)-3,5-dihydroxy-2,4,6-trimethyl-1-(1H-
pyrrol-1-yl)hept-6-en-1-one (176). To a stirred solution of the 
aldol product 174 (0.638 g, 1.61 mmol) in 10 mL MeOH at room 
temperature, was added a 12-15 drops of 1 N aqueous HCl solution and the reaction mixture was 
stirred at room temperature for 15 min.  The reaction was then diluted with sat. aqueous NaHCO3 
solution (30 mL) and extracted with EtOAc (3×30 mL).  The combined organic extracts were 
dried (Na2SO4) and concentrated. The resulting crude product was purified by column 
chromatography (10-15% ethyl acetate in hexanes) to afford 0.393 g (97%) of the title compound 
as a colorless, crystalline solid.  mp 96-98 °C; [α]D –42 (c 0.63, CHCl3); IR νmax(thin film) cm-1:  
3400, 2976, 2937, 1707, 1651, 1467, 1372, 1274, 1073;  1H NMR (300 MHz, CDCl3) δ 7.36 (t, J 
= 2.1 Hz, 2H), 6.32 (t, J = 2.1 Hz, 2H), 4.99 (m, 1H), 4.94 (app sextet, J = 1.5 Hz, 1H), 4.30 (br 
s, 1H), 4.21 (ddd, J = 7.8, 2.7, 2.7 Hz, 1H), 3.33 (quint, J = 7.8 Hz, 1H), 3.32 (d, J = 2.4 Hz,  
1H), 2.05-2.02 (m, 1H), 1.90 - 1.80 (m, 1H), 1.66 (s, 3H), 1.44 (d, J = 6.9 Hz, 3H), 0.83 (d, J = 
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6.9 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 173.4, 145.8, 119.0, 113.6, 110.3, 78.8, 76.4, 41.9, 
36.5, 19.4, 15.0, 5.7; HRMS (EI) m/z calcd for C14H21NO3: 251.1521; found: 251.1517. 
 
(R)-1-(1H-pyrrol-1-yl)-2-[(4S,5S,6R)-2,2,5-trimethyl-6-
(prop-1-en-2-yl)-1,3-dioxan-4-yl]propan-1-one (177).  To a 
solution of the diol 176 (0.80 g, 3.18 mmol) in 2,2-
dimethoxypropane (20 mL) was added camphor sulfonic acid (0.037 g, 0.16 mmol) and the 
resulting solution was stirred at ambient temperature for 2 h.  The reaction was quenched by 
adding 4 mL of Et3N and the reaction mixture was concentrated and the resulting crude oil was 
purified by flash chromatography (3% ethyl acetate in hexanes) to afford the 0.81 g of the 
acetonide (88%) as a white crystalline solid.  mp 73-75 °C; [α]D –37 (c 0.42, CHCl3); IR νmax(thin 
film) cm-1:  3144, 3100, 2989, 2936, 1702, 1471, 1381, 1273, 1252, 1180;  1H NMR (300 MHz, 
CD2Cl2) δ 7.35 (s, 2H), 6.32 (t, J = 2.4 Hz, 2H), 4.98 (m, 1H), 4.85 (m, 1H), 4.34 (s, 1H), 4.25 
(dd, J = 9.6, 2.1 Hz, 1H), 3.23 (dq, J = 9.6, 6.9 Hz, 1H), 1.80 (tq, J = 6.9, 2.4 Hz, 1H),  1.61 (s, 
3H), 1.49 (s, 3H), 1.44 (s, 3H), 1.37 (d, J = 6.9 Hz, 3H),  0.64 (d, J = 6.9 Hz, 3 H); 13C NMR (75 
MHz, CD2Cl2) δ 172.6, 143.2, 119.3, 113.8, 110.2, 99.6, 75.1, 75.0, 41.4, 31.4, 30.0, 19.8, 19.3, 
16.6, 5.8; HRMS (EI) m/z calcd for C17H25NO3: 291.1834; found: 291.1834. 
 
(R)-Methyl 2-[(4S,5S,6R)-2,2,5-trimethyl-6-(prop-1-en-2-yl)-1,3-
dioxan-4-yl]propanoate (186).  To a 0 °C solution of 177 (0.810 g, 
2.78 mmol) in 30 mL of MeOH was added solid NaOMe (0.451 g, 
8.34 mmol) after which the reaction was warmed to ambient temperature and stirred for 1 h.  
Saturated aqueous NH4Cl (30 mL) was added and the resulting mixture was extracted with 
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EtOAc (3×30 mL).  The combined organic extracts were dried (Na2SO4), filtered, and 
concentrated.  The crude product was purified by flash column chromatography (5% ethyl 
acetate in hexanes) to afford 0.683 g (96%) of the title compound as a clear colorless oil.  [α]D –
12 (c 0.60, CHCl3); IR νmax(thin film) cm-1: 2991, 2940, 2881, 1738, 1457, 1382, 1258, 1198, 1105;  
1H NMR (300 MHz, CD2Cl2) δ 7.32 (s, 2H), 6.31 (t, J = 2.4 Hz, 2H), 4.98 (t, J = 1.8 Hz, 1H), 
4.94 (s, 1H), 3.99 (dd, J = 8.7, 1.5 Hz, 1H), 3.93 (d, J = 9 Hz, 1H), 3.33-3.28 (m, 1H), 1.64 (s, 
3H), 1.29 (d, J = 6.9 Hz, 3H),  0.90 (d, J = 6.6 Hz, 3 H), 0.17 (s, 9H), 0,08 (s, 9H); 13C NMR (75 
MHz, CD2Cl2) δ 1735.2, 143.2, 110.2, 99.6, 75.4, 75.1, 51.8, 42.9, 32.3, 30.0, 19.7, 19.4, 15.3, 
5.4; HRMS (EI) m/z calcd for C13H21O4 [(M– CH3) •+]: 241.1439; found: 241.1431. 
 
 (R)-Methyl-2-[(4S,5S,6R)-6-acetyl-2,2,5-trimethyl-1,3-dioxan-4-
yl]propanoate (187).  A gaseous stream of ozone in O2 (generated 
using a standard ozonizer) was bubbled through a –78 °C solution of 
186 (0.245 g, 0.949 mmol) in 10 mL CH2Cl2 for ~10 min (until the reaction mixture becomes 
blue).  Dimethyl sulfide (2 mL) was added at –78 °C and the reaction was warmed to ambient 
temperature and stirred for 2 h.  Water (10 mL) was added and the misture was extracted with 
CH2Cl2 (2×10 mL).  The combined organic extracts were dried (Na2SO4) and concentrated to 
afford 0.260 g of a crude product. (NMR of the crude in CDCl3 showed the product as a mixture 
of its keto and enol tautomers.) It was carried to the next step without further purification.  
 
(R)-Methyl-2-[(4S,5S,6R)-6-{(R)-2-hydroxybut-3-
en-2-yl}-2,2,5-trimethyl-1,3-dioxan-4-yl]propanoate (188). 
To a solution of crude 187 in 10 mL THF was added vinyl 
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magnesium bromide (1.52 mL, 1 M in THF, 2.52 mmol) at –78 oC. The reaction was then stirred 
for 10 min at –78 oC followed by 1 h at 0 oC after which it quenched with sat. aqueous NH4Cl 
(20 mL) and extracted with Et2O (2×20 mL). The crude product was purified by column 
chromatography (15% ethyl acetate in hexanes) to afford 0.272 g (99% over two steps) of the 
title compound as a clear colorless oil. [α]D + 27 (c 0.70, CHCl3); IR νmax(thin film) cm-1:  3563, 
3055, 2991, 2939, 1734, 1458, 1380, 1265, 1170, 1064;  1H NMR (300 MHz, CDCl3) δ 5.88 (dd, 
J = 17.1, 10.5 Hz, 1 H), 5.22 (dd, J = 17.1, 1.2 Hz, 1 H), 5.02 (dd, J = 10.5, 1.2 Hz, 1 H), 3.83 
(dd, J = 9.9, 1.8 Hz, 1 H), 3.68 (s, 3H),  3.67 (d, J = 2.1 Hz, 1H), 2.64 (dq, J = 9.9, 6.9 Hz, 1 H), 
1.66 (tq, J = 6.6, 2.1 Hz, 1 H), 1.39 (s, 3H), 1.38 (s, 3H), 1.21 (d, J = 6.6 Hz, 3H), 1.21 (s, 3H), 
1.02 (d, J = 6.9 Hz, 3 H; 13C NMR (75 MHz, CDCl3) δ 175.0, 144.8, 112.1, 99.7, 75.7, 74.0, 
51.7, 41.6, 31.7, 29.6, 22.6, 19.5, 15.2, 6.6; HRMS (EI) m/z calcd for C15H26O5: 286.1770; 
found: 286.1780. 
 
(R)-Methyl-2-[(4S,5S,6R)-6-{(S)-2-hydroxy-1-oxopropan-
2-yl}-2,2,5-trimethyl-1,3-dioxan-4-yl]propanoate (190). A  soluti-
on of 188 (0.200 g, 0.699 mmol) in 7 mL CH2Cl2 at –78 ˚C, was 
ozonolyzed for 10 min (or until color of the solution turned blue) 
followed by addition of dimethyl sulfide (1.280 mL, 17.47 mmol) at –78 ˚C. The reaction 
mixture was then warmed to ambient temperature and stirred for additional 2 h after which it was 
diluted with water (10 mL) and extracted with CH2Cl2 (2×20 mL). The combined organic 
extracts were dried (Na2SO4) and concentrated. The resulting crude product was purified by 
column chromatography (6% ethyl acetate in hexanes) to afford 0.185 g (92%) of the title 
compound as a clear colorless oil. [α]D +4.29 (c 1.12, CHCl3); IR νmax(thin film) cm-1: 3490, 2991, 
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2942, 1735, 1459, 1382, 1200, 1099; 1H NMR (300 MHz, CD2Cl2): δ 9.61 (s, 1H), 4.12 (d, J = 
2.4 Hz, 1H), 3.88 (dd, J = 9.9, 2.1 Hz, 1H), 3.66 (s, 3H), 3.29 (br s, 1H), 2.60 (dq, J = 9.9, 6.9 
Hz, 1H), 1.73 (tq, J = 6.6, 1.8 Hz, 1H), 1.40 (s, 3H), 1.37 (s, 3H), 1.19 (d, J = 6.9 Hz, 3H) , 1.19 
(s, 3H), 0.93 (d, J = 7.2 Hz, 3H); 13C NMR (75 MHz, CD2Cl2): δ 205.4, 174.9, 100.2, 79.1, 76.3, 
75.8, 51.9, 42.2, 31.4, 29.6, 19.6, 19.3, 15.2, 6.9. HRMS (EI) m/z calcd for C13H21O6 [(M–CH3) 
•+]: 273.1338; found: 273.1329. 
 
(R)-Methyl-2-[(4S,5S,6R)-2,2,5-trimethyl-6-{(S)-1-oxo-2-
(triethylsilyloxy)propan-2-yl}-1,3-dioxan-4-yl]propanoate (191). 
To a solution of aldehyde 190 (0.120 g, 0.416 mmol) in 5 mL 
CH2Cl2 at 0 °C was added 2,6-lutidine (0.087 mL, 0.75 mmol). After 
5 minutes, TESOTf (0.113 mL, 0.499 mmol) was added and the reaction was allowed to stir for 
4.5 h at 0 °C. The reaction was quenched by adding a saturated aqueous solution of NaHCO3 (10 
mL) and extracted with CH2Cl2 (2×10 mL). The combined organic extracts were washed with 
brine, dried (Na2SO4) and concentrated.  The resulting crude oil was purified by flash 
chromatography (2-3% ethyl acetate in hexanes), affording 0.135 g (81%) of the title compound 
as a clear colorless oil. [α]D −1.50 (c 1.50, CHCl3); IR νmax(thin film) cm-1: 2921, 2852, 1739, 1650, 
1457, 1379, 1162, 1061; 1H NMR (300 MHz, CDCl3): δ 9.71 (s, 1H), 3.88 (d, J = 2.1 Hz, 1H), 
3.79 (dd, J = 10.2, 2.1 Hz, 1H), 3.65 (s, 3H), 2.62 (dq, J = 9.9, 6.6 Hz, 1H), 1.78 (tq, J = 4.8, 2.1 
Hz, 1H), 1.40 (s, 3H), 1.39 (s, 3H), 1.30 (s, 3H), 1.20 (d, J = 6.6 Hz, 3H), 0.93 (t, J = 7.8 Hz, 
9H), 0.83 (d, J = 6.6 Hz, 3H), 0.71-0.51 (m, 6H); 13C NMR (75 MHz, CDCl3): δ 203.9, 174.8, 
99.7, 80.6, 80.4, 75.7, 51.5, 42.0, 31.2, 29.6, 22.5, 19.2, 14.9, 7.0, 6.8, 6.6. HRMS (EI) m/z calcd 
for C20H39O6Si: 403.2516; found: 403.2523. 
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(R)-Methyl 2-((4S,5S,6R)-6-{(2R,3R, 
4R,6R,7S,8R,9R)-7-(4-methoxybenzyloxy)-9-
(tert-butyldimethylsilyloxy)-3-hydroxy-4,6,8-
trimethyl-5-oxo-2-(triethylsilyloxy)undecan-
2-yl}-2,2,5-trimethyl-1,3-dioxan-4-yl)propanoate (192). To a solution of LHMDS (0.398 mL, 
1.0 M in THF, 0.398 mmol) in 0.8 mL THF at  −78 °C, was added a solution of the ketone 105 
(0.116 g, 0.265 mmol) in 0.5 mL of THF. The resulting solution was stirred for 10 min at −78 °C 
and at 0 °C for 2.5 h, after which it was recooled to −78 °C and a solution of aldehyde 191 
(0.160 g, 0.398 mmol) in 0.5 mL THF was added via cannula. The resulting solution was then 
allowed to stir for 1 h at −78 °C and  quenched by dropwise addition of precooled acetic acid 
(1.1 mL, 1N in THF, 4 equiv) at the same temperature.  After stirring for additional 20 min at 
−78 °C, the reaction was warmed to 0 °C and quenched with saturated aqueous NaHCO3 solution 
(10 mL). The reaction mixture was extracted with ether (3×10 mL). The organic extracts were 
combined, dried (Na2SO4) and concentrated.  The resulting crude oil was purified by flash 
chromatography (gradient elution with 0-30% ethyl acetate in hexanes) affording 0.112 g (51%) 
of the title compound in the form of a clear colorless oil as a single observable diastereomer (by 
NMR) along with 0.043 g (0.098 mmol, 38%) of the unreacted ketone. [α]D −32 (c 0.38, CHCl3); 
IR νmax
(thin film) cm-1: 3466, 2954, 2936, 2879, 1737, 1613, 1514, 1460, 1380, 1250, 1199, 1098; 
1H NMR (500 MHz, CDCl3): δ 7.26 (d, J = 8.5 Hz, 2H), 6.85 (d, J = 8.5 Hz, 2H), 4.38 (d, J = 
10.5 Hz, 1H), 4.11 (app t, J = 3.0 Hz, 1H), 3.94 (ddd, J = 8.0, 5.0, 2.5 Hz, 1H), 3.86-3.81 (m, 
2H), 3.80 (dd, J = 5.0, 1.5 Hz, 1H), 3.79 (s, 3H), 3.65 (s, 3H), 3.52 (d, J = 4.0 Hz, 1H), 3.12 (dq, 
J = 7.0, 2.5 Hz,  1H), 2.94 (dq, J = 7.0, 2.5 Hz,  1H), 2.66 (dq, J = 10.0, 7.0 Hz,  1H), 1.80 – 1.70 
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(m, 2H), 1.60-1.48 (m, 2H), 1.44 (s, 3H), 1.42 (s, 3H), 1.27 (s, 3H), 1.25 (d, J = 7.0 Hz, 3H), 
1.21 (d, J = 6.5 Hz, 3H), 1.15 (d, J = 7.0 Hz, 3H), 1.04 (d, J = 6.5 Hz, 3H), 0.96 (t, J = 8.0 Hz, 
9H), 0.90 (s, 9H), 0.85 (d, J = 7.0 Hz, 3H), 0.81 (t, J = 7.5 Hz, 3H), 0.69-0.60 (m, 6H), 0.07 (s, 
3H), 0.06 (s, 3H); 13C NMR (125 MHz, CDCl3): δ 215.6, 174.8, 159.0, 131.1, 129.1, 113.6, 99.9, 
81.2, 79.0, 78.3, 76.5, 74.6, 72.8, 55.2, 51.6, 46.6, 45.9, 41.7, 39.5, 32.0, 29.7, 28.3, 26.0, 23.2, 
19.6, 18.3, 15.1, 11.9, 10.4, 9.9, 7.2, 6.9, –3.4, –4.2; HRMS (ESI) m/z calcd for C45H82O10Si2Na 
[(M+Na)+]: 861.5344; found: 861.5367. 
 
(R)-Methyl 2-[(4S,5S,6R)-6-{(2R,3R, 
4S,5S,6S,7R,8R,9R)-7-(4-methoxybe 
nzyloxy)-9-(tert-butyldimethylsilylox 
y)-3,5-dihydroxy-4,6,8-trimethyl-2-(tr 
iethylsilyloxy)undecan-2-yl}-2,2,5-trimethyl-1,3-dioxan-4-yl]propanoate (193). To a solution 
of aldol adduct 192 (0.115 g, 0.137 mmol) in 2 mL of CH2Cl2 at 0 °C was added 2.75 mL (0.548 
mmol, 0.20 M in Et2O) of Zn(BH4)2. After 8.5 h at 0 °C, the reaction was quenched with 
saturated aqueous NH4Cl solution (5 mL) and the resultant mixture was extracted with CH2Cl2 
(3×5 mL). The combined organic extracts were dried (Na2SO4) and concentrated. The residue 
was dissolved in 20 mL of MeOH and stirred at 23 °C for 24 h. Following concentration, the 
residue was purified by flash chromatography (10% EtOAc in hexanes) affording 0.115 g 
(100%) of the title compound as a white foam as a single diastereomer. [α]D −4.5 (c 0.20, 
CHCl3); IR νmax(thin film) cm-1: 3402, 2954, 2879, 1736, 1612, 1513, 1458, 1248, 1168, 1066; 1H 
NMR (500 MHz, CDCl3): δ 7.26 (d, J = 8.5 Hz, 2H), 6.85 (d, J = 8.5 Hz, 2H), 4.74 (d, J = 11.0 
Hz, 1H), 4.63 (d, J = 11.0 Hz, 1H), 4.04 (d, J = 3.0 Hz, 1H), 4.01 (ddd, J = 9, 5.5, 1.5 Hz, 1H), 
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3.97 (dd, J = 9.5, 1.5 Hz, 1H), 3.84 (d, J = 2.0 Hz, 1H), 3.80 (s, 3H), 3.80 (dd, J = 10.0, 2.0 Hz, 
1H), 3.70 (d, J = 10.0 Hz, 1H), 3.63 (s, 3H), 3.57 (s, 1H), 2.66 (dq, J = 10.0, 6.5 Hz, 1H), 2.10 
(q, J = 6.5 Hz, 1H), 1.78-1.68 (m, 3H), 1.65-1.48 (m, 2H), 1.43 (s, 6H), 1.33 (s, 3H), 1.21 (d, J = 
7.0 Hz, 3H), 1.02 (d, J = 7.0 Hz, 3H), 0.96 (d, J = 7.0 Hz, 3H), 0.94 (t, J = 8.0 Hz, 9H), 0.91 (s, 
9H), 0.84 (t, J = 7.5 Hz, 3H), 0.77 (d, J = 7.0 Hz, 3H), 0.76 (d, J = 7.0 Hz, 3H), 0.62 (dq, J = 8.0, 
3.0 Hz, 6H), 0.11 (s, 3H), 0.07 (s, 3H); 13C NMR (CD2Cl2, 75 MHz) δ 174.8, 159.3, 132.7, 
129.2, 113.9, 100.4, 82.8, 81.7, 79.9, 79.0, 78.7, 76.9, 74.6, 74.0, 55.6, 51.9, 42.2, 39.5, 37.9, 
33.9, 32.5, 29.9, 29.0, 26.3, 23.9, 19.7, 18.7, 15.2, 10.5, 9.5, 9.4, 7.6, 7.4, 7.3, 6.0, –3.1, –4.0; 
HRMS (ESI) m/z calcd for C45H84O10Si2Na [(M+Na)+]: 863.5501; found: 863.5435. 
 
(R)-Methyl 2-[(4S,5S,6R)-6- -{(2R,3R, 
4R)-4-((5S,6R)-6-((2R,3R)-3-(tert- butyldimeth 
ylsilyloxy)pentan-2-yl)-2-(4-methoxyphenyl)-5 
-methyl-1,3-dioxan-4-yl)-3-hydroxy-2-triethy-  
lsilyloxy)pentan-2-yl}-2,2,5-trimethyl-1,3-dioxan-4-yl]propanoate (194).  To a mixture of 
azeotropically dried 193 (28 mg, 0.033 mmol) and 70 mg of activated powdered 4 Å molecular 
sieves in 0.3 mL of CH2Cl2 was added a solution of DDQ (9.1 mg, 0.039 mmol) in 0.2 mL of 
CH2Cl2 at 0 °C by syringe. After stirring at the same temperature for 0.5 h, the reaction was 
quenched by adding saturated aqueous NaHCO3 solution (5 mL) and the aqueous layer was 
extracted with CH2Cl2 (2×5 mL). The combined organic layers were washed with brine, dried 
(Na2SO4), and concentrated. Purification by flash chromatography (10% EtOAc in hexanes) 
afforded the title compound as white foam (27 mg, 98%). [α]D −8.7 (c 0.55, CHCl3); IR νmax(thin 
film) cm-1: 3364, 2954, 2879, 1738, 1615, 1459, 1383, 1250, 1199, 1102, 1014; 1H NMR (500 
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MHz, CD2Cl2): δ 7.41 (d, J = 9.0 Hz, 2H), 6.89 (d, J = 9.0 Hz, 2H), 5.53 (s, 1H), 4.03 (ddd, J = 
9.0, 6.0, <1 Hz, 1H), 3.97 (d, J = 2.0 Hz, 1H), 3.86 (dd, J = 10.0, 1.5 Hz, 1H), 3.84 (dd, J = 10.0, 
1.5 Hz, 1H), 3.80 (s, 3H), 3.67 (d, J = 5.0 Hz, 1H), 3.66 (s, 3H), 3.65 (d, J = 9.5 Hz, 1H), 3.57 (d, 
J = 5.0 Hz, 1H), 2.64 (dq, J = 10.0, 7.0 Hz, 1H), 2.51 (dq, J = 11.0, 6.5 Hz, 1H), 1.82 (dq, J = 
6.5, 1.0 Hz, 1H), 1.75 (ddq, J = 10.0, 7.0, 1.0 Hz, 1H), 1.69 (tq, J = 7.0, 1.5 Hz, 1H), 1.56-1.47 
(m, 2H), 1.48 (s, 3H), 1.43 (s, 3H), 1.24 (s, 3H), 1.20 (d, J = 7.0 Hz, 3H), 1.18 (d, J = 7.0 Hz, 
3H), 1.08 (d, J = 7.0 Hz, 3H), 1.06 (d, J = 7.0 Hz, 3H), 0.98 (t, J = 7.5 Hz , 3H), 0.90 (s, 9H), 
0.82 (t, J = 8.0 Hz, 3H), 0.76 (d, J = 7.0 Hz, 3H), 0.72-0.60 (m, 6H), 0.04 (s, 3H), 0.01 (s, 3H); 
13C NMR (CD2Cl2, 125 MHz) δ 174.9, 160.2, 132.7, 127.7, 113.7, 100.3, 95.3, 82.7, 80.7, 78.8, 
77.7, 76.7, 75.0, 71.2, 55.6, 51.9, 42.1, 37.5, 33.0, 32.5, 29.9, 29.5, 28.5, 26.2, 24.5, 20.4, 18.4, 
15.3, 13.6, 10.6, 10.4, 7.9, 7.4, 7.2, 7.0, –4.0, –4.1; HRMS (EI) m/z calcd for C45H82O10Si2: 
838.5446; found: 838.5478. 
 
(R)-Methyl 2-[(4S,5S,6R)-6-{(2S,3R,4S)-4-
((5S,6R)-6-((2R,3R)-3-(tert-butyldimethylsil  
yloxy)pentan-2-yl)-2-(4-methoxyphenyl)-5-
methyl-1,3-dioxan-4-yl)-3-(methylthiocarb 
onothioyloxy)-2-(triethylsilyloxy)pentan-2-
yl}-2,2,5-trimethyl-1,3-dioxan-4-yl]propanoate (195).  To a solution of 194 (27 mg, 0.032 
mmol) and CS2 (0.078 mL, 1.3 mmol) in 0.5 mL of THF at –78 °C, KHMDS (0.193 mL, 0.5 M 
in toluene, 0.0970 mmol) was added dropwise. The resultant solution was stirred for 2.5 h at –78 
°C and MeI (0.080 mL, 1.3 mmol) was added. After stirring for additional 20 min at –78 °C, the 
reaction was quenched with saturated aqueous NH4Cl solution (5 mL). The layers were separated 
OO
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and the aqueous layer was extracted with ether (3×5 mL). The combined organic extracts were 
dried (Na2SO4) and concentrated. Purification by flash chromatography (2.5% EtOAc in 
hexanes) afforded 27 mg (90%) of the title compound as a foam. [α]D −35 (c 0.20, CHCl3); IR 
νmax
(thin film) cm-1: 2955, 1737, 1613, 1590, 1459, 1380, 1250, 1198, 1170, 1057, 1011; 1H NMR 
(500 MHz, CD2Cl2): δ 7.39 (d, J = 9.0 Hz, 2H), 6.87 (d, J = 9.0 Hz, 2H), 6.06 (s, 1H), 5.46 (s, 
1H), 4.03 (ddd, J = 8.0, 6.0, 1.0 Hz, 1H), 3.84 (dd, J = 10.0, 2.0 Hz, 1H), 3.80 (s, 3H), 3.69 (d, J 
= 2.0 Hz, 1H), 3.64 (s, 3H), 3.63 (d, J = 11.5 Hz, 1H), 2.96 (dq, J = 11.0, 7.0 Hz, 1H), 2.60 (dq, J 
= 10.0, 7.0 Hz, 1H), 2.53 (s, 3H), 1.90 (dq, J = 7.0, 1.5 Hz, 1H), 1.82 (tq, J = 7.0, 2.0 Hz, 1H), 
1.77 (ddq, J = 10.0, 7.0, 2.0 Hz, 1H), 1.56- 1.49 (m, 2H), 1.44 (s, 3H),  1.39 (s, 3H),  1.34 (s, 
3H), 1.20 (d, J = 7.0 Hz, 3H), 1.19 (d, J = 7.0 Hz, 3H), 1.13 (d, J = 7.0 Hz, 3H), 1.00 (t, J = 8.0 
Hz, 9H), 0.99 (d, J = 6.0 Hz, 3H), 0.89 (s, 9H), 0.81 (t, J = 7.5 Hz, 3H), 0.79 (d, J = 7.0 Hz, 3H), 
0.71 (q, J = 7.5 Hz, 6H), 0.03 (s, 3H), 0.00 (s, 3H); 13C NMR (CD2Cl3, 125 MHz) δ 215.9, 174.8, 
160.2, 132.6, 127.7, 113.7, 100.2, 95.7, 84.5, 80.9, 80.7, 80.0, 76.4, 75.5, 71.3, 55.6, 51.9, 42.3, 
37.5, 34.9, 32.4, 30.6, 29.5, 28.7, 26.2, 25.5, 19.6, 19.2, 18.4, 15.3, 13.6, 12.1, 10.4, 8.2, 7.7, 7.4, 
7.3, –3.7, –4.4; HRMS (ESI) m/z calcd for C47H84O10Si2S2Na [(M+Na)+]: 951.4942; found: 
951.4922. 
 
(R)-Methyl 2-[(4S,5S,6R)-6- {(2R,3R, 
4R)-4-((5S,6R)-6-((2R,3R)-3-(tert-butyldime  
thylsilyloxy)pentan-2-yl)-2-(4-methoxyphen 
yl)-5-methyl-1,3-dioxan-4-yl)-3-hydroxy-2-
(triethylsilyloxy)pentan-2-yl}-2,2,5-
trimethyl-1,3 -dioxan-4-yl]propanoate (197).  Azeotropically dried (benzene) xanthate 195 
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(0.160 g, 0.172 mmol) was taken up in 3.20 mL of tributyltin hydride and heated to 110 °C at 
which point a catalytic amount of AIBN (2.0 mg, 0.014 mmol) was added. After heating for 30 
min, the reaction mixture was cooled to 23 °C and quenched by the addition of water (5 mL) and 
extracted with CH2Cl2 (3×5 mL). The combined organic extracts were dried (Na2SO4) and 
concentrated. The resulting colorless oil was passed through a silica column eluting first with 
hexanes followed by 20% EtOAc in hexanes to afford the deoxygenated product (111 mg, 78%) 
as a mixture of (R)- and (S)- PMP acetals. To a solution of this mixture in 3.0 mL of CD2Cl2 
were added p-anisaldehyde dimethyl acetal (0.110 mL, 0.674 mmol) and CSA (32.0 mg, 0.135 
mmol). The reaction was stopped after 25-30 minutes (NMR monitoring showed complete 
disappearance of minor acetal isomer) by addition of Et3N (~2 mL). Concentration and further 
purification by flash chromatography (15% EtOAc/hexanes) afforded the pure diastereomer 197 
as a clear colorless oil (0.100 g, 71% over 2 steps).  [α]D −9.4 (c 0.18, CHCl3); IR νmax(thin film) cm-
1: 2955, 2878, 1738, 1612, 1515, 1460, 1379, 1251, 1168, 1104, 1057, 1015; 1H NMR (300 
MHz, CD2Cl2): δ 7.39 (d, J = 8.5 Hz, 2H), 6.88 (d, J = 8.5 Hz, 2H), 5.50 (s, 1H), 4.01 (ddd, J = 
8.5, 5.5, 1 Hz , 1H), 3.90 (dd, J = 10.0, 2.0 Hz, 1H), 3.81 (dd, J = 10.0, 2.0 Hz , 1H), 3.79 (s, 
3H), 3.65 (s, 3H), 3.61 (d, J = 2.0 Hz, 1H), 3.22 (d, J = 10.5 Hz, 1H), 2.62 (dq, J = 10.0, 6.5 Hz, 
1H), 2.25 – 2.18 (m, 1H), 1.85 (dq, J = 7.0, 1.0 Hz, 1H), 1.75 – 1.70 (m, 2H), 1.63 (tq, J = 6.5, 
1.5 Hz, 1H), 1.55-1.46 (m, 1H), 1.43 (s, 3H), 1.40 (s, 3H), 1.35-1.25 (m, 2H), 1.22 (s, 3H), 1.19 
(d, J = 7.0 Hz, 3H), 1.16 (d, J = 7.0 Hz, 3H), 1.07 (d, J = 7.0 Hz, 3H), 0.99 (d, J = 7.0 Hz, 3H), 
0.95 (t, J = 8.0 Hz, 9H), 0.89 (s, 9H), 0.81 (t, J = 7.5 Hz, 3H); 13C NMR (CD2Cl2, 75 MHz) δ 
175.1, 160.2, 132.6, 127.7, 113.7, 99.9, 95.4, 85.3, 78.2, 77.9, 76.6, 75.0, 71.3, 55.6, 51.8, 44.3, 
42.3, 37.6, 32.3, 29.9, 29.4, 28.9, 28.5, 26.5, 26.2, 20.4, 18.6, 18.4, 15.3, 13.6, 10.4, 7.8, 7.5, 7.4, 
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6.9, –3.9, –4.3;  HRMS (ESI) m/z calcd for [(M+Na)+] C45H82O9Si2Na: 845.5395; found: 
845.5405. 
 
(2R,3S,4R,5S,6S,8R,9S,10S,11R,12R,13R)-13-Ethyl-6-
hydroxy-9,11-[(R)-(p-methoxybenzylidine)dioxy]-3,5-[(1-
methylethylidene)dioxy]-2,4,6,8,10,12-hexamethyltetradeca-  
nolide (198). To a solution of 197 (35 mg, 0.043 mmol) in 3 
mL of THF/MeOH (1:1 v:v), was added was added 0.210 mL 
(0.425 mmol) of  a 2 M aqueous solution of LiOH. The resultant clear solution was heated at 55 
°C with a reflux condenser for 20 h. The reaction mixture was then diluted with water (2.5 mL), 
acidified to pH 1 with a solution of 1 M NaHSO4 and extracted with Et2O (3×5 mL). The 
combined organic layers were washed with brine (10 mL), dried (Na2SO4), filtered, and 
concentrated. Purification by flash chromatography (20-25% EtOAc in hexanes) afforded the 
carboxylic acid as colorless oil (33 mg, 96%). The acid was immediately carried to the next step 
as it was unstable. 
 To a solution of the acid (30 mg, 0.037 mmol) in 2.5 mL of THF at 0 °C was added n-
Bu4NF (0.223 mL, 1.0 M in THF, 0.223 mmol). The resultant solution was heated at reflux for 
10 h after which another equal amount of n-Bu4NF was added. The reaction was allowed to 
reflux for additional 10 h, then quenched by the addition of a saturated aqueous solution of 
NH4Cl (5 mL) and extracted with EtOAc (3×10 mL). The combined organic layers were dried 
(Na2SO4) and concentrated. The resultant yellow oil was purified by flash chromatography (50% 
EtOAc/hexanes followed by 60-100% EtOAc/hexanes with two drops of acetic acid per 100 mL 
eluant), affording a mixture of the pure seco-acid along with TBAF salts which was carried to 
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the next step without further purification.  
 To a stirred solution of the crude azeotropically dried (2×5 mL of benzene) hydroxy acid  
(24 mg) in 2 mL of benzene at 23 °C was added Et3N (0.230 mL, 1.65 mmol), followed by 2,4,6-
trichlorobenzoyl chloride (0.258 mL, 1.65 mmol). After 24 h, N, N-(dimethylamino)pyridine 
(0.400 g, 3.30 mmol) was added as well as 3 mL of benzene and the white cloudy reaction 
mixture was allowed to stir for additional 15 h at room temperature. The reaction was quenched 
by the addition of 1 N NaHSO4 (10 mL) and extracted with CH2Cl2 (3×10 mL). The combined 
organic layers were washed with brine (10 mL), dried (Na2SO4), and concentrated. Purification 
by flash chromatography (20-25% EtOAc/hexanes) afforded 198 as a white solid (18 mg, 81%). 
m.p. 95-97 ˚C;   [α]D +0.53 (c 0.45, CHCl3); IR νmax(thin film) cm-1: 3429, 2971, 2935, 1723, 1615, 
1516, 1457, 1384, 1249, 1173, 1098, 1037; 1H NMR (CDCl3, 600 MHz) δ 7.50 (d, J = 8.4 Hz, 
2H), 6.89 (d, J = 8.4 Hz, 2H), 5.68 (s, 1H), 5.45 (dd, J = 10.2, 4.2 Hz, 1H), 4.05 (s, 1H), 3.89 (d, 
J = 10.8 Hz, 1H), 3.80 (s, 3H), 3.64 (d, J = 9.6 Hz, 1H), 3.34 (d, J = 10.8 Hz, 1H), 2.77 (dq, J = 
10.8, 6.6 Hz, 1H), 2.50 (m, 1H), 2.23 (br. s, 1H), 1.80-1.67 (m, 4H), 1.52 (s, 3H), 1.47 (s, 3H), 
1.50-1.45 (m, 2H), 1.33 (dd, J = 15.0, 12.0 Hz, 1H), 1.25 (d, J = 6.6 Hz, 3H), 1.24 (s, 3H), 1.22 
(d, J = 6.6 Hz, 3H), 1.20 (d, J = 6.6 Hz, 3H), 1.01 (d, J = 6.6 Hz, 3H),  0.86 (d, J = 7.2 Hz, 3H), 
0.85 (t, J = 7.2 Hz, 3H); 13C NMR (CDCl3, 75 MHz) δ 175.8, 159.8, 131.7, 127.5, 113.6, 101.1, 
95.4, 85.3, 79.9, 77.6, 75.7, 75.2, 74.8, 55.3, 41.8, 39.7, 39.2, 32.1, 29.6, 28.3, 26.8, 26.7, 25.4, 
20.1, 17.3, 13.9, 12.6, 10.4, 7.5, 7.0; HRMS (EI) m/z calcd for C32H50O8: 562.3506; found: 
562.3498. 
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6.0  DEVELOPMENT OF A TWO STEP PROTOCOL FOR CONVERSION OF 
LACTONE TO ALDEHYDE 
6.1 REACTION DESIGN AND RESULTS 
The iterative AAC methodology has been demonstrated to be a very useful catalytic method for 
the synthesis of polypropionate frameworks. So far the method relies on a sequence of three 
steps, ring opening to Weinreb amide, protection and reduction, to convert the lactone to the 
aldehyde before another iteration can take place, making up to a total of four steps per iterative 
cycle.  In Nature, the iterative process of chain elongation in polyketides requires as few as two 
steps.  Thus, in order to achieve maximum efficiency in iterative AAC-based polypropionate 
construction, the expedient transformation of the β-lactone propionate surrogates to the 
corresponding β-alkoxy aldehydes is required.  Merging the AAC bond constructions with an 
efficient (1-2 steps), economical, and operationally simple lactone-to-aldehyde conversion would 
yield an exceptionally efficient strategy for continued chain extension in the catalytic asymmetric 
construction of polypropionate units (Figure 41).  
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Figure 41. Ideal two step iterative chain elongation via AAC methodology 
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To that end, we envisioned that the facile nucleophile-mediated β-lactone ring opening by 
thiolate nucleophiles 199 can be exploited to realize an efficient method for directly converting 
the enantioenriched β-lactones to the corresponding β-hydroxy aldehydes. A catalytic amount of 
the reactive thiolate nucleophile 199 will first be generated via reaction of thiol with a suitable 
base, which will trigger the ring opening of the β-lactone to the thiolate intermediate 200. 
Reprotonation of 200 with thiol will regenerate the thiolate catalyst providing the β-hydroxythiol 
ester 201. Protection of the free alcohol functionality in 201 in the same pot will enable a one 
step procedure for conversion of the lactone to the ring opened form (Figure 42).  
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Figure 42. Catalytic cycle for conversion of lactone to thioester  
 
To test this idea, KHMDS was chosen as the base. We were pleased to find that when the 
ring opening of the β-lactone 202 was carried out with 1.2 equiv of EtSH in presence of 10 mol% 
of KHMDS at room temperature, the ring opened product 203 was afforded cleanly in 3 h in 
98% yield (eq 23). In subsequent experiments, the β-hydroxy thioester product was converted to 
the protected silyl ether 204 in the same reaction pot (in nearly quantitave yield) by adding 2,6-
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lutidine and R3SiOTf to the reaction mixture after all of the β-lactone starting material had been 
consumed (by TLC) (eq 24).  
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(23)
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   KHMDS (10 mol%)
THF, 0 °C, 3h
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TBSOTf (2 equiv.)
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A commonly used method for the reduction of thioesters to aldehydes is the Fukuyama 
reaction76
                                                 
76 (a) Fukuyama, T.; Lin, S.-C.; Li, L. J. Am. Chem. Soc. 1990, 112, 7050-7051. (b) Kanda, Y.; Fukuyama, T. J. Am. 
Chem. Soc. 1993, 115, 8451-8452. (c) Tokuyama, H.; Yokoshima, S.; Lin, S.-C.; Li, L.; Fukuyama, T. Synthesis 
2002, 1121-1123. 
 where H2 or Et3SiH is used as the reducing agent in presence of catalytic Pd/C. In 
addition to using expensive Pd metal, this reaction often suffers from long reaction times as the 
rate of the reduction highly varies with the activity of the Pd catalyst used. In contrast, reduction 
with iBu2AlH is more convenient and can be achieved in much shorter reaction times. The TBS-
protected thioester 204 was thus subjected to reduction with iBu2AlH at −78 ˚C in CH2Cl2 as 
solvent to provide the corresponding aldehyde 205 in excellent yield (94%) (eq 25). Over-
reduction to alcohol was eliminated by slow addition of MeOH to the reaction mixture at −78 ˚C, 
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prior to addition of Rochelle’s salt solution. In a separate experiment, the reactions in eq 24 and 
25 were carried out sequentially without purification of the intermediate 204. In this case the 
overall isolated yield of the aldehyde was 80% which is inferior to the combined yield of the two 
steps when performed with purification of 204 (93%). The substrate scope of the reaction was 
next examined using other β-lactones which include 76 and 86 involved in erythronolide B 
synthesis. As shown in Table 2, in all cases the aldehyde products were obtained in good yields. 
  
 
205
H
O
Me
OTBS
Ph
(93%)
(25)
204
EtS
O
Me
OTBS
Ph
iBu2AlH
CH2Cl2 , −78 °C
 
 
 
Table 2. Conversion of lactones to β-silyloxy aldehydes 
O
O
O
O
Me
Me
Me
Me
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Me Ph
OTMSO
Me Me
H
OTBSO
Me
H
Me
OTBSO
Me
H Ph
89%a
85%a
93%a
Entry Substrate Product Yield
1.
2
3
86
76
89
79
202 205
80%b
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OPMB
OTBSO
Me
Me
OPMB
H 74%
b4
206 207
O
O
TMS
OTBSO
H
TMS
O
O
Me OPMB
OTBSO
Me
H OPMB
78%a
86%a
5
6
208 209
210 211
aThe intermediate siloxy thioester was purified before subjecting to reduction
with DIBAL-H. bThe intermediate siloxy thioester was not purified before subjecting to reduction 
with DIBAL-H.  
6.2 EXPERIMENTAL 
General Information: Optical rotations were measured on a Perkin-Elmer 241 digital 
polarimeter with a sodium lamp at ambient temperature and are reported as follows: [α]λ (c 
g/100mL, solvent). Infrared spectra were recorded on a Nicolet Avatar 360 FT-IR spectrometer. 
NMR spectra were recorded on a Bruker Avance-300 (1H: 300 MHz; 13C: 75 MHz), 500 (1H: 
500 MHz; 13C: 125 MHz) or 600 (1H: 600 MHz; 13C: 150 MHz) spectrometers with chemical 
shifts reported relative to residual CHCl3 (7.26 ppm) for 1H and CDCl3 (77.0 ppm) for 13C NMR 
spectra or residual CH2Cl2 (5.32 ppm) for 1H and CD2Cl2 (53.8 ppm) for 13C NMR spectra. 
Unless otherwise stated, all reactions were carried out in flame-dry glassware under a nitrogen 
atmosphere using standard inert atmosphere techniques for the manipulation of solvents and 
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reagents. Anhydrous solvents (CH2Cl2, THF) were obtained by passage through successive 
alumina and Q5 reactant-packed columns on a solvent purification system. All the commercial 
chemicals are purchased from Aldrich Chemical Co. Flash chromatography was performed on 
EM silica gel 60 (230-240 mesh) unless noted otherwise.75  
 
   (2R,3S)-3-(tert-Butyldimethylsilyloxy)-2-methyl-5-phenylpentanal 
(205) To a solution of EtSH (0.095 ml, 1.30 mmol) in 5 mL THF at 0 °C, 
was added KHMDS (0.214 mL, 0.5 M in toluene, 0.107 mmol). After stirring for 5 min, a 
solution of the lactone 202 (0.204 g, 1.07 mmol) in THF (0.5 mL) was added dropwise and the 
reaction was allowed to warm to ambient temperature. The reaction was stirred for 4.5 h at 25 
°C, then cooled to 0 °C whereupon 2,6-lutidine (0.375 mL, 3.22 mmol) was added followed by 
TBSOTf (0.490 mL, 2.14 mmol). After stirring for 30 min at 0 °C, the reaction was quenched by 
adding a saturated aqueous solution of NaHCO3 (10 mL) and extracted with ether (2 x 10 mL). 
The combined organic extracts were washed with water, dried (Na2SO4) and concentrated. The 
crude oil was purified by flash chromatography (1-2% ethyl acetate in hexanes) to afford 0.393 g 
(100%) of the thioester in the form of a colorless oil.  
To a solution of the thioester (0.296 g, 0.808 mmol) in 10 mL CH2Cl2 at −78 °C, iBu2AlH 
(2.02 mL, 1.0 M in hexane, 2.02 mmol) was added dropwise. After stirring for 30 min, the 
reaction was quenched by careful dropwise addition of MeOH (10 mL). After stirring for an 
additional 20 min at −78 °C, a saturated aqueous solution of Rochelle salt (20 mL) was added. 
The resulting gel-like mixture was warmed to ambient temperature and stirred vigorously until 
two homogeneous layers separated. The organic layer was separated, dried (Na2SO4) and 
concentrated. Purification by flash chromatography (5% ethyl acetate in hexanes) afforded 0.230 
O
H
Me
OTBS
Ph
 162 
g (93%) of the title compound as colorless oil. [α]D −22.6 (c 0.84, CHCl3); IR νmaxthin film cm-1 
2953, 2930, 2857, 2709, 1726, 1603, 1459, 1458, 1362, 1254, 1102, 1034; 1H NMR (300 MHz, 
CDCl3) δ 9.78 (d, J = 0.9 Hz, 1H), 7.34-7.15 (m, 5H), 4.15 (dt, J = 6.3, 3.6 Hz, 1H), 2.76-2.63 
(m, 1H), 2.62-2.45 (m, 2H), 1.94-1.72 (m, 2H), 1.09 (d, J = 6.9 Hz, 3H), 0.89 (s, 9H), 0.09 (s, 
3H), 0.04 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 205.0, 141.6, 128.5, 128.2, 126.0, 71.8, 51.3, 
36.4, 32.1, 25.8, 18.0, 7.9, –4.2, –4.6; HRMS (ES) m/z calcd for C17H27O2Si:  291.1788; found: 
291.1780. 
 
(2S,3R)-3-(tert-Butyldimethylsilyloxy)-2-methylpentanal (79)  
To a solution of EtSH (0.390 ml, 5.26 mmol) in 20 mL THF at 0 
°C, was added KHMDS (0.877 mL, 0.5 M in toluene, 0.438 mmol). After stirring for 5 min, a 
solution of the lactone 76 (0.500 g, 4.38 mmol) in THF (2 mL) was added dropwise. The 
reaction was stirred for 3.5 h at 0 °C whereupon 2,6-lutidine (1.532 mL, 13.16 mmol) was added 
followed by TBSOTf (2.02 mL, 8.77 mmol). The reaction was warmed to ambient temperature 
and stirred for another 1 h. The reaction was quenched by adding a saturated aqueous solution of 
NaHCO3 (20 mL) and extracted with ether (2 x 10 mL). The combined organic extracts were 
washed with water, dried (Na2SO4) and concentrated. The resulting crude oil was purified by 
flash chromatography (2-3% ethyl acetate in hexanes) and the pure thioester was immediately 
carried to the next step.  
To a solution of the thioester (1.19 g, 4.10 mmol) in 20 mL CH2Cl2 at −78 °C, iBu2AlH 
(10.26 mL, 1.0 M in hexane, 10.26 mmol) was added dropwise. After stirring for 45 min, the 
reaction was quenched by careful dropwise addition of MeOH (10 mL). After stirring for an 
additional 20 min at −78 °C, a saturated aqueous solution of Rochelle salt (30 mL) was added. 
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The resulting gel-like mixture was warmed to ambient temperature and stirred vigorously until 
two homogeneous layers separated. The organic layer was separated, dried (Na2SO4) and 
concentrated. Purification by flash chromatography (2% ethyl acetate in hexanes) afforded 0.858 
g (86% over two steps) of the title compound as colorless oil. [α]D +58.5 (c 1.10, CH2Cl2); IR 
νmax
thin film cm-1 2958, 2708, 1726, 1463, 1361, 1254, 1103, 1047, 1029, 837, 775; 1H NMR (300 
MHz, CDCl3): δ 9.76 (d, J = 0.9 Hz, 1H), 4.02 (dt, J = 6.6, 3.6 Hz, 1H), 2.45 (tq, J = 6.9, 3.6, 0.9 
Hz, 1H), 1.58-1.42 (m, 1H), 1.04 (d, J = 6.9 Hz, 3H), 0.87 (t, J = 7.2 Hz, 3H), 0.84 (s, 9H), 0.05 
(s, 3H), 0.02 (s, 3H); 13C NMR (75 MHz, CDCl3): δ 205.4, 73.4, 50.8, 27.4, 25.8, 18.0, 10.1, 7.6, 
−4.2, −4.7. HRMS (EI) m/z calcd for C12H26 O2Si: 230.1702; found: 230.1691. 
 
(2R,3R)-2,4-Dimethyl-3-(trimethylsilyloxy)pent-4-enal 
(89) To a solution of EtSH (0.332 ml, 4.49 mmol) in 15 mL THF 
at 0 °C, was added KHMDS (0.748 mL, 0.5 M in toluene, 0.374 
mmol). After stirring for 5 min, a solution of the lactone 86 (0.471 g, 3.74 mmol) in THF (2 mL) 
was added dropwise. The reaction was allowed to stir for 3 h at 0 °C whereupon 2,6-lutidine 
(1.31 mL, 11.2 mmol) was added followed by TMSOTf (1.35 mL, 7.48 mmol). The reaction was 
warmed to ambient temperature and stirred for additional 3 h. The reaction was quenched by 
adding a saturated aqueous solution of NaHCO3 (20 mL) and extracted with ether (2 x 10 mL). 
The combined organic extracts were washed with water, dried (Na2SO4) and concentrated. The 
crude oil was purified by flash chromatography (1-3% ethyl acetate in hexanes) and the pure 
thioester was immediately carried to the next step.  
To a solution of the thioester (0.935 g, 3.59 mmol) in 20 mL CH2Cl2 at −78 °C, iBu2AlH 
(8.98 mL, 1.0 M in hexane, 8.98 mmol) was added dropwise. After stirring for 15 min, the 
O
H
Me
OTMS
Me
 164 
reaction was quenched by careful dropwise addition of MeOH (10 mL). After stirring for an 
additional 20 min at −78 °C, a saturated aqueous solution of Rochelle salt (30 mL) was added. 
The resulting gel-like mixture was warmed to ambient temperature and stirred vigorously until 
two homogeneous layers separated (~1 h). The organic layer was separated, dried (Na2SO4) and 
concentrated. Purification by flash chromatography (2.5% ethyl acetate in hexanes) afforded 
0.667 g (89% over two steps) of the title compound as colorless oil. [α]D +10 (c 0.23, CHCl3); IR 
νmax
thin film cm-1 2959, 2715, 1727, 1452, 1252, 1113, 1036, 872, 843, 752; 1H NMR (300 MHz, 
CDCl3): δ  9.66 (d, J = 1.8 Hz, 1H), 4.97 (s, 1H), 4.91 (s, 1H), 4.41 (d, J = 5.1 Hz, 1H), 2.54-
2.43 (m, 1H), 1.69 (s, 3H), 1.03  (d,  J = 6.6 Hz, 3H),  0.08 (s, 9H); 13C NMR (75 MHz, CDCl3): 
δ 204.5, 144.7, 112.7, 75.5, 50.0, 18.4, 8.1, −0.1; HRMS (EI) m/z calcd for C10H20O2Si: 
200.1233; found: 200.1233. 
 
(2R,3R,4S)-3-(tert-Butyldimethylsilyloxy)-4-(4-methoxybenzyloxy)-2-
methylpentanal (207) To a solution of EtSH (0.053 ml, 0.72 mmol) in 3 mL 
THF at 0 °C, was added KHMDS (0.12 mL, 0.5 M in toluene, 0.060 mmol). After stirring for 5 
min, a solution of the lactone 206 (0.15 g, 0.60 mmol) in THF (2 mL) was added dropwise and 
the reaction was allowed to warm to ambient temperature. The reaction was stirred for 3 h at 25 
°C, then cooled to 0 °C whereupon 2,6-lutidine (0.21 mL, 1.8 mmol) was added followed by 
TBSOTf (0.276 mL, 1.20 mmol). After stirring for additional 30 min at 0 °C, the reaction was 
quenched by adding a saturated aqueous solution of NaHCO3 (10 mL) and extracted with ether 
(2 x 10 mL). The organic extracts were washed with water, dried (Na2SO4) and concentrated. 
The crude oil was purified by flash chromatography (1-3% ethyl acetate in hexanes) and the 
thioester was immediately carried to the next step.  
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To a solution of the thioester in 3 mL CH2Cl2 at −78 °C, iBu2AlH (1.50 mL, 1.0 M in 
hexane, 1.50 mmol) was added dropwise. After stirring for 35 min, the reaction was quenched by 
careful dropwise addition of MeOH (5 mL). After stirring for an additional 20 min at −78 °C, a 
saturated aqueous solution of Rochelle salt (10 mL) was added. The resulting gel-like mixture 
was warmed to ambient temperature and stirred vigorously until two homogeneous layers 
separated (~1 h). The organic layer was separated, dried (Na2SO4) and concentrated. Purification 
by flash chromatography (0%- 2.5% ethyl acetate in hexanes) afforded 0.162 g (74% over two 
steps) of the title compound as colorless oil. [α]D +2.39 (c 0.67, CHCl3); IR νmaxthin film cm-1 2955, 
2933, 2857, 2708, 1725, 1612, 1513, 1463, 1302, 1250, 1104, 1035; 1H NMR (300 MHz, 
CDCl3): δ 9.69 (s, 1H), 7.23 (d, J = 8.4 Hz,  2H),  6.87 (d, J = 8.4 Hz, 2H ), 4.53 (d, J = 11.1 Hz, 
1H), 4.36 (d, J = 11.1 Hz, 1H), 4.07 (dd, J = 6.3, 3.6 Hz, 1H ), 3.80 (s, 3H), 3.44 (dq, J = 12.3, 
6.0 Hz, 1H), 2.73 (dq, J = 6.9, 3.0 Hz, 1H), 1.22 (d, J = 6.3 Hz, 3H), 1.05 (d, J = 6.9 Hz, 3H), 
0.87 (s, 9H), 0.08 (s, 3H), –0.01 (s, 3H); 13C NMR (75 MHz, CDCl3): δ 204.6, 159.2, 130.4, 
129.4, 113.8, 75.9, 74.6, 70.6, 55.2, 49.9, 25.9, 18.2, 16.3, 8.0,  –4.0, –4.2; HRMS (Q-Tof) m/z 
calcd for C20H34O4SiNa (M+ + Na): 389.2124; found: 389.2149. 
 
(R)-3-(tert-Butyldimethylsilyloxy)-5-(trimethylsilyl)pent-4-
ynal (209) To a solution of EtSH (0.106 ml, 1.43 mmol) in 5 mL 
THF at 0 °C, was added KHMDS (0.238 mL, 0.5 M in toluene, 0.119 
mmol). After stirring for 5 min, a solution of the lactone 208 (0.200 g, 1.19 mmol) in THF (2 
mL) was added dropwise. The reaction was allowed to stir for 3 h at 0 °C whereupon 2,6-lutidine 
(0.346 mL, 2.97 mmol) was added followed by TBSOTf (0.464 mL, 2.023 mmol). The reaction 
was warmed to ambient temperature and stirred for additional 1 h. The reaction was quenched by 
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adding a saturated aqueous solution of NaHCO3 (10 mL) and extracted with ether (2 x 10 mL). 
The combined organic extracts were washed with water, dried (Na2SO4) and concentrated. The 
crude oil was purified by flash chromatography (1-3% ethyl acetate in hexanes) and the thioester 
was immediately carried to the next step.  
To a solution of the thioester (0.348 g, 1.01 mmol) in 5 mL CH2Cl2 at −78 °C, iBu2AlH 
(2.52 mL, 1.0 M in hexane, 2.52 mmol) was added dropwise. After stirring for 15 min, the 
reaction was quenched by careful dropwise addition of MeOH (8 mL). After stirring for an 
additional 20 min at −78 °C, a saturated aqueous solution of Rochelle salt (15 mL) was added. 
The resulting gel-like mixture was warmed to ambient temperature and stirred vigorously until 
two homogeneous layers separated (~1 h). The organic layer was separated, dried (Na2SO4) and 
concentrated. Purification by flash chromatography (2.5% ethyl acetate in hexanes) afforded 
0.263 g (78% over two steps) of the title compound as colorless oil. [α]D +55.56 (c 0.54, CHCl3); 
IR νmax
thin film cm-1 2958, 2931, 2897, 2858, 2716, 2174, 1730, 1469, 1337, 1252, 1095, 997; 1H 
NMR (300 MHz, CDCl3): δ 9.8 (t, J = 2.4 Hz, 1H), 4.85 (dd, J = 4.8, 7.2 Hz,  1H),  2.76 (ddd, J 
= 2.4, 6.9, 16.2 Hz, 1H ), 2.64 (ddd, J = 2.1, 4.8, 16.5 Hz, 1H), 0.88 (s, 9H), 0.16 (s, 12H), 0.12 
(s, 3H); 13C NMR (75 MHz, CDCl3): δ 200.4, 105.4, 90.6, 58.7, 51.2, 25.6, 18.1, –0.3, –4.5, –
5.1; HRMS (EI) m/z calcd for C14H28O2Si2: 284.1628; found: 284.1624. 
 
        (2S,3R)-3-(tert-Butyl-dimethyl-silanyloxy)-5-(4-methoxy-
benzyloxy)-2-methyl-pentanal (211) To a solution of EtSH (0.028 ml, 
0.384 mmol) in 1.5 mL THF at 0 °C, was added KHMDS (0.064 mL, 
0.5 M in toluene, 0.032 mmol). After stirring for 5 min, a solution of the lactone 210 (0.080 g, 
0.32 mmol) in THF (0.5 mL) was added dropwise and the reaction was allowed to warm to 
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ambient temperature. The reaction was stirred for 4.5 h at 25 °C, then cooled to 0 °C whereupon 
2,6-lutidine (0.111 mL, 0.960 mmol) was added followed by TBSOTf (0.146 mL, 0.640 mmol). 
After stirring for additional 1 h at 0 °C, the reaction was quenched by adding a saturated aqueous 
solution of NaHCO3 (5 mL) and extracted with ether (2 x 5 mL). The combined organic extracts 
were washed with water, dried (Na2SO4) and concentrated. The crude oil was purified by flash 
chromatography (1-2% ethyl acetate in hexanes) and the thioester was immediately carried to the 
next step.  
To a solution of the thioester (0.123 g, 0.289 mmol) in 2 mL CH2Cl2 at −78 °C, iBu2AlH 
(0.72 mL, 1.0 M in hexane, 0.72 mmol) was added dropwise. After stirring for 30 min, the 
reaction was quenched by careful dropwise addition of MeOH (5 mL). After stirring for an 
additional 20 min at −78 °C, a saturated aqueous solution of Rochelle salt (10 mL) was added. 
The resulting gel-like mixture was warmed to ambient temperature and stirred vigorously until 
two homogeneous layers separated (~1 h). The organic layer was separated, dried (Na2SO4) and 
concentrated. Purification by flash chromatography (0-2.5% ethyl acetate in hexanes) afforded 
0.100 g (85% over two steps) of the title compound as colorless oil. [α]D +47.7 (c 1.46, CHCl3); 
IR νmax
thin film cm-1 1726, 1613, 1514, 1250, 837, 776; 1H NMR (300 MHz, CDCl3) δ 9.78 (s, 1H), 
7.26 (d, J = 8.7 Hz, 2H), 6.89 (d, J = 8.6 Hz, 2H), 4.45 (d, J = 11.5 Hz, 1H), 4.39 (d, J = 11.5 Hz, 
1H), 4.31 (ddd, J = 7.2, 5.7, 3.7 Hz, 1H), 3.82 (s, 3H), 3.49 (t, J = 5.7 Hz, 2H), 2.53-2.44 (m, 
1H), 1.82-1.77 (m, 2H), 1. 06 (d, J = 7.0 Hz, 3H), 0.87 (s, 9H), 0.072 (s, 3H), 0.047 (s, 3H); 13C 
NMR (75 MHz, CDCl3) δ 204.3, 159.0, 130.1, 129.0, 113.5, 72.4, 69.0, 65.9, 54.8, 51.3, 34.4, 
25.5, 17.7, 7.5, –4.7, –4.9; HRMS (ESI) m/z calcd for (M++Na) C20H34O4SiNa:  389.2124; 
found: 389.2114. 
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Table 3. Crystal data for 99′ 
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Identification code  bcn411 
Empirical formula  C14 H24 O5 
Formula weight  1089.33 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group  P 2(1)2(1)2(1) 
Unit cell dimensions a = 11.545(11) Å α= 90°. 
 b = 8.456(8) Å β= 90°. 
 c = 15.803(15) Å γ = 90°. 
Volume 1543(3) Å3 
Z 4 
Density (calculated) 1.172 Mg/m3 
Absorption coefficient 0.088 mm-1 
F(000) 592 
Crystal size 0.18 x 0.22 x 0.26 mm3 
Theta range for data collection 2.18 to 24.98°. 
Index ranges -13<=h<=13, -10<=k<=10, -18<=l<=18 
Reflections collected 11811 
Independent reflections 1578 [R(int) = 0.1727] 
Completeness to theta = 24.98° 100.0 %  
Absorption correction Multi-scan 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 1578 / 0 / 179 
Goodness-of-fit on F2 1.010 
Final R indices [I>2sigma(I)] R1 = 0.0605, wR2 = 0.1378 
R indices (all data) R1 = 0.1147, wR2 = 0.1551 
Extinction coefficient 0.000(2) 
Largest diff. peak and hole 0.261 and -0.199 e.Å-3 
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Table 4. Crystal data for 147a 
 
Identification code  binita2s 
Empirical formula  C15 H27 N O5 
Formula weight  301.38 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group  P2(1)2(1)2(1) 
Unit cell dimensions a = 8.006(3) Å α= 90°. 
 b = 10.545(4) Å β= 90°. 
 c = 20.371(7) Å γ = 90°. 
Volume 1719.8(10) Å3 
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Z 4 
Density (calculated) 1.164 Mg/m3 
Absorption coefficient 0.086 mm-1 
F(000) 656 
Crystal size 0.25 x 0.25 x 0.03 mm3 
Theta range for data collection 2.00 to 26.00°. 
Index ranges -9<=h<=9, -13<=k<=13, -25<=l<=25 
Reflections collected 14583 
Independent reflections 1946 [R(int) = 0.1388] 
Completeness to theta = 26.00° 100.0 %  
Absorption correction Multi-scan 
Max. and min. transmission 0.9974 and 0.9787 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 1946 / 0 / 191 
Goodness-of-fit on F2 1.000 
Final R indices [I>2sigma(I)] R1 = 0.0592, wR2 = 0.1124 
R indices (all data) R1 = 0.1092, wR2 = 0.1250 
Extinction coefficient 0.0044(15) 
Largest diff. peak and hole 0.210 and -0.265 e.Å-3 
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Table 5. Crystal  data for 176 
 
 
 
Identification code  df82208s 
Empirical formula  C14 H21 N O3 
Formula weight  251.32 
Temperature  203(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P 21 
Unit cell dimensions a = 10.009(3) Å α= 90°. 
 b = 6.8235(18) Å β= 105.554(5)°. 
 c = 10.630(3) Å γ = 90°. 
Volume 699.4(3) Å3 
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Z 2 
Density (calculated) 1.193 Mg/m3 
Absorption coefficient 0.083 mm-1 
F(000) 272 
Crystal size 0.32 x 0.18 x 0.02 mm3 
Theta range for data collection 1.99 to 32.27°. 
Index ranges -14<=h<=14, -10<=k<=9, -15<=l<=15 
Reflections collected 8690 
Independent reflections 2512 [R(int) = 0.0564] 
Completeness to theta = 30.00° 100.0 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9983 and 0.9738 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2512 / 1 / 174 
Goodness-of-fit on F2 0.963 
Final R indices [I>2sigma(I)] R1 = 0.0607, wR2 = 0.1267 
R indices (all data) R1 = 0.1144, wR2 = 0.1524 
Largest diff. peak and hole 0.255 and -0.173 e.Å-3 
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